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ABSTRACT 
Polymer chemistry is an essential connection between organic chemistry, chemical biology and 
materials science. This living world has presented us many examples of the usages of polymers, such as 
delivery vehicle, recognition unit, support materials, information storage, and so on. Scientists have been 
trying to create synthetic polymers that can mimic such functionalities and bring widespread applications 
in different fields. For all synthetic polymers, their properties and potential applications are all based on 
their chemical nature. This is especially true for synthetic polymeric materials for bio-related applications, 
because of the delicate and complicated working environments and mechanisms of such biomaterials. 
Consequently, more facile and delicate controls over the polymers’ chemical nature are in great demand, 
and bottom-up strategy for the synthesis of smart polymers have been more common in the recent decades.  
In this thesis paper, multiple bottom-up syntheses of useful polymeric materials are recorded. In 
the first part of the thesis, a new approach to prepare functional organic nanoparticles (ONPs) from linear 
polymers is described. The nanoparticles were obtained by consecutive ring-opening metathesis 
polymerization and ring-closing metathesis. This flexible and mild synthesis allowed preparation of 
organic- and aqueous-soluble particles with controllable size and narrow molecular weight distributions. 
The use of functional monomer(s) and/or chain-transfer agents had led to controllable synthesis of 
nanoparticles containing single, dual, or multiple reactive functional groups. Such non-toxic ONPs with 
controllable functionalities could be used to study the effect of surface functional groups on the cellular 
uptake of corresponding nanoparticles. In addition, dye-functionalized ONPs could serve as water-soluble 
fluorophores with highly enhanced photostability. Moreover, other functional materials such as DNAs 
could be conjugated onto the ONPs, bringing in new hybrid materials with applications. The ONPs and 
ONP-DNA conjugates could also serve as templates for the synthesis of metal nanoparticles, providing a 
direct and facile synthetic route for functional metal nanoparticles. 
In the second part of this paper, major focus is set on a polymeric approach to enhance the 
efficacy of toxic r(CUG)n-binding compounds for potential Myotonic Dystrophy Type I (DM1) treatment. 
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Also using a bottom-up living polymerization strategy, cell-penetrating polymers bearing active r(CUG)n 
binding ligands are prepared. The synthetic polypeptide binder was shown to have excellent performance 
in both molecular and cell studies, giving much enhanced binding to the toxic RNA. The ligand-
polypeptide conjugates could successfully disperse ribonuclear foci caused by r(CUG)n-MBNL1 complex, 
and could fully reverse the mis-splicing of Insulin receptor (IR) mRNAs in the model cells. In addition, 
potentially due to the polymer-mediated catalytic degradation, r(CUG)n level in the model cells could be 
greatly reduce by low concentration treatment of the ligand-bearing polymeric material. 
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PART 1 
SYNTHESIS AND APPLICATION OF SINGLE-CHAIN ORGANIC 
NANOPARTICLES FROM CONSECUTIVE RING-OPENING 
METATHESIS POLYMERIZATION AND RING-CLOSING METATHESIS  
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Chapter 1 
INTRODUCTION 
 
Part of this chapter is adapted from the following publications: 
1. Yugang Bai, Hang Xing, Gretchen A. Vincil, Jennifer Lee, Essence J. Henderson, Yi Lu, N. 
Gabriel Lemcoff and Steven C. Zimmerman, Practical synthesis of water-soluble organic 
nanoparticles with a single reactive group and a functional carrier scaffold. Chem. Sci. 2014, 5, 
2862-2868. 
2. Yugang Bai, Hua Lu, Ettigounder Ponnusamy and Jianjun Cheng, Synthesis of hybrid block 
copolymers via integrated ring-opening metathesis polymerization and polymerization of NCA. 
Chem. Commun. 2011, 47, 10830-10832. 
 
1.1. Introduction to nanoparticles 
Nanomaterials have been a major research focus of chemistry and materials science in the 
past decade. Such novel materials are often referred to as the “next-generation materials” in 
many areas, such as catalysis, targeted delivery, photonics, bioimaging, detection and diagnostics, 
and therapy.
1-4  The small size and variable shape brings nanomaterials many unique properties. 
For example, their high surface area to volume ratio,
5
 lattice defects,
6
 plasmonic properties,
7
 
stable fluorescence,
8
 enhanced permeation and retention (EPR) effect,
9
 can all find multiple 
usefulness in different areas. Combined with their variable chemical nature and post-
functionalization capabilities, these nanomaterials can provide almost infinite possibilities.  
3 
 
Both organic and inorganic nanoparticles are among the most widely used nanomaterials 
because of their simple synthesis, variable chemical nature, facile surface modification, and 
tunable cytotoxicity/biocompatibility.
10-15
 Organic nanoparticles (ONPs) are usually prepared 
from polymers using various methods. Considerable attention has focused on “top-down” 
approaches to prepare smaller ONPs in the 5 to 50 nm range, which are more suitable for 
photonic and biological applications. These methods include the use of microfluidics, laser 
ablation, solvent evaporation, nanoprecipitation, emulsion polymerization to afford smaller and 
more uniform ONPs.
16-17
 The organic nature of ONPs also offers unique synthetic strategies that 
allow “bottom-up” approaches. For example, single-chain ONPs have been prepared by the 
intramolecular crosslinking of functional polymers.
18
 In general, ONPs typically provide more 
pathways for functionalization and post-functionalization because of their organic nature. They 
can also be very precisely tailored through these “bottom-up” synthetic strategies. Moreover, the 
degradability offered by certain polymers may grant additional usefulness to such materials.
19-20
  
Inorganic nanoparticles are also variable in their compositions and structures, and their 
bulk chemical nature tends to give dominant influence on their properties and applications. For 
example, gold and silver nanoparticles (AuNPs and AgNPs) are especially common in 
nanoparticle application on cellular analysis, due to their excellent plasmonic properties.
21-22
 
Silica nanoparticles (SiO2NPs) are widely known for their precise and simple size control during 
synthesis.
23
 Such NPs exhibit excellent biocompatibility and allow facile cargo loading. As a 
result, they have been used extensively in bioimaging and drug delivery fields.
24
 Quantum dots 
(QD) have also attracted much attention and interests in the recent years. Because of their 
fluorescence stability, highly tunable optical properties and narrow emission range, these 
semiconducting nanocrystals are well suited for the high resolution imaging of cells,
25-26
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although their toxicity and functionalization remains problematic. It is worth noting that carbon 
based nanomaterials such as fullerenes, carbon nanotubes, graphene and graphene oxides have 
all found applications in bio-related fields.
27-29
 Moreover, hybrid materials that contain both 
inorganic and organic nature have been extensively studied and used, such as Janus nanoparticles, 
AuNP-DNA conjugates, and metallo-organic nanoparticles.
30-31
 
 
1.2. Ring-opening metathesis polymerization 
As a relatively new technique in the field of polymer science, ring-opening metathesis 
polymerization (ROMP) has been recognized as a powerful tool to tailor macromolecules with 
diverse functionalities.
32
 Similar to other living polymerization techniques, living ROMP is a 
chain-growth polymerization process.
33
 In a typical ROMP process, a mixture of cyclic olefins 
reacts with the initiators or active polymer chain-ends to be converted into polymeric materials. 
The mechanism of the polymerization is shown in Scheme 1.1.  
 
 
Scheme 1.1. Illustration of the mechanism of typical ROMP chain-propagation process. 
 
In short, the initiation starts as the catalyst, which is a transition metal alkylidene 
complex, is coordinated with the monomeric cyclic olefin. The coordination results in a [2+2]-
cycloaddition reaction, affording a substituted, meta-stable metallacyclobutane. The reverse 
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[2+2]-reaction then takes place, giving a new metal alkylidene with the ring-opening of the 
involved cyclic olefin. This new metal alkylidene then reacts with more cyclic olefins to elongate 
itself, gradually forming a polymeric material.
34
 The driving force of the polymerization is 
usually the release of ring-strain in the cyclic olefins, such as norbornene and cyclooctadiene, 
which are the most commonly used ROMP monomers. Other monomers include cyclobutene, 
cyclopentene and trans-cyclooctene (Figure 1.1). All these cyclic olefins possess a high strain 
energy ( > 20 kJ/mol), which drives the polymerization process to go forward. 
 
 
Figure 1.1. Structure of some useful ROMP monomers for functional polyolefin synthesis. 
 
Major advantages of living ROMP technique using Grubbs catalysts include precise 
molecular weight control, high tolerance of air, water and many functional groups, low 
polydispersity, as well as unsaturated nature of the yielded polymers. This is especially true for 
the polymerization of nobornenyl derivatives mediated by the Grubbs 3
rd
 generation catalyst.
35
 
The ability of these ruthenium catalysts to react with terminal olefins also provides a convenient 
method for functionalizing the terminal sites of polymer chains. For example, end-functionalized 
polymers using Grubbs 3
rd
 generation catalyst can be achieved by adding functionalized vinyl 
ethers, vinyl lactones or symmetrical cis-alkenes, effectively installing a pre-defined functional 
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group on the growing end of the polymer chain.
35-41
 Re-forming and re-using the functionalized 
initiator for new batches of polymerization can even be possible in the case of cis-alkenes, 
leading to a very economical strategy to prepare functionalized polyolefins.
42
 
  
1.3. Copolymers as useful biomaterials 
 Copolymers can contain segments with distinct structures and properties, and are thus 
useful materials in various fields such as novel plastics development, polymeric catalysis, 
preparation of smart materials, macromolecular self-assembly, and bionanotechnology.
43-45
 
Copolymers include (but are not limited to) random copolymers, block copolymers, and hybrid 
copolymers. They can be prepared through copolymerization, conjugation of different polymeric 
segments, or sequential polymerization with the use of corresponding initiators, terminating 
agents (TAs) or chain-transfer agents (CTAs). These approaches offer different advantages, and 
at the same time, have certain disadvantages. For example, copolymerization is straightforward 
and easily-controlled when living polymerization techniques are applied, but such 
polymerizations are usually limited to the usage of the same monomer type. Conjugation of 
polymeric segments offers the opportunity to synthesize parts of the final products separately, 
and thus allows diverse combinations of materials of different types, yet the reaction between 
two or more macromolecules can be very difficult because of the steric effect. The last approach 
can be attractive as the hybrid polymers with tunable molecular weights and low polydispersity 
indices (PDIs) of each block may be readily achieved via controlled polymerizations. In parallel 
to the studies of utilizing AB-type dual initiator to facilitate two distinct, controlled 
polymerizations from the initiators A and B of the same center, there are also significant interests 
in preparing linear hybrid copolymers via controlled, sequential polymerizations, using a mono-
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initiator for the synthesis of the first polymeric block followed by transformation of the active 
chain-end of the resulting first block to an active site of a macromolecular initiator using CTA or 
TA, enabling the synthesis of a second polymer block. Scheme 1.2 shows a typical example of 
such strategy, by which polynorbornene-polypeptide block copolymers can be synthesized 
through sequential living polymerizations.
46
 
 
 
Scheme 1.2. Illustration on a synthetic strategy of polyolefin-polypeptide copolymers using 
chain-transfer agent mediated functionalization. 
 
 
1.4. Terms and abbreviations 
Grubbs 1
st
 generation catalyst: Benzylidene-bis(tricyclohexylphosphine)dichlororuthenium, 
also named as bis(tricyclohexylphosphine)benzylidine ruthenium(IV) dichloride, CAS No. 
172222-30-9. 
8 
 
Grubbs 2
nd
 generation catalyst: (1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)-
dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium, CAS No. 246047-72-3. 
Pyridine-modified Grubbs 2
nd
 generation catalyst, also referred as Grubbs 3
rd
 generation 
catalyst: Dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene](benzylidene)bis(pyri-
dine)ruthenium(II), synthesized from Grubbs 2
nd
 generation catalyst and pyridine. 
ROMP: Ring-opening metathesis polymerization. 
RCM: Ring-closing metathesis. 
PGD: Polyglycerol dendron. 
EDC: N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide, peptide coupling reagent, CAS No. 
1892-57-5. Its hydrochloride salt (EDC·HCl, CAS No. 25952-53-8) is usually employed. 
Trolox: (±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid, CAS No. 53188-07-1. 
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CHAPTER 2 
SYNTHESIS OF SINGLE-CHAIN ORGANIC NANOPARTICLES 
BY RING-OPENING METATHESIS POLYMERIZATION  
AND RING-CLOSING METATHESIS 
 
Part of this chapter is adapted from the following publication:  
1. Yugang Bai, Hang Xing, Gretchen A. Vincil, Jennifer Lee, Essence J. Henderson, Yi Lu, N. 
Gabriel Lemcoff and Steven C. Zimmerman, Practical synthesis of water-soluble organic 
nanoparticles with a single reactive group and a functional carrier scaffold. Chem. Sci. 2014, 5, 
2862-2868. 
Collaboration and contribution statement: 
The TEM characterization and cell uptake study were performed in collaboration with Hang 
Xing. The cytotoxicity study was performed in collaboration with Essence J. Henderson. The 
ONP’s Large-scale synthesis trial was performed in collaboration with Gretchen A. Vincil. 
 
2.1. Introduction 
Although the term of organic nanoparticle (ONP) may be a concept without a strict 
definition in the literature, any nanoscale structures that have relatively fixed architectures and 
shapes, and consist mostly of carbon and hydrogen atoms, can be recognized as ONPs. 
Dendrimers, hyperbranched polymers, as well as organic nanocrystals, are typically classified as 
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ONPs, although the broadest definition of ONPs could include nanoscale biomolecules such as 
enzymes, proteins, and chromosomes. As an ongoing effort to better utilizing artificial polymeric 
biomaterials, the usefulness of dendrimers and hyperbranched polymers as ONPs has been 
revealed in many cases of recent years.
1-3
 These single-molecule ONPs have been synthesized 
using various strategies and utilized in different ways, such as drug delivery, gene delivery, 
4
 
catalysis
5
 and bioimaging.
6
 However, the repetitive steps and long time in the synthesis of 
monodisperse dendrimers is universally acknowledged, especially for large ONPs; whereas the 
relatively convenient hyperbranched polymerization technique usually gives polymers with high 
polydispersity indices (PDIs) and unpredictable molecular weights.
7-8
 On the other hand, a minor 
strategy for ONP synthesis involves intramolecular crosslinking of linear polymers.
9-13
 The 
strategy does provide a fast and controlled route for ONPs of different sizes, but it usually lacks 
efficient pathways for functionalization, therefore effective application of such materials have 
been very limited. 
Living ring-opening metathesis polymerization (ROMP) of norbornenyl derivatives, 
catalyzed by a pyridine-modified Grubbs 2
nd
 generation catalyst, is one of the most commonly 
used living polymerization techniques because of the excellent functional group tolerance, 
narrow molecular weight distribution and highly-controllable molecular weight it could offer. 
14-
15
 It is also unique among all the polymerization strategies that a ROMP polymer is always 
highly unsaturated and contains a large amount of alkene functionalities, which could possibly be 
used for post-functionalization. Synthesis of crosslinked glycerol dendrimers was previously 
reported by the Zimmerman group.
16
 In that work, ring-closing metathesis (RCM) reactions were 
limited to take place only intramolecularly, and consequently, denser and monodisperse 
dendrimers were obtained, which could be further dihydroxylated to grant water solubility. 
16 
 
Based the previous work, I designed and optimized an integrated ROMP-RCM process to 
generate unique polymeric materials, which can benefit from advantageous characteristics of 
both techniques. 
Key to this strategy is the ROMP of functionalized norbornene dicarboximides 1, 
catalyzed by pyridine-modified Grubbs catalyst 2 (Scheme 2.1). As was previously reported, this 
catalyst is highly tolerant, allowing a wide range of functionalities to be placed on the ONP 
scaffold.  At the same time, precise control over chain length and polydispersity is provided, as 
well as straightforward chain-end functionalization using chain-transfer agents (CTAs). 
Importantly, the high alkene content of the polymers from such a ROMP-RCM process allows 
dihydroxylation, yielding non-ionic, hydrophilic ONPs with high aqueous solubility. The outline 
of this ONP synthesis is illustrated in Scheme 2.1. 
 
Scheme 2.1. Synthesis of organic nanoparticles (ONPs) using a sequential ROMP and RCM 
process.  Py = pyridine, Mes = 2,4,6-trimethylphenyl, OSu = N-hydroxysuccinimidyl ester. 
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2.2. Synthesis of essential monomers and chain-transfer agents 
 For ROMP of norbornenyl derivatives, endo- and exo- monomers each have their own 
advantages and disadvantages. Endo-monomers are generally more readily available, as endo-
carbic anhydride is the sole product of the Diels-Alder reaction between cyclopentadiene and 
maleic anhydride at low temperature. Endo-norbornene dicarboximides are typically much easier 
to crystallize, and many endo-monomers can be purified by recrystallization. However, endo-
monomers have a much slower polymerization rate, meaning that the polymerization must be 
performed in oxygen-free conditions, either in a degassed Schlenk tube or in a glove box. On the 
contrary, synthesis of exo-monomers requires the preparation of exo-carbic anhydride. Most exo-
norbornene dicarboximides can only purified via column chromatography because they do not 
crystallize easily. In comparison, the polymerization of exo-monomers is extremely fast, 
reaching completion in 3-10 min, depending on the degree of polymerization. Such a fast 
reaction allows the polymerization reaction to be performed under air, because the alkene 
metathesis is several magnitudes faster compared to the coordination of molecular oxygen with 
the ruthenium complex. In addition, polymers from endo-monomers and exo-monomers have 
different cis/trans ratio of their backbone alkenes, although this hardly affects the materials’ 
application. Albeit all these differences, both endo- and exo- monomer can be polymerized 
reliably and controllably, yielding high-quality polymers with pre-defined molecular weights and 
monomer ratios. For all the work described in this chapter (Part 1, Chapter 2), only endo-
monomers were synthesized and used. 
Chain-transfer agents (CTAs) can also be applied in both cases, giving end-functionalized 
polynorbornenes. In typical syntheses, a functionalized symmetrical cis-alkene is used as CTA
17-
19
 and is added at the end of the polymerization process. Due to the living nature of ROMP, the 
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polymer chains all have an active propagation site, which is a ruthenium complex derived from 
Grubbs catalyst. This active site can also do cross-metathesis with the CTA, forming a new small 
molecule ruthenium complex and installing half of the CTA on the polymer chain-end. The 
functionalization usually takes 2-3 h with nearly 100% efficiency. Similarly, a CTA can also be 
mixed with the catalyst before polymerization to generate a functionalized initiator in situ, and 
this technique will be used in later chapters for the preparation of dual-functionalized polymers. 
 
2.3. Polymerization and CTA-mediated functionalization 
The polymerization reactions can be performed outside the glove box, although it takes 
some time to thoroughly remove all the oxygen in the reaction vessel. Multiple freeze-pump-
thaw cycles (usually 3 times) are needed if the reactions are conducted outside the glove box. All 
the monomers should be accurately weighed, as their weight ratio (thus the molar ratio) will 
precisely determine the final composition of the resulting polymers. For ROMP of typical 
norbornenyl derivatives whose side chains are not too bulky, and do not coordinate/ react with 
the catalyst, monomers can usually reach > 99% conversion given enough time. Because of the 
high reactivity of the monomer, the resulting polymers are with random monomer sequences, 
and their loading is the same as their monomer feed ratio. The control over the molecular weight 
is largely determined by the accuracy with which the monomers and catalyst can be weighed (i.e., 
the monomer to initiator ratio). Absolute molecular weights of the polymers were measured by 
multi-angle laser light scattering technique (MALLS). The difference between experimental 
molecular weight and expected molecular weight is usually within the error range of the 
instruments and mathematical model used for calculation (5% - 10%). 
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The living nature of the ROMP process allows the use of a CTA to react with the active 
polymer propagation site, which is a metal complex on the growing chain-end. This reaction will 
cap the end of the polymer chain directly, producing a monovalent polymer with a single reactive 
group on one of the chain-end (Scheme 2.2). The chain-transfer step is less sensitive to air, and it 
can be performed without strict degassing. If the polymerization is carried out in a degassed 
reaction vessel, an additional degassing step is not needed after the addition of CTA solution into 
the vessel. Keeping the vessel or vial capped is enough for the chain-transfer functionalization. It 
is worth mentioning that the chain-transfer step is not mandatory for the polymerization as it is 
only used for functionalizing the polymer chain-ends. Polymerization procedures with or without 
CTA are both provided in the experimental section. 
 
 
Scheme 2.2. Schematic illustration of the functionalization of ROMP polymer using a pre-
functionalized chain-transfer agent. 
 
Initial efforts were made to examine whether a tandem ROMP-RCM process using 
monomer 1 with pendant alkene moieties is possible. This single step approach to ONPs is 
appealing; however, despite investigating multiple monomers with different types of alkene 
groups, either the ROMP or RCM step was problematic due to cross-reactivity. As outlined in 
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Scheme 2.1, a sequential process, wherein the alkene groups for RCM are added in a second step, 
was developed to bypass the possibility of cross-reactivity.  Thus, each ROMP was carried out 
with monomer 1a carrying an activated ester and a co-monomer, initially 1b.  The ROMP 
proceeded smoothly to give the corresponding poly(endo-norbornenes) 3 with low polydispersity 
indices (PDIs) and a range of molecular weights that could be readily controlled by setting the 
initiator to monomer ratio (Table 2.1). Treatment of 3 with tri-O-allyl-Tris (4) afforded polymer 
5 displaying a large number of allyl groups along its backbone.  The 
1
H NMR of 5 (Figure 2.1a) 
showed a complete absence of the succinimidyl group indicating that within the detection limit 
of NMR, the activated esters were fully converted to the amide. Nitrobenzene was used as a co-
solvent in the amidation reaction to suppress radical mediated cross-linking of the allyl groups,
20
 
which was previously observed with allylated polyglycerol dendrimers.
16, 21  Instrument setup, 
 
Table 2.1. Representative characterization data for polymers synthesized in this chapter. 
[a] Molar ratio of 1a/comonomer (1x, x can be b-g)/2, see Scheme 2.1. [b] Absolute number-average 
molecular weight determined by a GPC with a multi-angle laser light scattering (MALLS) detector. [c] 
Not determined. [d] Interference of fluorescence in MALLS detection prevented absolute molecular 
weight determination, but polystyrene calibration gave similar “molecular weight shrinking” compared to 
other entries. [e] Polydispersity was calculated by Breeze 2 software from Waters Corporation based on 
RI data and traditional polystyrene calibration method. 
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Figure 2.1. (a) Partial 
1
H NMR spectra of 4 (top) and 7 (bottom) showing loss of terminal alkene 
(red box). Residual solvent peaks are diethyl ether and dichloromethane; (b) Overlaid GPC 
curves of polymers 3, 5, and 7 (DMF, 0.1 M LiBr, eluent).  Both (a) and (b) are of polymers 
prepared in entry 1, Table 2.1. 
 
materials and synthetic details of the above steps can be found in the experimental section of this 
chapter. 
 
2.4. Intramolecular crosslinking 
 The keys for a successful intramolecular crosslinking were found to be: 1) a suitable 
crosslinking reaction with appropriate reactivity & selectivity, and 2) low polymer concentration 
during reaction. The ruthenium-mediated RCM reaction is an ideal choice for effecting 
intramolecular crosslinking, because of the inherent selectivity of the ruthenium complex that 
favors intramolecular reactions. This preference is even observed in small molecule synthesis. It 
is possibly because that the reaction requires a metal center with two coordinated alkene 
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substrates, and intermolecular reactions in this scenario would require two large macromolecules 
to be brought together around the metal center. On the negative side, low concentrations were 
needed for all the crosslinking examples described in this chapter, and this makes scale-up of the 
preparation difficult. Nonetheless, gram-scale syntheses of the ONPs were possible. Considering 
the very small dosage commonly needed for bio-related applications of NPs, this gram-scale of 
ONP synthesis is deemed satisfactory. 
The intramolecular crosslinking (RCM) of 5 was effected using 1
st
 generation Grubbs 
catalyst (6), whose lower reactivity avoided intermolecular metathesis during work-up.
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Evidence for fully cross-linked ONPs was readily observed in the 
1
H NMR. Thus, the terminal 
alkene CH groups that appear between δ 5.0-5.5 ppm in 5 are replaced by a broad peak at δ 5.7 
ppm in the spectrum of 7, consistent with the formation of 1,2-disubstituted alkene groups (see 
Figure 2.1a). The GPC analysis also indicated extensive intramolecular cross-linking.  Thus, 
whereas the conversion of 3 to 5 gave a small shift to a shorter retention time consistent with an 
increase in size, the RCM product 7 gave a single peak that eluted significantly later (Figure 
2.1b). The molecular weight of 7 determined by conventional calibration gave much smaller 
values than expected for loss of ethylene units from 5, reflecting its collapsed, cross-linked 
structure. In contrast, multi-angle laser light scattering (MALLS) detection gave a more accurate 
assessment of the actual molecular weight of the polymers; thus the Mn value for 7 was found 
typically only about 1-4% lower than the Mn obtained for 5 (Table 2.1). The resulting ONP are 
generally very soluble in common organic solvents. 
It is worth noting that intramolecularly crosslinked polymers may not be suitable for 
MALLS analysis for absolute molecular weights, because they are no longer linear and light 
scattering theory is based on free-moving linear polymers. This is especially true for smaller 
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ONPs, and is more obvious on MALLS detectors with fewer light angles, such as a 3-angle 
miniDAWN TREOS. In this chapter, MALLS detection was performed using a DAWN 
HELEOS 18-angle detector, an instrument that was able to give meaningful results on larger 
ONPs. 
 
2.5. Dihydroxylation and hydrolysis 
In an effort to render these ONPs water-soluble, monomers 1c and 1d were synthesized 
and used in the copolymerization with 1a. These two new monomers formed polymer 5 and ONP 
7 in the same manner as 1b did, showing the versatility of the synthetic strategy. The large 
number of alkene groups in 7, arising from both the ROMP and RCM steps, allowed use of 
dihydroxylation chemistry to prepare water-soluble ONP. Using the Upjohn conditions, i.e., N-
methylmorpholine N-oxide (NMO) and K2OsO4 in acetone-water at room temperature,
16, 21
 led to 
ONP that were fully soluble in water but not in organic solvents, including DMF and DMSO  
 
Figure 2.2. (a) Dihydroxylation protocol to generate water-soluble ONPs;  (b) Gram-scale 
preparation of ONP 8 containing a monomer to initiator ratio of 1a:1d:1f:2 = 100:50:4:1. Note: 
exo-norbornene monomers used in gram-scale prep. Gram-scale preparation was performed by 
Gretchen A. Vincil. 
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Figure 2.3. 
1
H NMR spectrum of water-soluble ONP (dihydroxylated Entry 5, ONP 7 of Table 
2.1) in D2O. PDI was not seen in the spectrum presumably because its peaks were too small and 
broad. The presence of the PDI moieties in the polymer was observed by fluorescence of the aq. 
solution under UV irradiation (upper right), which did not diminish during dialysis.  
 
(Figure 2.2a). The ONP containing monomer 1d was hydrolyzed in aqueous hydrochloric acid to 
provide additional diol units. In each case, the 
1
H NMR spectrum in D2O revealed complete 
disappearance of the alkene peaks, indicating complete oxidation of the double bonds (Figure 2.3) 
 
2.6. Control over size, valence and functionality 
 To determine the shape of the ONPs prepared in this study and provide direct information 
about their sizes, transmission electron microscopy (TEM) was performed on three separate 
batches of ONPs 8 prepared with different sizes.  The polymers were prepared using monomer to 
initiator ratios for 1a:1d:2 = 100:200:1, 50:100:1, and 10:20:1, giving GPC determined absolute 
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molecular weights of 102, 53, and 12 kDa respectively.  As seen in Figure 2.4, the ONP are 
roughly spherical with diameters ranging from ca. 5-10 nm up to ca. 50 nm. Additional 
characterization using dynamic light scattering (DLS) technique also afforded results consistent 
with TEM characterization (Figure 2.5). 
 
Figure 2.4. Selected TEM images of water-soluble ONPs of different sizes.  The polymer Mn 
values are (a) 102 kDa, (b) 53 kDa, and (c) 12 kDa.  
 
Figure 2.5. DLS analysis of 52 kDa dihydroxylated organic nanoparticles. 
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Scheme 2.3. Schematic illustration of the synthesis of monovalent ONPs using CTAs, and 
further functionalization pathways using RCM or facile bioconjugation reactions. 
 
The copolymerization approach described above with functional monomers such as 1e 
and 1f and subsequent cross-linking and dihydroxylation smoothly produced a wide range of 
ONPs with multiple hydroxyl groups on their surfaces and interiors. This same "bottom-up" 
approach appeared to offer a special opportunity to install a single, uniquely reactive functional 
moiety onto the nanoparticle. The general strategy used is shown in the preparation of ONPs 7 
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and 8. As described in Section 2.3, the living nature of the ROMP process allows the use of a 
CTA to cap the end of the polymer chain directly, producing a monovalent ONP (Scheme 2.3). 
The mono-functionalization was confirmed by 
1
H NMR analysis prior to the RCM-mediated 
cross-linking. To demonstrate the reactivity and accessibility of the functional group of the 
monovalent ONP, a 21.8 kDa ONP, 7 (entry 4, Table 2.1) prepared using CTA-2 (9b) was 
successfully conjugated to a 10 kDa thiol-functionalized mPEG.  
Beyond its use in RCM reactions, Grubbs catalyst 6 is able to mediate olefin cross-
metathesis.
22
 Because a common catalyst is used for these two processes, it suggested the 
possibility of integrating in new functionality during the cross-linking process (i.e., RCM of 5 to 
7).  To test this possibility, perylenediimide 10 was prepared from allylamine and 1,6,7,12-
tetrachloroperylene-3,4,9,10-tetracarboxylic acid dianhydride and was added into the reaction 
mixture during intramolecular crosslinking. The resultant perylenedimide-containing polymer 7 
(entry 5, Table 2.1) was fluorescent and exhibited a low PDI. The GPC trace from the UV 
detector showed a peak with an identical shape and elution time to that from the RI detector. 
Fluorescent polymer 7 underwent dihydroxylation using the conditions in Figure 2.2, yielding 
water-soluble, fluorescent ONP 8 after purification via dialysis (see Figure 2.3). 
Various functional groups can also be incorporated into the ONPs at the monomer stage. 
Although the exact number of a certain functional group per ONP cannot be controlled in this 
way, the average number of the desired moieties can be precisely controlled by tuning the 
monomer to initiator (M/I) ratio. As an example, fluorescein monomer 1g was synthesized and 
incorporated into the ONP by copolymerization in the first step. The calculated loading of 
fluorescein was set to be 1-6 based on the M/I ratio, and the six resulting ONPs showed a linear 
relationship between their fluorescence intensities and the calculated loading per ONP (Figure 
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2.6). This example provided support for the notion that the incorporation of monomers in the 
ROMP can be extremely regular and predictable. The usefulness of this feature will be 
highlighted in the next chapter. 
 
 
Figure 2.6. Accurate tuning of ONP fluorescence intensity by adjusting the equivalents of 
fluorescein monomer 1g during ROMP. 
 
2.7. Cell uptake and cytotoxicity 
 With the help of my collaborators, I was able to investigate the ONP’s ability to enter live 
HeLa cells (human cervical canceras). This is very important for such a material to serve as a 
nanoscale delivery and imaging system for potential intracellular theranostic applications (Figure 
2.7a). Fluorescein ONPs (1a:1d:1g ratio = 10:20:4, ca. 12 kDa) were synthesized and incubated 
with HeLa cells for 6 h before further characterization. As shown in Figure 2.7b-f, HeLa cells 
treated with ONPs exhibited bright green fluorescence inside cells under confocal microscope, 
indicating the significant internalization of ONPs. To study the intracellular distribution of ONPs, 
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LysoTracker red was used to stain the lysosomes of HeLa cells. The co-localization of 
fluorescence from ONPs and LysoTracker demonstrate that the ONPs are mainly transported to 
the lysosomes of HeLa cells, suggesting a receptor-mediated endocytosis process. To further 
ensure that the observations through confocal microscope apply to whole cell population, 
quantitative fluorescence analysis for whole cell population was examined using flow cytometry 
 
 
Figure 2.7. (a) Schematic view of the 12 kDa fluorescent ONPs entering HeLa cells. (b-f) 
Confocal microscopy images of HeLa cells treated with 12 kDa fluorescent ONPs: (b) brightfield 
image of cells; (c) blue channel image showing nucleus staining with DAPI; (d) red channel 
image showing LysoTracker red staining; (e) fluorescein ﬂuorescence from ONPs; (f) overlay of 
nucleus, LysoTracker red and ONP ﬂuorescence; (g) the cell-associated fluorescence intensities 
of HeLa cells (grey) and fluorescent ONPs (green) treated HeLa cells using flow cytometry. 
Confocal microscopy and flow cytometry studies were performed by Peiwen Wu, and the data 
was analyzed together with Hang Xing. 
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for HeLa cell samples with or without ONP treatment. The result shows that HeLa cells treated 
with green fluorescent ONPs had a more than two-fold higher level of ﬂuorescence than 
untreated cells (Figure 2.7g), which is consistent with the observations under a confocal 
microscope, confirming the uptake of ONPs. The excellent photostability and cellular uptake 
features of these ONPs, as demonstrated in the above example, have shown significant potential 
for applications of bioimaging and continuous tracking of living cells. 
 
Figure 2.8. Results of MTT toxicity study of the organic nanoparticles (10 µM) of different 
molecular weights.  The y-axis shows% cell viability. This cytotoxicity study was performed by 
Essence J. Henderson, guided by Dawn Ernenwein and me. 
 
One potential concern given the heavy metal-containing reagents used in the synthesis of 
ONP 8 is the presence of residual osmium and ruthenium.  Indeed, the ICP analysis showed 
significant levels of both. Preliminary studies showed that treating solutions of 8 with a 
polyvinylpyridine-based resin such as Smopex-105 reduced the metal ion contamination to parts 
per million levels.  Even before treatment with the coordinating resin, ONP 8 ranging from ca. 
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10 - 100 kDa exhibited MTT HeLa cell viabilities of ≥ 80% at a concentration of 10 µM (See 
Figure 2.8). 
 
2.8. Experimental section 
Instrumentation. NMR spectra were recorded using a Varian U400, UI400, U500 or 
VXR500 spectrometer in the NMR Laboratory, School of Chemical Science, University of 
Illinois. The data was processed in MestReC v4.8.1.1. Some spectra were treated with the 
smoothing function of the software to obtain a better baseline. NMR images were screenshots 
taken from MestReC and aligned/annotated in Adobe Photoshop CS4 (Figure 7.2a) or Microsoft 
Paint of Windows 7. Mass spectral analyses were provided by the Mass Spectrometry Laboratory, 
School of Chemical Science, University of Illinois, using ESI on a Waters Micromass Q-Tof 
spectrometer, FD on a Waters 70-VSE spectrometer, or MALDI-TOF on a Bruker 
UltrafleXtreme spectrometer. Analytical LC-MS experiments were conducted on an Agilent 
1100 LC/MSD Trap XCT Plus in the Metabolomics Lab, Roy J. Carver Biotechnology Center, 
University of Illinois. Analytical gel permeation chromatography (GPC) experiments without 
MALLS detection were performed on a Waters system equipped with an Waters 1515 isocratic 
pump, a Waters 2414 refractive index detector, and a Waters 2998 photodiode array detector. 
Separations were performed at 50 °C using DMF containing 0.1 M LiBr as the mobile phase. 
Relative molecular weights and PDIs were calculated by Breeze 2 software from Waters 
Corporation, based on conventional calibration method. For Chapter 2 of Part 1, absolute 
molecular weight analyses were conducted on a GPC system equipped with an isocratic pump 
(Model 1100, Agilent Technology, Santa Clara, CA, USA), a DAWN HELEOS 18-angle laser 
light scattering detector, a multi-angle laser light scattering (MALLS) detector, (Wyatt 
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Technology) and an Optilab rEX refractive index detector (Wyatt Technology). The detection 
wavelength of HELEOS was set at 658 nm. Separations were performed at 60 °C using DMF 
containing 0.1 M LiBr as the mobile phase. For all other chapters, absolute molecular weight 
analyses were conducted on a Waters system equipped with an Waters 1515 isocratic pump, a 
Waters 2414 refractive index detector, a Waters 2998 photodiode array detector, and a 
miniDAWN TREOS 3-angle MALLS detector. Separations were performed at 60 °C using DMF 
containing 0.1 M LiBr as the mobile phase. For all the GPC-MALLS studies, the MALLS 
detector was calibrated using pure toluene and used for the determination of the absolute 
molecular weights. The molecular weights of all polymers were determined based on the dn/dc 
value of each sample calculated offline by using the internal calibration system processed by the 
ASTRA software (Wyatt Technology).  DLS analysis was performed on a Brookhaven Zeta 
PALS instrument. Circular dichroism (CD) results were obtained on a JASCO J-815 CD 
spectrometer (JASCO, Easton, MD, USA). UV-vis spectrometry was performed on a Hewlett–
Packard 8453 or Shimadzu UV-2501PC spectrophotometer. Fluorescence study was performed 
on a Horiba FluoroMax-4 spectrofluorometer. GPC, HPLC, DLS, UV-vis, fluorescence and CD 
data points were exported as ASCII files, re-imported into OriginPro 8 or Excel, plotted, copied 
as vector image files (*.ai) and colored/annotated in Adobe Illustrator CS6. TEM images were 
collected with a JEOL 2100 Cryo transmission electron microscope. Negative staining of 
polymer nanoparticles with ammonium molybdate was applied when preparing TEM samples to 
achieve better contrast if necessary. Samples were prepared by drop casting polymer 
nanoparticle and ammonium molybdate mixture solutions onto a carbon-coated copper TEM grid 
or a silicon wafer (Ted Pella), followed by removing excess solution with filter paper after 10 
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min. TEM grids were then left dried for another 15 min before imaging. Fluorescent confocal 
microscopy was conducted using a LSM700 confocal microscope (Zeiss).  
Materials. All reagents were purchased from Acros Organics, Fisher Scientific, AK 
Scientific, TCI America, or Sigma-Aldrich, and used without further purification unless 
otherwise noted. Dichloromethane (DCM), pyridine, THF, toluene, DMSO and DMF were dried 
and stored over activated 4 Å molecular sieves. For synthesis performed in the Argon-filled 
glovebox, all the solvents were taken from a MBraun solvent purification system. Pyridine-
modified Grubbs 2nd generation catalyst
22
 for ROMP polymerization, N-carboxymethyl cis-5-
norbornene-endo-2,3-dicarboximide,
23
 N-benzyl cis-5-norbornene-endo-2,3-dicarboximide 
(1b),
24
 and N-methyl cis-5-norbornene-endo-2,3-dicarboximide (1c)
25
 were each prepared 
according to literature procedures. The preparation of N-(6-amino)hexyl cis-5-norbornene-endo-
2,3-dicarboximide was similar to that reported by Hanson and coworkers,
26
 but replacing the 
diamine (ethylenediamine) with 6-amino-1-hexylamine and further purifying the crude product 
with flash chromatography (DCM-MeOH, 10:1 to 5:1). N,N’-DiBoc cis-1,4-di(4-
aminoethylphenoxyl)-2-butene (CTA-2)
27
 and tris(allyloxymethyl)-aminomethane (triallyl-
Tris)
28
 were synthesized according to procedures in literature. 
N-Carboxymethyl cis-5-norbornene-endo-2,3-dicarboximide NHS ester (1a). N-
Carboxymethyl cis-5-norbornene-endo-2,3-dicarboximide (2.21 g, 10 mmol) was dissolved in 
anhydrous dichloromethane (40 mL) in an ice bath. Oxalyl chloride (0.93 mL, 11 mmol, 1.1 eq) 
and one drop of DMF as catalyst was added to the solution. The reaction was stirred for 3 h with 
the temperature gradually increased to 25 
o
C. Volatiles were removed under reduced pressure to 
yield a white powder. The solid was dissolved in 40 mL of dry dichloromethane, and N-
hydroxysuccinimide (1.27 g, 11 mmol, 1.1 eq) and K2CO3 (2.07 g, 15 mmol, 1.5 eq) were added. 
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The suspension was stirred overnight. To the suspension was added 100 mL of dichloromethane 
and the organic solution washed with water twice and dried over Na2SO4. The solvent was 
removed under reduced pressure and a white solid was obtained. The crude product was 
dissolved in anhydrous acetone and crystallized by adding a layer of hexane, affording 2.4 g of 
1a as a fluffy white solid. Yield: 75%. 
1
H NMR (400 MHz, CDCl3): δ 6.11 (s, 2H), 4.40 (s, 2H), 
3.41 (m, 2H), 3.35 (m, 2H), 2.81 (s, 4H), 1.73 (d, J = 8.8 Hz, 1H), 1.53 (d, J = 8.8 Hz, 1H). 
13
C 
NMR (500 MHz, CDCl3): δ 176.2, 168.4, 162.8, 134.8, 52.4, 46.4, 45.3, 37.0, 25.7. ESI-MS: m/z 
calculated 318.1, found 319.1 [M+H
+
]. 
N-(2,2-Dimethoxy)ethyl cis-5-norbornene-endo-2,3-dicarboximide (1e). To 2-amino-
acetaldehyde dimethyl acetal (3.15 g, 30 mmol) was slowly added a solution of carbic anhydride 
(4.92 g, 30 mmol) in 40 mL of warm toluene (toluene was heated until all carbic anhydride could 
be dissolved). The suspension was heated to reflux on a heating mantle overnight. Solvent was 
removed under reduced pressure. The crude product was purified by column chromatography 
(silica, EtOAc-hexanes, 1:1 v/v) followed by recrystallization in EtOAc-hexanes to yield 4.2 g of 
1e as a colorless crystal. Yield: 55%. 
1
H NMR (400 MHz, CDCl3) δ 6.09 (s, 2H), 4.54 (t, J = 5.8 
Hz, 1H), 3.47 (d, J = 5.8 Hz, 2H), 3.39 (m, 2H), 3.30 (s, 6H), 3.26 (m, 2H), 1.73 (d, J = 8.7 Hz, 
1H), 1.53 (d, J = 8.7 Hz, 1H). 
13
C NMR (500 MHz, CDCl3): δ 177.7, 134.6, 99.5, 53.1, 52.4, 
46.0, 54.2, 39.2. ESI-MS: m/z calculated 251.1, found 274.1 [M+Na
+
]. 
N-(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl cis-5-norbornene-endo-2,3-dicarboximide 
(1d). 3-Amino-1,2-propanediol (1.92 g, 21 mmol, 1.05 eq) was dissolved in warm toluene-
dioxane mixture (50 mL, 10:1 v/v) and cis-5-norbornene-endo-2,3-dicarboxylic anhydride (3.28 
g, 20 mmol, 1 eq) was added. The mixture was heated at reflux overnight. The solution was 
decanted while hot to remove insoluble residue (if present) and cooled to 50 
o
C. To the solution 
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was added p-toluenesulfonic acid monohydrate (0.38 g, 2 mmol, 0.1 eq) and 2,2-
dimethoxypropane (10 mL, excess). The reaction was monitored by TLC, and the volatiles were 
removed under reduced pressure once the protection was complete. The residue was dissolved in 
40 mL of EtOAc, and washed by saturated aqueous NaHCO3, water, and brine (50 mL for each 
washing). The organic phase was collected, dried over Na2SO4, and the solvent removed under 
reduced pressure to give the crude product, which could be further purified by flash column 
chromatography (silica, EtOAc-hexanes, 1:3 v/v) to give 5.3 g of 1d as a white solid. Yield: 96%. 
1
H NMR (400 MHz, CDCl3): δ 6.08 (s, 2H), 4.16 (m, 1H), 3.93 (dd, J = 8.5, 6.1 Hz, 1H), 3.57-
3.67 (m, 2H), 3.33-3.40 (m, 3H), 3.27 (m, 2H), 1.72 (d, J = 8.8 Hz, 1H), 1.53 (d, J = 8.8 Hz, 1H), 
1.40 (s, 3H), 1.28 (s, 3H). 
13
C NMR (500 MHz, CDCl3): δ 177.7, 134.7, 109.8, 72.8, 67.8, 52.4, 
46.0, 45.2, 41.3, 27.0, 25.7. ESI-MS: m/z calculated 277.1, found 300.1 [M+Na
+
]. 
5(6)-Carboxyfluorescein diacetate (CFDA) monomer (1g). Commercially available 
5(6)-carboxyfluorescein (0.92 g, 2.4 mmol, 1.0 eq) was dissolved in DMF (10 mL). EDC 
hydrochloride (0.50 g, 2.6 mmol, 1.1 eq) and N-hydroxysuccinimide (0.30 g, 2.6 mmol, 1.1 eq) 
were added and the mixture was stirred for 10 min and N-(6-amino)hexyl cis-5-norbornene-
endo-2,3-dicarboximide (0.68 g, 2.6 mmol, 1.1 eq) was added. The solution was stirred at room 
temperature overnight. The resulting solution was diluted with 50 mL of EtOAc and washed 
three time with water and once each with aqueous HCl (0.1 M) and brine. The organic solution 
was dried over Na2SO4 and evaporated to a residue, which was purified by column 
chromatography (silica, DCM-MeOH, 10:1) to give approximately 1.0 g of product as a yellow 
solid. Note: due to the lactone-acid equilibrium of fluorescein moiety, it is difficult to obtain this 
intermediate in very high purity, but the subsequent acetyl protection locks the fluorescein in its 
lactone form and significantly reduces the polarity of the compound, facilitating its purification. 
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The solid was suspended in 5 mL of acetic anhydride and heated at 50 
o
C overnight to give a 
homogeneous, dark red solution. Acetic anhydride was removed under reduced pressure. The 
residue was purified by column chromatography using silica that was dried in a vacuum oven at 
150 
o
C for 48 h and pre-treated with EtOAc-hexanes (3:2 v/v) to give 0.7 g of 1g as a white, non-
fluorescent solid, which was approximately a 4:3 mixture of 5-isomer and 6-isomers. Yield: 50%. 
1
H NMR (400 MHz, CDCl3): 5-isomer: δ 8.42 (s, 1H), 8.21 (dd, J = 8.1 Hz, J = 1.5 Hz, 1H), 
7.27 (d, J = 8.1 Hz), 7.09 (m, 2H), 6.81 (m, 4H), 6.61 (t, J = 5.4 Hz), 6.10 (s, 2H), 3.16-3.51 (m, 
8H), 2.30 (s, 6H), 1.16-1.74 (m, 10H). 6-isomer: δ8.05-8.12 (m, 2H), 7.52 (s, 1H), 7.08 (m, 2H), 
6.80 (m, 4H), 6.42 (t, J = 5.5 Hz, 1H), 6.04 (s, 2H), 3.16-3.51 (m, 8H), 2.30 (s, 6H), 1.16-1.74 
(m, 10H). 
13
C NMR was not attempted as the product was a mixture. High resolution ESI-MS: 
m/z calculated for [M+H
+
]: 705.2673; found: 705.2672. Elemental analysis: calculated for 
C40H36N2O10: 68.17% C, 5.15% H, 3.98% N; found: 68.03% C, 5.07% H, 3.96% N. 
Cis-2-Butene-1,4-diol bis(5-azidovaleric acid) ester (CTA-1). A solution of 5-
bromovaleric acid (3.7 g, 20 mmol) and oxalyl chloride (1.8 mL, 21 mmol, 1.05 eq) in 30 mL of 
dichloromethane was cooled in an ice bath and one drop of DMF added. The ice bath was 
removed and the solution stirred for 3 h. Solvent was removed under reduced pressure, and the 
resulting residue was dissolved in 5 mL of dry dichloromethane and added to a mixture of cis-
1,4-dihydroxy-2-butene (0.80 g, 9.1 mmol, 0.91 eq) and K2CO3 (4.0 g, 29 mmol, 1.45 eq) in 
THF (25 mL). The mixture was stirred at room temperature overnight. Volatiles were removed 
under reduced pressure and the residue was partitioned between EtOAc and water. The organic 
layer was washed with water and brine, then dried over Na2SO4. The solvent was removed under 
reduced pressure and the crude product purified by column (silica, EtOAc-hexanes, 1:5 v/v) to 
give a olorless oil. The oil was dissolved in 20 mL of DMF, added NaN3 (1.3 g, 20 mmol), and 
37 
 
stirred at 50 
o
C for 24 h. The mixture was partitioned between EtOAc and water. Organic phase 
was collected and washed further by water and brine. Crude product was obtained after 
evaporation, and was further purified by column (silica, EtOAc-hexanes, v/v 1:5) to give 1.6 g of 
CTA-1 as a colorless oil. Overall yield: 52%, relative to the diol. 
1
H NMR (500 MHz, CDCl3): δ 
5.75 (t, J = 4.3 Hz, 2H), 4.70 (d, J = 4.3 Hz, 4H), 3.30 (t, J = 6.6 Hz, 4H), 2.37 (t, J = 7.2 Hz, 
4H), 1.73 (m, 4H), 1.64 (m, 4H). 
13
C NMR (500 MHz, CDCl3): δ 173.0, 128.3, 60.2, 51.3, 33.8, 
28.5, 22.3. ESI-MS: m/z calculated 338.2, found 339.2 [M+H
+
]. 
Cis-1,4-Bis(4-(2-azidoethyl)phenoxy)-2-butene (CTA-3). To a suspension formed from 
2-(4-hydroxyphenyl)ethanol (2.8 g, 20 mmol), K2CO3 (4.0 g, 29 mmol) and cis-1,4-dichloro-2-
butene (1.0 mL, 9.5 mmol) in anhydrous DMF (10 mL), was added tetrabutylammonium iodide 
(10 mg, catalytic) and the mixture stirred at 40 
o
C for 24 h. The resulting mixture was partitioned 
between diethyl ether and water, separated, and the organic phase was washed with water and 
brine. The solution was dried over Na2SO4 and filtered, then cooled in a -20 
o
C freezer. The 
crystalline white solid was collected by filtration and dried under vacuum to get the pure 
intermediate compound cis-1,4-bis(4-(2-hydroxyethyl)phenoxy)-2-butene.  
The intermediate cis-1,4-bis(4-(2-hydroxyethyl)phenoxy)-2-butene (1.7 g, 5.2 mmol) was 
dissolved in 40 mL of DMF-CCl4 (4:1 v/v). To the solution was added NaN3 (0.9 g, 14 mmol) 
and PPh3 (2.7g, 10.3 mmol) and the mixture was heated to 90 
o
C for 5 h and cooled to room 
temperature. The mixture was poured into 350 mL of water and extracted by diethyl ether. The 
organic layer was collected and washed with water and brine, dried over Na2SO4, and the solvent 
removed under reduced pressure to give a crude oil. The crude product was purified by column 
chromatography (EtOAc-hexanes, 1:4 v/v) to give 0.7 g of pure CTA-3 as a colorless or light-
yellow oil. Yield: 19%, from cis-1,4-dichloro-2-butene. 
1
H NMR (400 MHz, CDCl3): δ 7.11 (d, J 
38 
 
= 8.5 Hz, 4H), 6.84 (d, J = 8.5 Hz, 4H), 5.91 (t, J = 3.6 Hz, 2H), 4.64 (d, J = 3.6 Hz, 4H), 3.44 
(dd, J = 7.2 Hz, 4H), 2.81 (t, J = 7.2 Hz, 4H). 
13
C NMR (500 MHz, CDCl3): δ 157.5, 130.7, 
130.1, 128.8, 115.1, 64.5, 52.9, 34.7. ESI-MS: m/z calculated 378.2, found 401.2 [M+Na
+
]. 
N,N’-Diallyl-1,6,7,12-tetrachloroperylenediimide (PDI-allyl). To a suspension of 
1,6,7,12-tetrachloroperylene tetracarboxylic acid dianhydride (0.3 g, 0.56 mmol) in 8 mL of 
pyridine was added allylamine (0.2 mL, 2.7 mmol, 4.8 eq.), and the suspension heated to reflux 
under nitrogen for 16 h. Solvent was removed under reduced pressure and the residue was 
purified by column (silica, DCM-hexanes, 4:1 to 5:1 v/v) to yield 110 mg of a dark orange-red 
powder. Yield: 31%. 
1
H NMR (500 MHz, CDCl3): δ 8.71 (s, 4H), 6.00 (ddt, J = 10.2 Hz, J = 
17.1 Hz, J = 5.9 Hz, 2H), 5.41 (dd, J = 1.3 Hz, J = 17.1 Hz, 2H), 5.38 (dd, J = 1.3 Hz, J = 10.2 
Hz, 2H), 4.85 (d, J = 5.9 Hz, 4H). 
13
C NMR (500 MHz, CDCl3): δ 162.2, 135.7, 133.3, 133.3, 
131.7, 128.9, 123.6, 123.4, 118.8, 43.0. MALDI-TOF: m/z calculated 610.0, found 610.1 [M
+
]. 
Typical procedure for polymerization without a CTA. 1a (95 mg, 0.3 mmol, 50 eq) 
and 1b (151 mg, 0.6 mmol, 100 eq) were dissolved in anhydrous DCM (10 mL). The solution 
was degassed with three freeze-pump-thaw cycles to remove oxygen. Under a nitrogen 
atmosphere, pyridine-modified Grubbs 2
nd
 generation catalyst 2 (0.04 M in DCM, 0.15mL, 0.006 
mmol, 1 eq) was added. The solution was stirred at room temperature for 4 h and butyl vinyl 
ether (1 mL) was added to quench the catalyst. Solvent was removed under reduced pressure. 
The solid residue was sonicated in ether and centrifuged for 3 times before it was dried under 
reduced pressure to give an off-white solid. Yield: 213 mg (86%). 
Typical procedure for polymerization with a CTA. 1a (95 mg, 0.3 mmol, 50 eq) and 
1c (106 mg, 0.6 mmol, 100 eq) were dissolved in anhydrous dichloromethane (10 mL). The 
solution was degassed with three freeze-pump-thaw cycles to remove oxygen. Under a nitrogen 
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atmosphere, pyridine-modified Grubbs 2
nd
 generation catalyst 2 (0.04 M in DCM, 0.15 mL, 
0.006 mmol, 1 eq) was added. The solution was stirred at room temperature for 2.5 h and CTA2 
(0.2 M in DCM, 0.15 mL, 5 eq) was added. The solution was stirred for 3 h and butyl vinyl ether 
(1 mL) was added to quench the catalyst. Solvent was removed under reduced pressure. The 
solid residue was sonicated in ether, centrifuged, and the supernatant discarded 3 times before 
the solid was dried under reduced pressure to give an off-white solid. Yield: 187 mg (93%). 
Typical procedure for functionalization with triallyl-Tris. The poly(activated ester) 
(180 mg) was dissolved in a mixture of DCM (8 mL) and nitrobenzene (1 mL) in a 20 mL vial. 
Triallyl-TRIS (0.2 mL) was added. The vial was capped and sealed by parafilm, and the solution 
was stirred in a 40 
o
C oil bath overnight. Most of the solvent was removed under reduced 
pressure, and the viscous residue was precipitated in 15 mL of a 2:1 (v/v) mixture of ether-
hexanes and centrifuged. The precipitate was sonicated two times in ether (12 mL) and two times 
in methanol (10 mL) each time centrifuging and discarding the supernatant to remove triallyl-
TRIS, NHS and nitrobenzene. The remaining solid was dried under reduced pressure to give the 
product as an off-white powder. Yield: 160 mg (80%). 
Typical procedure for intramolecular crosslinking. In a 1 L round-bottom flask, 50 
mg of polymer 5 (Entry 5, Table 2.1) was dissolved in 600 mL of anhydrous DCM under a 
nitrogen atmosphere, and the solution was stirred at room temperature for 15 min. To the 
solution was added 12 mg of 1
st
 Generation Grubbs catalyst in 1 mL of DCM and the lower 1/3 
of the flask immersed in a 35 
o
C oil bath. The solution was stirred for 6 h and 6 mg catalyst 
added and stirred 18 h and 6 mg catalyst added. The mixture was stirred for a total of 48 h after 
the first catalyst addition and 3 mL of butyl vinyl ether was added to quench the catalyst.  The 
solution was stirred 30 min and evaporated under reduced pressure. The solid residue was 
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dissolved in DCM and purified by passing through silica gel eluted by DCM. Solvent was 
evaporated and the residue was sonicated and triturated in diethyl ether. Decantation gave a grey 
powder after vacuum drying. 
Typical procedure for intramolecular crosslinking with PDI-allyl. Crosslinking was 
performed similarly in a 1 L round-bottom flask with 50 mg of polymer P5-b and 3.3 mg of PDI-
allyl (5 eq relative to the amount of polymer chains) dissolving in 600 mL of anhydrous DCM 
under a nitrogen atmosphere. The solution was stirred at room temperature for 15 min. To the 
solution was added 12 mg of 1st Generation Grubbs catalyst in 1 mL of DCM and the lower 1/3 
of the flask immersed in a 35 
o
C oil bath. The solution was stirred for 6 h and 6 mg catalyst 
added and stirred 18 h and 6 mg catalyst added. The mixture was stirred for a total of 48 h after 
the first catalyst addition and 3 mL of butyl vinyl ether was added to quench the catalyst.  The 
solution was stirred 30 min and evaporated under reduced pressure. The solid residue was 
dissolved in DCM and purified by passing through silica gel eluted by DCM. Solvent was 
evaporated and the residue was sonicated and triturated in diethyl ether. Decantation gave a 
reddish powder after vacuum drying. The resulting alkene ONP could be dihydroxylated using 
the protocol showing below. 
Typical procedure for dihydroxylation of the alkene ONPs. In a 20 mL glass vial, 40 
mg of polymer P3-c was suspended in a mixture of water (3 mL) and acetone (7 mL). NMO (50% 
wt in H2O, 0.4 mL) and K2OsO4 (catalytic amount) was added to the mixture. The vial was 
loosely capped and heated in a 40 
o
C oil bath for 5 h, before the cap was removed and the vial 
was covered by a piece of chemical paper wipe. Acetone was allowed to evaporate naturally 
(approximately 16 h) and 3 mL of water was gradually added when the mixture became almost 
homogeneous. Heating and stirring was continued for another 2-3 h and the solution decanted to 
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remove any insoluble residue. The supernatant was stirred with Smopex-105 metal scavenger at 
50 
o
C. The solution could be further purified by dialysis against water using a 1 kDa cutoff 
membrane and the solution lyophilized to yield a grayish-white solid. Yield: 32 mg. 
Typical procedure for dihydroxylation and hydrolysis of acetal groups in one pot. 
The crosslinked polymer (40 mg, from the linear polymer in which M1:M5:M6 = 25:50:4) was 
suspended in a mixture of acetone and water (10 mL, 7:3 v/v) in a 20 mL vial. NMO (0.4 mL, 50% 
w/w in water) was added, followed by K2OsO4 (catalytic amount). The vial was loosely capped 
and heated in a 40 
o
C oil bath for 5 h, before the cap was removed and the vial was covered by a 
piece of chemical paper wipe. Acetone was allowed to evaporate naturally (approximately 16 h) 
and 3 mL of water was gradually added when the mixture became almost homogeneous. Heating 
and stirring was continued for another 2-3 h and the solution decanted to remove any insoluble 
residue. The solution was cooled to room temperature and quenched by adding NaHSO3 (200 mg) 
and stirring for 30 min. Concentrated HCl was added dropwise to the fast-stirring solution until 
pH < 1 as measured by pH test paper. Precipitates formed during this process because the 
polymer before hydrolysis was not soluble in aqueous solution with high ionic strength. The 
reaction was stirred at 35 
o
C for 3-4 h or until the solution became almost clear, then filtered or 
centrifuged to remove any insoluble residue and purified by dialysis using dilute aqueous 
NaHCO3 once and water once. The purified solution was lyophilized to give a yellow solid (29 
mg). 
Conjugation of mPEG on monofunctionalized ONP. This synthesis was performed by 
Hang Xing. The NHBoc-containing ONP was treated by trifluoroacetic acid (TFA) in 
dichloromethane to generate the corresponding amine-ONP. The dried amine-ONP (5 mg) was 
dispersed in 0.1 M sodium phosphate buffer (with 0.1 M NaCl, pH 7.3) and DMF to form a 0.2 
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mM suspension. Sulfo-SMCC (1 mg) was added into 500 µL of the amine-ONP suspension, and 
then placed on a shaker for 2 h at room temperature. The excess sulfo-SMCC was removed and 
the sulfo-SMCC-activated amine-ONPs were purified by Amicon-30K passing 0.1 M sodium 
phosphate buffer (with 0.1 M NaCl, pH 7.3) through 8 times. Thiolated mPEG-10,000 (2 mg) 
was activated by using tris(2-carboxyethyl) phosphine (TCEP) in sodium acetate buffer (pH 5.2). 
The purified sulfo-SMCC-activated ONPs solution and the activated thiolated mPEG-10,000 
solution were mixed together and vortexed for 1 min. The mixture was then incubated at room 
temperature under shaking for 48 h. After incubation, non-reacted ONPs were not water-soluble 
and can be centrifuged down as precipitates and removed by filtration. The reacted PNPs formed 
water-soluble ONP-mPEG conjugates and stayed in supernatant. The conjugate was purified by 
8 passes through an Amicon-30K centrifugal filter using 0.1 M sodium phosphate buffer (with 
0.1 M NaCl, pH 7.3) to remove any unreacted thiolated mPEG-10,000. The mPEG conjugation 
was immediately apparent given that the functionalized ONPs became soluble in water. 
Cell culture. HeLa cells used for ONP uptake experiments were cultured in Dulbecco’s 
modification of Eagle’s medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS), 
100 U/mL penicillin, and 100 µg/mL streptomycin, on 25 cm
2
 culture flasks in a humidified 5% 
CO2 incubator at 37°C. Hela cells were plated onto 35 mm glass-bottom dishes (MatTek) and 
grown to 70 – 90% confluence before confocal microscopy imaging. 
ONP uptake, imaging and flow cytometry study. HeLa cells were incubated for 6 h 
with 2 mL of Opti-MEM containing 5 µM ONPs in glass-bottom dish. Cells were washed with 
PBS 3 times and fresh DMEM was added. ONPs treated cells were then stained with Hoechst 
33258 (Invitrogen) of 2.5 ng/mL for 20 min. Lysotracker Red (Invitrogen) of 50 nM was added 
and the cells were incubated for 30 min. Confocal images were obtained using a Zeiss LSM 710 
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NLO confocal microscope at 63x magnification equipped with a Mai-Tai Ti-Sapphire laser. 
Fluorescence emission was obtained over 450-520 nm (DAPI), 510-570 nm (ONP), and 575-620 
nm (LysoTracker Red) ranges, with excitation at 401 nm, 488 nm, and 561 nm, respectively. The 
pinhole and gain settings were kept constant throughout the whole imaging process. 
For flow cytometry study, HeLa cells were incubated with ONPs for 6 h. Cells were 
washed with 1× PBS and detached by 0.05% trypsin. The suspended cell solution was collected 
by centrifugation at 2,000 g for 5 min and further washed with PBS three times. Flow cytometry 
was performed using a BD FACSCanto system under 488 nm excitation. Control cells without 
any treatment were used to set the gating. Each measurement set was performed using 10,000 
cells. 
MTT cell viability assay. Cellular toxicity of the organic nanoparticles (ONPs) was 
examined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell 
viability assay.  HeLa cells were seeded into 96-well plates at a density of 2,000 cells/well in 
DMEM media with 10% fetal bovine serum (200 µL) and grown in a humidified 5% CO2 
atmosphere at 37 
o
C for 24 h.  The media was removed, cells were rinsed with 200 µL of PBS, 
and incubated for 24 hrs in the presence of ONP (60 µL/well).  25 mg of MTT in 5 mL of PBS 
was added to each well (20 µL/well) and incubated for an additional 1.5 h protected from light.  
The solution was removed and the reduced formazan was solubilized with the addition of DMSO 
(200 µL/well), producing a purple color and mixed for 15 min.  The absorbance of each well was 
read with a fluorescence plate reader at 590 nm. For each experiment, a control of cells that were 
not incubated with ONPs was also analyzed. All samples were run in quadruplet. The average 
absorbance for each sample was calculated and percent viability was determined using the 
following equation:% cell viability = A590 treated cells/A590 untreated cells × 100. 
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2.9. Conclusion 
In conclusion, a new synthetic approach was developed, allowing the preparation of non-
toxic, water-soluble organic nanoparticles by intramolecular crosslinking of linear polymers 
obtained from living ROMP technique. By adjusting parameters of the living ROMP, the 
molecular weight and size of the ONP could be precisely controlled, with the polydispersity 
being excellent in each case. The synthesized organic-soluble alkene ONPs could be 
dihydroxylated under Upjohn condition, providing water solubility. The ONP could also be made 
monovalent, by the end-capping of a chain-transfer agent followed by crosslinking. The 
monovalent particle was shown to be active in bioconjugation. In addition, covalent conjugation 
of small molecules to the polymer could be achieved simultaneously with the RCM process, 
making the ONP a convenient carrier for molecules like drugs and dyes. Monomers used in the 
synthesis can also be readily replaced with others containing a broad range of with desired 
functionalities, providing multiple sites for post-functionalization. New applications of these 
ONPs in the delivery and bioimaging fields are the focuses of the other chapters of Part 1. 
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CHAPTER 3 
PREDICTABLE CHEMICAL CONTROL OVER  
CELLULAR UPTAKE OF ORGANIC NANOPARTICLES 
BY FINE TUNING SURFACE FUNCTIONAL GROUPS 
 
Collaboration and contribution statement: 
The cell uptake and flow cytometry study were performed in collaboration with Hang Xing, 
Kevin Hwang and Peiwen Wu. The lipophilicity study using LC-MS was performed in 
collaboration with Xinxin Feng. 
 
3.1. Introduction 
Nanoparticles (NPs) are important vectors for transporting desired cargo into cells, and 
are thus widely used in different areas of biological researches, such as drug delivery
1-5
 and gene 
therapy.
1, 5-7
 For more efficient delivery and targeting, as well as better biocompatibility of the 
particles, surface functional groups of the particles need to be tuned by a wide range of surface 
coating methods, such as ligand-exchange,
8-10
 PEGylation
10-12
 and targeting-moiety 
conjugation.
10-11, 13
 These simple methods can significantly change the properties of the 
nanoparticles, providing additional features like surface charges, increased circulation time, bio-
derived recognition and so on. Appropriate and clever use of such strategies has actually become 
one of the most important parts of nanoparticle design. 
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Figure 3.1. Left: possible features of the ONPs synthesized from ROMP-RCM process that is 
described in Chapter 2. Right: illustration on the chemical control of ONP cell uptake by tuning 
particles’ surface functional groups using different monomers. 
 
However, the mechanism of nanoparticle internalization, although explicitly important, is 
far from well understood. One of the reasons is that precise chemical control over nanoparticle 
surfaces is still limited. Common inorganic nanoparticles, such as metal nanoparticles (MNPs), 
silica nanoparticles (SiO2-NPs) and quantum dots (QDs), all have homogeneous surfaces and the 
available chemical modifications are inherently limited. Surface deposition and ligand exchange 
are commonly employed in this scenario. For systems working in aqueous media, highly-charged 
or PEGylated surfaces are needed. This applies to organic nanoparticles (ONPs) synthesized 
from polymers via different ways,
14-16
 as these ONPs also lack of reactive functional groups on 
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their homogeneous surfaces. On the other hand, single-molecule ONPs, such as dendrimers
17-18
 
and intramolecularly crosslinked polymers
19-22
 from bottom-up synthesis, both potentially 
provide more ways of functionalization. These macromolecules can bear controlled number of 
specific functional groups, designed internal structures, and narrow size distributions. However, 
the limitations are also apparent, especially for the multi-step synthesis of dendrimers that limits 
the synthesis of particles with multiple different functionalities or larger sizes. Furthermore, most 
of the reported ONPs from single-chain crosslinking are insoluble in water, leaving considerable 
restraints on their potential applications in biological field. 
A new strategy to synthesize water-soluble, biocompatible ONPs from a consecutive 
ring-opening metathesis polymerization and ring-closing metathesis (ROMP-RCM) process is 
described in Chapter 1.
23
 The strategy allows facile loading of diverse functionality, good size 
control and large scale synthesis (Figure 3.1, left). In my continued research of this new material 
with my collaborator Hang Xing, we found that the monomer used in the linear polymerization 
had a profound effect on the cell internalization of the final ONPs. This phenomenon was 
significant, and as a result we considered this new material an excellent platform for determining 
the role of ONP surface functionality in ONP-cell interactions. Importantly, the synthetic route 
offers very fine control over ONP surface properties (Figure 3.1, right). While this work was in 
progress, Rotello and co-workers reported the synthesis of corona-free, zwitterionic gold 
nanoparticles with tuneable hydrophobicity and cell uptake kinetics.
24
 However, to our 
knowledge, similar research on non-ionic, water-soluble organic nanoparticles is absent, likely 
because of the challenges of synthesizing neutral, highly functionalized, water soluble ONPs. 
The bottom-up ONP synthesis also offers more controlled and tuneable degree of 
functionalization. I hope that such fundamental research, combined with previous work, can 
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offer a complete story on surface-controlled NP internalization, and potentially serve as useful 
references in future design of NPs for biological applications. In addition, such research may add 
to the common effort of unmasking the mechanism of NP cell uptake. 
 
3.2. Synthesis of monomers with different functional groups 
 
 
Scheme 3.1. Synthesis of all monomers and the corresponding water-soluble ONPs with 
different functional groups from various exo-norbornene derivatives synthesized from exo-carbic 
anhydride.  
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 In this chapter, exo-monomers were used for the polymerizations. The advantages and 
disadvantages of these two categories of monomers were described in the previous chapter. The 
polymer synthesis using exo-monomers can be performed without a glove box with ease and 
efficiency. Syntheses of the exo-monomers are very similar to their corresponding endo-
monomers, yet the purification procedures usually take more time. Reagents, instrumentation 
setup and synthetic procedures for these new monomers are described below. This library 
enables the synthesis of multiple ONPs with different surface functional groups to be performed 
with ease. The syntheses of materials used in this chapter are illustrated in Scheme 3.1. The 
synthetic protocols can be found in the experimental section of this chapter. 
 
3.3. Synthesis of ONPs with different surface functional groups 
 As mentioned in the previous chapter, ROMP of norbornenyl derivatives mediated by 
Grubbs 3
rd
 generation catalyst offers precise control over polymer composition, length and 
dispersity, based only on feed ratio of monomers and catalyst. Similar to our previous work, 
careful weighing of all monomers and catalyst yield all the linear polymers with molecular 
weights very close to expected numbers (See Table 3.1), as well as low polydispersity indices 
(PDIs), based on GPC-MALLS characterization. These linear poly(activated esters) with 
different co-monomers were then functionalized by tris(allyloxymethyl)aminomethane (Triallyl-
Tris), crosslinked intramolecularly, and finally dihydroxylated to give well-defined water-soluble 
ONPs. The acetyl protected ONPs were hydrolyzed under basic condition, and the acetonide 
protected ONPs were hydrolyzed under acidic condition. Unfortunately, four ONPs (ONP175, 
ONP375, ONP475 and ONP575) were not well soluble in pH 7.4 phosphate buffer, and were not 
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Table 3.1. Top: list of monomers and feed ratios of all the synthesized ONPs. Bottom: molecular 
weight and fluorescence intensity comparison of selected ONPs. 
 
 
[a] 
The poly(activated ester)s, based on monomer feed ratio and monomer/initiator ratio. 
[b] 
Multi-angel Laser Light 
Scattering (MALLS) technique allows the detection of absolute (true) molecular weights of linear, non-fluorescent 
polymers, without the need of calibration of any polymer standards. Note: the protected fluorescein (fluorescein 
diacetate) moieties are not fluorescent without protection. Thus these polymers can be characterized by MALLS 
without fluorescence interference. 
[c] 
Calculated based on experimental molecular weight of the parent linear 
polymers. 
[d] 
ONPs all had a concentration of 1µM, in 0.1 M aqueous NaOH. Excitation was at 499 nm. 
Fluorescence intensity was calculated by integrating emission from 510-530 nm. ONP1175 was set as the reference 
(intensity = 1.00).  
54 
 
used in the cell studies, although these ONPs were soluble in slightly more basic buffers. The 
polymerization, functionalization, crosslinking and deprotection procedures are described in the 
experimental section. 
 All the final ONPs had very close fluorescence intensities at the same molar concentration, 
and this requires accurate weighing of the monomers before polymerization. To confirm this, 
molecular weights of the final ONPs were calculated based on the molecular weights of their 
corresponding parent linear polymers (determined by GPC-MALLS). The ONPs were made into 
1 µM solutions in 0.1 M NaOH based on the calculated molecular weights. The results are listed 
in Table 3.1. This is essential for the flow cytometry studies and worth being emphasized again 
here. 
 
3.4. Flow cytometry study of different sets of ONPs 
The uptake of ONPs by HeLa cells was examined first by flow cytometry. Because all of 
the ONPs had a precisely controlled degree of polymerization (DP) and crosslinking density, 
they were approximately equal in size and fluorescence intensity in aqueous solutions at the 
same molar concentration. Based on this observation, after incubating the ONPs in cell culture 
for a set period, the fluorescent intensity was measured by the flow cytometry and taken as 
proportional to the uptake efficiency of each ONP. The cell uptake efficiency was evaluated by 
calculating an uptake index defined as: 
Uptake Index =  
𝑀𝑒𝑎𝑛 𝐼𝑓 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑏𝑦 𝑂𝑁𝑃𝑠
𝑀𝑒𝑎𝑛 𝐼𝑓 𝑜𝑓 𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
 
55 
 
 
Figure 3.2. HeLa cell uptake study with ONP675, ONP775 and ONP875. (a) Flow cytometry 
curves overlay. (b) Calculated cell uptake indices of the three ONPs. Note: for (b), the y-axis 
starts at 1 because the uptake index cannot be lower than 1 by definition. All the flow cytometry 
studies were performed by Peiwen Wu, and the data collected was analyzed and plotted together 
with Hang Xing. 
 
We had chosen the seven co-monomers carefully so that they would cover a wide 
solubility range from lipophilic to hydrophilic, and display several different structural features 
for systematic comparison. The most obvious set among all structures consist of ONP675, 
ONP775 and ONP875, which all have a single hydroxyl group on the side chains but have 
increasing degrees of lipophilicity in the order of ONP675 < ONP775 < ONP875, because of the 
elongation in their aliphatic linker length.  These ONPs at a concentration of 2 µM were 
incubated with HeLa cells for 3 h in Dulbecco's Modified Eagle Medium (DMEM) at 37 °C. The 
ONP-treated HeLa cells were then carefully washed and lifted for analysis by flow cytometry. 
As shown in Figure 3.2, an increase in the -(CH2)n- linker length is accompanied by a positive 
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(rightward) shift in the peak toward higher fluorescence intensity, indicating more efficient 
cellular uptake for more lipophilic nanoparticles (Figure 3.2a). This trend can be more easily 
seen in Figure 3.2b, where the uptake index of the ONPs increased for the longer carbon chains 
on the backbone of the ONP. For example, the ONP875 showed an uptake index almost 80% 
higher than that of ONP675 under the same conditions. 
To examine further the effect of hydrophobicity on cell uptake of these ONPs, ONP275, 
ONP775 and ONP975 were examined as a second comparison set, wherein the number of 
hydroxyl groups per substituent was varied (2, 1, and 0). Using the same cellular uptake protocol 
as described above, the peak in the flow cytometer shifted to higher fluorescence intensity across 
the series of ONP275, ONP775 and ONP975 (Figure 3.3a). Thus, the uptake index of ONP975, 
lacking a hydroxyl group on side-chains, was clearly higher than the uptake index of ONP775  
with one hydroxyl group per side chain, and this, in turn, was higher than the uptake index of  
 
 
Figure 3.3. HeLa cell uptake study with ONP975, ONP775 and ONP275. (a) Flow cytometry 
curves overlay. (b) Calculated cell uptake indices of the three ONPs. 
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Figure 3.4. Results from HeLa cell uptake studies with ONP275, ONP1075 and ONP1175. (a) 
Flow cytometry curves overlay. (b) Calculated cell uptake indices of the three ONPs. 
 
ONP275 containing two hydroxyl groups per side chain (Figure 3.3b). The results confirm the 
previous finding that ONPs with more hydrophobic domains are more readily taken up by cells. 
A special advantage of this bottom-up strategy is illustrated by the third set of ONPs. In 
particular, the ROMP-RCM strategy used in this work allows easier and more precise control 
over the NP functionality because two or more functional monomers can be randomly 
copolymerized at any feed ratio.  The ONPs thusly produced have a broad range of different 
functional groups with well-defined ratios. A new ONP, ONP1175, was synthesized from M1, 
M3, M9 and M2 (with feed ratio of 25:25:25:2), and was compared with ONP275 and ONP1075 
by flow cytometry. Similar to the previous two sets, ONP1075 showed much higher uptake index 
compared to ONP275 because of the additional lipophilic methyl groups. In accord with 
prediction, this “hybrid” ONP showed a cell uptake index between that of ONP275 and ONP1075 
(Figure 3.4). This result is important, because it indicates that an averaged NP internalization 
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profile could be obtained by “combining” two other internalization profiles with mixed 
monomers in linear polymer synthesis.  This approach may eliminate the need to synthesize and 
test additional monomers with optimized delivery properties and allow for predictable, fine-
tuning of ONP uptake properties. 
 
 
Figure 3.5. HeLa cell uptake study with ONPs of different sizes. (a) Flow cytometry curves 
overlay. (b) Calculated cell uptake indices of the three ONPs. Note: the apparent uptake indices 
are higher than previous experiments due to the higher dye loading of these ONPs. 
 
In addition to ONPs with different functionalities, the single-chain ONP strategy also 
allows facile synthesis of ONPs of different-sizes with the same monomer composition.  To 
study the effect of ONP size on cell uptake, monomers M1, M2 and M3 were used to prepare 
ONP2′ with DP values of approximately 30, 75, 150, and 300.  These ONPs, prepared with a 
constant ratio of M1:M3 (1:2) but an increasing M/I ratio, were evaluated in the cell uptake 
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experiments (Figure 3.5). The fluorescein loading was doubled for these ONPs (4 per ONP), and 
as a result, these particles were more fluorescent, showing larger apparent uptake indices and 
better illustrating the size differences. The results showed a clear trend that the uptake index of 
the ONP increases with a decrease in particle size. With gold nanoparticles (AuNPs), the uptake 
is seen to increase with increasing size up to ca. 50 nm, but then to decrease beyond that size.
25
 
The results seen here indicate that ONPs behave very differently than AuNPs. The former are 
more flexible than AuNPs and their uptake profile is more consistent with their organic nature. 
We did not examine larger ONPs because of concerns about clearance. Overall, the results show 
that, similar to lipophilicity, the size of ONPs also plays a key role in cell uptake. It is worth 
noting that ONP2′75 showed approximately twice the uptake index of ONP275, which was 
reasonable because of its doubled brightness.  In addition, all the previous experiments were 
conducted with carefully prepared ONPs with very close DPs, hence the influence of their size 
difference was negligible when we were investigating the co-monomer effect. 
Although we have demonstrated that the cell uptake capability of ONPs can be tuned by 
surface functional groups and sizes in serum-free condition, the mechanism for ONP uptake is 
still unclear. Previous studies on NP cell uptake suggest that in natural biological environments, 
protein corona can form on the surface of the NPs, and play a central role in determining 
nanoparticle behavior.
26-29
 Corona formation on nanoparticle surfaces can be reversible or 
irreversible.
24, 30-32
 For NP studies in serum-free conditions (no corona formation), trends similar 
to our work with ONPs were reported for metal NPs, e.g., lipophilic NPs lead to higher cellular 
uptake.
33-34
 However, the trend was completely reversed in the presence of serum, because the 
higher hydrophobicity leads to more protein absorption, significantly reducing NP 
internalization.
35-37
 In a very recent report, Rotello and co-workers showed that zwitterionic 
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AuNPs form reversible coronas and exhibit the same internalization trend as NPs in serum-free 
conditions.
24
 This important finding showed the possibility of using the presentation of chemical 
functionality to control the NP cell uptake under physiological conditions. 
To determine the potential role of protein coronas in mediating the cellular uptake of the 
polymeric ONPs investigated here, the uptake studies with all the ONPs (ONP175 – ONP1175) 
were measured in 10% FBS-containing DMEM medium. The flow cytometry data showed that 
HeLa cells treated with ONP875 (with the longest hydrocarbon chain), ONP975 (with no hydroxyl 
group) and ONP1075 (with most methyl groups) exhibited the highest fluorescent intensity 
among each group, following the same trend seen in serum-free medium (Figure 3.6). The 
overall uptake efficiency with 10% FBS was lower compared to the studies of “naked” NPs 
under serum-free conditions, consistent with previously reported results.
24, 38-40
 However, we 
observed only an attenuation of uptake, not a reversal of uptake rates with the more hydrophobic 
ONPs. 
These observations suggest that the ONPs have relatively weak, non-specific interactions 
with serum proteins, and whatever corona is formed is readily reversible. As a result, the cell 
uptake ability of ONPs can also be tuned under physiological conditions. It is important to note 
that the lipophilicity tuning was a profound effect, allowing some ONPs in serum media to 
exhibit significantly higher uptake efficiency in comparison to some of the “naked” ONPs. The 
hydroxyl-rich, charge-free nature of the cross-linked ONPs were anticipated to be biocompatible 
and resist forming irreversible coronas with serum treatment.
41-42
 Although it is difficult to verify 
directly the absence of a hard corona because of the very low density of our ONPs,
23
 we could 
confirm the absence of larger aggregates in a mixture of the ONP and 10% FBS by dynamic light 
scattering (DLS, see Figure 3.7). These experiments suggest the possibility of direct presentation 
61 
 
of ONP surface properties on cells under physiological condition, due to the absence of 
irreversibly formed coronas. 
 
Figure 3.6. Uptake indices of the three sets of ONPs from repeated HeLa cell uptake studies 
with 10% FBS. ONPs showed the same trend in these studies as they did under serum-free 
conditions. 
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Figure 3.7. DLS characterization of ONP275, DMEM with 10% FBS, and their mixture. The 
mixture was incubated at 37 
o
C for 3 h before characterization. No large protein-ONP aggregates 
were observed in the mixture. 
 
Two limiting mechanisms for NP cell uptake have been proposed, which involve passive 
diffusion across the cell membrane, and semi-specific interactions between NP surface functional 
groups and cell surface that leads to receptor-mediated internalization. To obtain evidence that 
might distinguish these possibilities, we repeated the flow cytometry experiments with all the  
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Figure 3.8. Results of cell uptake study at low temperature (4 
o
C) without FBS. Left: overlay of 
flow cytometry curves. Right: calculated uptake indices of all the tested ONPs. 
 
ONPs (ONP175-ONP1175) at 4 
o
C, where the cell surface receptor-mediated internalization is 
prohibited.
43-46
 As shown in Figure 3.8, at 4 
o
C, almost no uptake was observed, suggesting that 
the ONPs entered HeLa cells mainly through a receptor-mediated internalization process, instead 
of by passive permeation, which is consistent with our previously reported results.
23
 
 
3.5. Repeating unit lipophilicity as a semi-quantitative parameter for prediction of ONP 
cellular uptake capability 
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 In seeking a more quantitative analysis, we wondered if subunit lipophilicity itself could 
be used as a parameter to predict the cellular uptake efficiency of ONPs from corresponding 
repeating units. To determine the relative lipophilicity of the variable repeating units in the ONPs 
semi-quantitatively, monomers M3-M8 were dihydroxylated under Upjohn conditions and 
deprotected when necessary, affording a total of ten repeating unit mimics (RUM1-RUM10), 
which were obtained and used without separating possible stereoisomeric products (see Figure 
3.9). The protocols of these experiments are listed in the experimental section. 
The retention time of RUM1-RUM10 in a reverse-phase HPLC system was taken as a 
relative measure of the repeating unit’s lipophilicity and it was assumed to correlate with that of 
the corresponding ONP (see Table 3.2). For ONP1175 (which has 2 RUMs with 1:1 ratio), a 
virtual retention time was estimated as an average of the two RUMs: RUMavg = 10
[(lgRUM1 + 
lgRUM2)/2]
, due to the direct correlation between LC retention time and partition coefficient P.
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These RUMs covered a wide range of lipophilicity, with RUM2 being the most hydrophilic and 
RUM5 being the most lipophilic. It is worth noting that RUM2, RUM6, RUM7 and RUM8 are 
unmasked product of RUM1, RUM3, RUM4 and RUM5. Such hydrophobic-hydrophilic pairs 
can be used to prepare ONPs with tuneable cell uptake properties using an “on-demand 
unmasking” strategy, as exemplified in the synthesis of ONP1175. It is also possible to install 
active functional groups such as azides or thiols on the ONPs in order to allow “on-demand 
masking” and alter the ONP’s cell uptake profile in situ. These possibilities are being tested and 
may be reported in due course. 
As it is shown in Figure 8, under serum-free condition (Figure 3.10a), the ONPs with 
more lipophilic repeating units and thus higher retention time exhibit higher cell uptake index, 
and the uptake efficiency increased dramatically for monomers whose retention times were more 
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Figure 3.9. Structure of “repeating unit mimics” that resembles the functional repeating units 
within the ONP scaffolds. For easy comparison, these mimics have the same numbering as their 
corresponding ONPs (e.g. ONP1 has the repeating units analogous to RUM1). 
 
than 4 min. Moreover, in 10% FBS condition (Figure 3.10b), a similar trend was observed, but 
with ~ 50% lower uptake indices than those corresponding indices under serum-free conditions, 
suggesting the formation of the reversible protein corona on ONP surface. However, since the 
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Table 3.2. Detailed LC-MS retention times of repeating unit mimics (RUMs). 
 
Note: Because all the synthesized RUMs were mixed isomers, and all the compounds must be eluted under the same 
condition, the peaks were relatively broad, especially for the hydrophilic compounds. The retention times were the 
positions of the peak (when the signal reaches highest value). Ranges in the brackets were the starting and ending 
time of the peak at half-height. The ranges were used as error bars in Figure 8 in the article and Figure S5 in the SI. 
All the ONPs consisting of RUMs more hydrophobic than RUM8 were not well soluble in pH 7.4 phosphate buffer 
(they were soluble in slightly more basic buffers though). As was mentioned in the article, these ONPs were not 
used in flow cytometry experiments. However, hybrid ONPs with such hydrophobic RUMs could still be very useful, 
as was illustrated in the case of ONP1175. 
 
cell uptake of NPs is a complicated process and could be influenced by many factors other than 
NPs’ lipophilicity and size, deviations from the general trend can also be observed in Figure 8. 
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Figure 3.10. Illustration of the relationship between ONP cellular uptake efficiency and their 
corresponding repeating units in (a) serum-free and (b) 10% FBS conditions. Lipophilicity of the 
repeating units was represented as the LC-MS retention time of synthesized RUMs mimicking 
such repeating units’ structures. 
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For example, the most hydrophilic ONP275 showed slightly higher uptake than the less 
hydrophilic ONP675. In addition, RUM7 and RUM9 had extremely close retention times, yet 
ONP775 exhibited a smaller uptake index compared to ONP975. Nevertheless, the LC retention 
time of RUMs serves as a quantitative experimental parameter that can approximate the cellular 
uptake efficiency of the ONPs. The quantitative analysis not only helps estimate the properties of 
ONPs synthesized from mixed monomers, but also suggests a potential approach for rational 
design of ONPs with tuneable biological properties. 
 
3.6. Experimental section 
Instrumentation. The general instrument setup was described in Section 2.8. 
Materials. All reagents were purchased from Acros Organics, Fisher Scientific, AK 
Scientific, TCI America, or Sigma-Aldrich, and used without further purification unless 
otherwise noted. Dichloromethane (DCM), pyridine, THF, benzene, toluene, nitrobenzene, 
DMSO and DMF were stored over activated 4Å molecular sieves. Other solvents were used as 
received. Triethylamine was dried over KOH pallets. Diisopropylethylamine was dried over 4Å 
molecular sieves. cis-5-norbornene-exo-2,3-dicarboxylic anhydride,
48
 N,N’-diBoc cis-1,4-di(4-
aminoethylphenoxyl)-2-butene (NHBoc-CTA)
23
 and tris(allyloxymethyl)-aminomethane 
(Triallyl-Tris)
49
 were synthesized according to procedures in literature. N-Carboxymethyl cis-5-
norbornene-exo-2,3-dicarboximide was first synthesized according to literature procedure.
50
 cis-
5-Norbornene-exo-2,3-dicarboximide was synthesized from urea and cis-5-norbornene-exo-2,3-
dicarboxylic anhydride according to a literature procedure.
51
 Pyridine-modified Grubbs 2
nd
 
Generation catalyst (usually referred as Grubbs 3
rd
 Generation catalyst) for ROMP 
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polymerization was synthesized using a modified literature protocol
52
 from Grubbs 2
nd
 
Generation catalyst and pyridine instead of bromopyridine. 
 M1. In a 100 mL round bottom flask, N-carboxymethyl cis-5-norbornene-exo-2,3-
dicarboximide (2.21 g, 10 mmol) was mixed with N-hydroxysuccimide (1.27 g, 11 mmol) and 
EDC·HCl (2.29 g, 12 mmol) in 15 mL of anhydrous DMF. The reaction was stirred at room 
temperature overnight. The resulting solution was diluted with EtOAc (150 mL), and washed 
first with 0.1 M phosphate buffer (pH 7.4, 100 mL), water (50 mL x 2) and brine (50 mL). The 
organic layer was dried over Na2SO4, evaporated, and the residue was purified by flash column 
chromatography (100% EtOAc, silica was pre-dried in a vacuum oven at 150 
o
C for 48 h) to give 
2.1 g of M1 as a white solid. Yield: 66%. 
1
H NMR (400 MHz, CDCl3): δ 6.32 (s, 2H), 4.58 (s, 
2H), 3.34 (s, 2H), 2.85 (s, 4H), 2.79 (s, 2H), 1.53-1.59 (m, 2H). 
13
C NMR (500 MHz, CDCl3): δ 
176.5, 168.3, 163.3, 138.2, 48.2, 45.7, 43.1, 37.3, 25.7. ESI-MS: calculated for [M+Na
+
]: 
341.0750, found 341.0750. 
 M2. The synthesis of M2 was following the protocol in our previous work,
23
 using N-(4-
aminobutyl)-cis-5-norbornene-exo-2,3-dicarboximide (synthesized from cis-5-norbornene-exo-
2,3-dicarboxylic anhydride and 1,4-diaminobutane) and 5(6)-carboxyfluorescein. Briefly, 5(6)-
carboxyfluorescein (0.75 g, 2.0 mmol) was mixed with EDC·HCl (0.42 g, 2.2 mmol) and N-
hydroxysuccinimide (0.25 g, 2.2 mmol) in 10 mL of DMF, and stirred for 20 min. N-(4-
Aminobutyl)-cis-5-norbornene-exo-2,3-dicarboximide (0.47 g, 2.0 mmol) was added, and the 
reaction was stirred at room temperature overnight. The resulting solution was diluted by EtOAc 
(40 mL) and extracted with water (40 mL), 0.1 M HCl (40 mL), water (40 mL) and finally brine 
(20 mL). The EtOAc solution was dried and evaporated to a residue, which was purified by 
column (silica, DCM/MeOH, 10:1). Yield: 0.86 g. 
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The above product (0.80 g) was suspended in 5mL of acetic anhydride. The suspension 
was heated at 50 
o
C overnight to give a homogeneous dark red solution. The solvent was 
evaporated under reduced pressure and the residue was purified by column (3:2 EtOAc/Hexanes, 
silica was pre-dried in vacuum oven at 150 
o
C for 48 h). After the column, the product was dried 
under high vacuum at room temperature for several days to remove the trace amount of acetic 
acid/anhydride, making 0.75 g of M2 as a foam-like solid. The product was stored in a -20 
o
C 
freezer with drying agents. Note: the two isomers could possibly be separated by careful column 
chromatography, but the separation was not needed and attempted. Combined yield for the 
mixture of 5- and 6-isomer: 55%. 5-isomer 
1
H NMR (500 MHz; DMSO-d6): δ  8.85 (t, J = 5.8 
Hz, 1H), 8.51 (dd, J1 = 1.6 Hz, J2 = 0.7 Hz, 1H), 8.26 (dd,  J1 = 8.1 Hz, J2 = 1.6 Hz, 1H), 7.53 
(dd, J1 = 8.1 Hz, J2 = 0.7 Hz, 1H), 7.30 (dd, J1 = 2.1 Hz, J2 = 0.6 Hz, 2H), 6.95 (dd,  J1 = 8.7 Hz, 
J2 = 2.1 Hz, 2H), 6.93 (dd, J1 = 8.7 Hz, J2 = 0.6 Hz, 2H), 6.30 (t, J = 1.7 Hz, 2H), 3.39 (t,  J = 6.5 
Hz, 2H), 3.32 (m, 2H), 3.09 (quintet,  J = 1.6 Hz, 2H), 2.69 (d, J = 0.8 Hz, 2H), 2.29 (s, 6H), 
1.53 (m, 2H), 1.51 (m, 2H), 1.36 (dt, J1 = 9.7 Hz, J2 = 1.4 Hz, 1H), 1.13 (d,  J = 9.7 Hz, 1H).  
6-isomer 
1
H NMR (500 MHz; DMSO-d6): δ 8.69 (t, J = 5.7 Hz, 1H), 8.21 (dd, J1 = 8.1 Hz, J2 = 
1.4 Hz, 1H), 8.16 (dd,  J1 = 8.1 Hz, J2 = 0.7 Hz, 1H), 7.79 (dd, J1 = 1.4 Hz, J2 = 0.7 Hz, 1H), 
7.31 (dt, J1 = 2.1 Hz, J2 = 0.6 Hz, 2H), 6.97 (dd,  J1 = 8.7 Hz, J2 = 2.1 Hz, 2H), 6.95 (dd, J1 = 8.7 
Hz, J2 = 0.6 Hz, 2H), 6.28 (q, J = 1.7 Hz, 2H), 3.32 (m, 2H), 3.20 (q, J = 6.1 Hz, 2H), 3.04 
(quintet, J = 1.8 Hz, 2H), 2.64 (d,  J = 1.3 Hz, 2H), 2.29 (s, 6H), 1.44 (m, 2H), 1.42 (m, 2H), 
1.30 (dt,  J1 = 9.7 Hz, J2 = 1.5 Hz, 1H), 1.07 (d, J = 9.7 Hz, 1H).   
13
C NMR was not attempted as the product was a mixture. ESI-MS (5- and 6- mixture): 
calculated for [M+H
+
]: 677.2135, found 677.2134. 
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M3. The synthesis of M3 was following the protocol in our previous work,
23
 using exo-
anhydride instead but keeping all other reagents and steps same as previously reported. Similar 
yield was obtained. 
1
H NMR (400 MHz, CDCl3): δ 6.30 (s, 2H), 4.39 (m, 1H), 4.03 (dd, J1 = 8.5 
Hz, J2 = 6.3 Hz, 1H), 3.77 (m, 2H), 3.48 (dd, J1 = 13.4 Hz, J2 = 4.9 Hz, 1H), 3.30 (s, 2H), 2.71 (s, 
2H), 1.51 (d, J = 9.9 Hz, 1H), 1.44 (s, 3H), 1.36 (d, J = 9.9 Hz, 1H), 1.31 (s, 3H). 
13
C NMR (500 
MHz, CDCl3): δ 178.2, 138.1, 110.0, 72.6, 67.5, 48.1, 45.5, 43.0, 41.8, 27.0, 25.6. ESI-MS: 
calculated for [M+Na
+
]: 300.1212, found 300.1225. 
M4. In a 200 mL round bottom flask, cis-5-norbornene-exo-2,3-dicarboxylic anhydride 
(1.64 g, 10 mmol) was suspended in 30 mL of toluene. Ethanolamine (0.61 g, 10 mmol) was 
added into the mixture, and the mixture was stirred and refluxed overnight to give a clear 
solution. The solution was transferred to another 200 mL round bottom flask while hot, to 
remove minor dark insoluble stuff sticking on the flask’s inner surface, if there was any. The 
solution was added acetic anhydride (1.9 mL, 20 mmol), and heated to reflux again. The reaction 
was monitored by TLC. Upon completion, the solution was cooled in an ice bath, and aqueous 
methylamine solution (40% wt. in water, 5 mL, excess) was slowly added to the solution to react 
with excess acetic anhydride, forming water-soluble salt and N-methylacetamide. The resulting 
mixture was partitioned between extra EtOAc (50 mL) and water (80 mL). The organic layer was 
isolated and further washed by aq. NaHCO3 (80 mL) then brine (50 mL), dried over Na2SO4, and 
evaporated to afford 2.27 g of M4 as a yellow oil. The purity of the product was usually high 
enough for successful ROMP, but it can be further purified by flash chromatography to yield a 
colorless oil, which could sometimes turn to a crystalline solid upon thorough drying and cooling 
to low temperature (-20 
o
C). Yield: 91%. 
1
H NMR (500 MHz, CDCl3): δ 6.28 (t, J = 1.6 Hz, 2H), 
4.22 (t, J = 5.4 Hz, 2H), 3.75 (t, J = 5.4 Hz, 2H), 3.27 (t, J = 1.5 Hz, 2H), 2.70 (d, J = 1.1 Hz, 
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2H), 1.99 (s, 3H), 1.51 (dt, J1 = 9.8 Hz, J2 = 1.4 Hz, 1H), 1.30 (d, J = 9.8 Hz, 1H). 
13
C NMR 
(500 MHz, CDCl3): δ 178.1, 171.1, 138.0, 61.9, 48.0, 45.3, 43.0, 35.9, 27.1, 21.1. ESI-MS: 
calculated for [M+Na
+
]: 272.0899, found 272.0898. 
M5. The synthesis of M5 was following the protocol for M4, using 3-amino-1-propanol 
instead but keeping all other reagents and steps as same as previously described. The pure 
product was a colorless oil with similar yield as M4. 
1
H NMR (500 MHz, CDCl3): δ 6.26 (t, J = 
1.7 Hz, 2H), 4.03 (t, J = 6.2 Hz, 2H), 3.54 (t, J = 7.1 Hz, 2H), 3.24 (t, J = 1.5 Hz, 2H), 2.66 (d, J 
= 1.0 Hz, 2H), 2.03 (s, 3H), 1.88 (m, 2H), 1.49 (dt, J1 = 9.8 Hz, J2 = 1.4 Hz, 1H), 1.19 (d, J = 9.8 
Hz, 1H). 
13
C NMR (500 MHz, CDCl3): δ 178.1, 171.1, 138.0, 61.9, 48.0, 45.4, 43.0, 35.9, 27.1, 
21.1. ESI-MS: calculated for [M+Na
+
]: 286.1055, found 286.1057. 
M6. The synthesis of M6 was following the protocol for M4, using 4-amino-1-butanol 
instead but keeping all other reagents and steps as same as previously described. The pure 
product was colorless oil with similar yield as M4. 
1
H NMR (500 MHz, CDCl3): δ 6.26 (t, J = 
1.7 Hz, 2H), 4.03 (m, 2H), 3.46 (m, 2H), 3.24 (t, J = 1.5 Hz, 2H), 2.65 (d, J = 1.1 Hz, 2H), 2.00 
(s, 3H), 1.57-1.63 (m, 4H), 1.48 (dt, J1 = 9.8 Hz, J2 = 1.4 Hz, 1H), 1.18 (d, J = 9.8 Hz, 1H). 
13
C 
NMR (500 MHz, CDCl3): δ 178.2, 171.2, 138.0, 63.9, 48.0, 45.4, 42.9, 38.4, 26.3, 24.7, 21.2. 
ESI-MS: calculated for [M+Na
+
]: 300.1212, found 300.1212. 
M7. In a 200 mL round bottom flask, cis-5-norbornene-exo-2,3-dicarboxylic anhydride 
(3.28 g, 20 mmol) was suspended in 40 mL of toluene. Aqueous methylamine (40% by weight, 
1.90 mL, 22 mmol) was added into the mixture, and the mixture was stirred for 1 h. The resulting 
suspension was heated to reflux overnight. No water removal apparatus was needed for this 
reaction. The resulting solution was concentrated, and the residue was diluted by ethyl acetate 
(60 mL) and washed with 0.1 M HCl (50 mL), water (50 mL) and brine (50 mL), dried over 
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Na2SO4, and evaporated to give a crystalline product. The product can be purified by 
recrystallization in EtOAc/hexanes to give 2.91 g of pure M7 as a white crystalline solid. Yield: 
82% after recrystallization. 
1
H NMR (500 MHz, CDCl3): δ 6.28 (t, J = 1.7 Hz, 2H), 5.14 (m, 1H), 
3.28 (t, J = 1.7 Hz, 2H), 2.97 (s, 3H), 2.70 (d, J = 1.1 Hz, 2H), 1.52 (dt, J1 = 9.9 Hz, J2 = 1.5 Hz, 
1H), 1.20 (d, J = 9.9 Hz, 1H). 
13
C NMR (500 MHz, CDCl3): δ 178.4, 138.0, 48.2, 45.4, 43.1, 
24.8. ESI-MS: calculated for [M+H
+
]: 178.0868, found 178.0870.  
 M8. The dicarboximide (3.26 g, 20 mmol) was dissolved in 40 mL of anhydrous THF, 
followed by the addition of K2CO3 (5.52 g, 40 mmol), dibenzo-18-crown-6 (10 mg, catalytical) 
and 1-chloro-3-methyl-2-butene (prenyl chloride, 2.30 g, 22 mmol). The reaction was refluxed 
overnight. Solvent was removed under reduced pressure, and the residue was partitioned between 
ethyl acetate (50 mL) and water (100 mL). Organic layer was isolated and further washed by 
water (50 mL) and brine (50 mL), dried over Na2SO4, and evaporated. The crude residue was 
purified by column chromatography (EtOAc/hexanes, 1:6 to 1:4) to give 3.61 g of M8 as a white 
solid. Yield: 78%. 
1
H NMR (500 MHz, CDCl3): δ 6.28 (t, J = 1.7 Hz, 2H), 5.14 (m, 1H), 4.05 (d, 
J = 7.1 Hz, 2H), 3.26 (s, 2H), 2.66 (d, J = 1.3 Hz, 2H), 1.76 (s, 3H), 1.69 (s, 3H), 1.49 (dt, J1 = 
9.8 Hz, J2 = 1.3 Hz, 1H), 1.22 (d, J = 9.8 Hz, 1H). 
13
C NMR (500 MHz, CDCl3): δ 178.0, 138.1, 
137.8, 117.6, 48.0, 45.4, 42.9, 36.8, 25.8, 18.2. ESI-MS: calculated for [M+H
+
]: 232.1338, found 
232.1341. Interestingly, this monomers works well with pyridine-modified Grubbs 3
rd
 generation 
catalyst (used in this Chapter) for ROMP, yet has some problems with bromopyridine-modified 
Grubbs 3
rd
 generation catalyst (commercially available from Aldrich), which has slightly higher 
reactivity compared to pyridine-Ru catalyst. Slow reaction between the prenyl groups and the 
catalyst was observed, leading to undesired chain-transfer, uncontrolled molecular weight and 
higher polydispersity. Yet, this cross-reactivity may potentially be useful in some situations. 
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 Typical procedure for polymerization. Monomer M1 (31.8 mg, 0.10 mmol, 25 eq), M2 
(5.4 mg, 0.008 mmol, 2 eq) and M3 (55.4 mg, 0.20 mmol, 50 eq) were dissolved in anhydrous 
dichloromethane (5 mL). The solution was roughly degassed by bubbling with N2 for 30 sec. 
With fast stirring, pyridine-modified Grubbs 2
nd
 Generation catalyst (stock solution, 0.025 M in 
DCM, 0.160 mL, 0.004 mmol, 1 eq) was quickly added. The solution was stirred at room 
temperature for 5 min and NHBoc-CTA (0.125 M in DCM, 0.16 mL, 5 eq) was added. The 
solution was stirred for 3 h and butyl vinyl ether (1 mL) was added to quench the catalyst. 
Solvent was removed under reduced pressure. The solid residue was re-dissolved in DCM (1.5 
mL) and precipitated in ether (12 mL) in a 15 mL polypropylene centrifuge tube. The mixture 
was sonicated, centrifuged, and the supernatant was discarded. The solid was further triturated, 
sonicated, and centrifuged in ether for another 2 times, and the resulting precipitates were dried 
under reduced pressure to give an off-white solid. Yield: 82 mg. Note: the CTA functionalization 
was optional. If the single reactive group is not needed, the polymerization can be directly 
quenched by adding 2 mL of butyl vinyl ether after polymerization. 
 Typical procedure for functionalization with triallyl-Tris. The poly(activated ester) from 
the previous step (80 mg) was dissolved in a mixture of DCM (6 mL) and nitrobenzene (0.1 mL) 
in a 20 mL vial. Triallyl-Tris (100 µL) was added. The vial was capped and sealed by parafilm, 
and the solution was stirred in a 40 
o
C aluminum heating block overnight. Most of the solvent 
was removed under reduced pressure, and the viscous residue was redissolved in DCM (1.5 mL) 
and precipitated in a 2:1 (v/v) mixture of cold ether-hexanes (-15 
o
C) in a 15 mL polypropylene 
centrifuge tube. The mixture was sonicated, centrifuged, and the supernatant was discarded. The 
solid was further triturated, sonicated, and centrifuged in ether for another 2 times. The solid was 
dried under reduced pressure to give an off-white powder. Yield: 69 mg. 
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Typical procedure for intramolecular crosslinking by RCM. A 1 L round-bottom 
flask was filled with 450 mL of anhydrous DCM under nitrogen atmosphere. Allyl polymer from 
previous step (60 mg) was dissolved in 1 mL of DCM in a 7 mL vial, and 12 mg of 1
st
 generation 
Grubbs catalyst was dissolved in 1 mL of DCM in another vial. 0.5 mL of the polymer solution 
was added into the 1 L flask, stirred at room temperature for 5 min, and 0.5 mL of the catalyst 
solution was added. After 3 h, the remaining polymer and catalyst solutions were added. The 
solution was kept stirring at room temperature, and 6 mg catalyst added was added after 6 h, and 
another 6 mg after 18 h. The mixture was stirred for a total time of 40 h after the first catalyst 
addition, and 1 mL of butyl vinyl ether was added to quench the catalyst.  The solution was 
stirred 15 min and evaporated under reduced pressure. The solid residue was dissolved in DCM, 
precipitated in diethyl ether to remove most of the catalyst, and dried on a rotary evaporator. The 
polymer was further purified by passing through silica gel eluted by DCM in a glass pipette. The 
collected fraction was evaporated, and the residue was redissolved in DCM (1.0 mL) and 
precipitated in ether (12 mL). The precipitates were collected after centrifuge, further washed 
with ether, and dried under reduced pressure to give a greyish-white powder. Yield: 57 mg. 
Typical procedure for dihydroxylation of the alkene ONPs. In a 20 mL glass vial, 50 
mg of alkene ONP was suspended in a mixture of water (3 mL) and acetone (12 mL). N-
Methylmorpholine N-oxide (50% wt. in H2O, 0.5 mL) and K2OsO4 (1 mg) was added to the 
mixture. The vial was loosely capped and heated in a 40 
o
C aluminum heating block for 3 - 4 h, 
and the cap was removed. The vial was covered by a piece of chemical paper wipe so that 
acetone can freely and slowly evaporate. Heating and stirring was continued for another 10 - 12 
h and most of acetone was evaporated during this process (and the solution should be 
homogeneous at this time). The solution was decanted to remove insoluble residue (black, if 
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there was any). The green solution was further purified by dialysis against water using a 
membrane (Spectra/Por 7 Membrane Tubing, MWCO = 1000 kDa) and the solution was 
lyophilized to yield a yellow to yellowish-grey solid. Yield: 46 mg. If further deprotection was 
needed, the product solution could be briefly dialyzed for 3 h and directly used in the next step 
without lyophilization (see below). 
Typical procedure for acid-deprotection of the dihydroxylated ONPs. Briefly 
dialyzed ONP solution (containing 40-50 mg of ONP, approximately 5 mL of solution) was 
added trifluoroacetic acid (0.4 mL) to remove the ketal protecting groups. The homogeneous 
solution might become cloudy after the acid addition. The reaction mixture was warmed to 40 
o
C, 
and was stirred for 2.5 h and the solution became mostly clear. The solution was cooled to room 
temperature and was directly dialyzed against dilute NaHCO3 (1.0 g in 4 L of water), then DI 
water, using a membrane (Spectra/Por 7 Membrane Tubing, MWCO = 1000 kDa). The solution 
was filtered and lyophilized to yield a yellow to yellowish-white solid. Yield: 27-40 mg. 
Typical procedure for base-deprotection of the dihydroxylated ONPs. Briefly 
dialyzed ONP solution (containing 40-50 mg of ONP) was added 1 M NaOH to bring the pH to 
13. The homogeneous solution was stirred overnight at room temperature. The resulting solution 
was directly dialyzed against water using a membrane (Spectra/Por 7 Membrane Tubing, 
MWCO = 1000 kDa). The purified solution was filtered and lyophilized to yield a yellow to 
yellowish-white solid. Yield: 30-45 mg. 
 Flow cytometry study. HeLa cells used for ONP uptake experiments were cultured in 
Dulbecco’s modification of Eagle’s medium (DMEM) supplemented with 10% Fetal Bovine 
Serum (FBS), 100 U/mL penicillin, and 100 µg/mL streptomycin, on 25 cm
2
 culture flasks in a 
humidified 5% CO2 incubator at 37 °C. Hela cells were plated onto 35 mm glass-bottom dishes 
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(MatTek) and grown to 70 - 90% confluence before they were used for the study. The cells were 
incubated with 2 mL of DMEM (with or without 10% FBS) containing 2 µM ONPs in glass-
bottom dish for 3 h. The cells were washed with PBS for three times and detached by 0.05% 
trypsin. The suspended cell solution was collected by centrifugation at 2,000 g for 5 min and 
further washed with PBS three times. Flow cytometry was performed using a BD FACSCanto 
system under 488 nm wavelength excitation. Control cells without any treatment were used to set 
the gating. Each measurement set was performed using 10,000 cells. 
RUM1, RUM3, RUM4, RUM5, RUM9 and RUM10. These 6 “imaginative monomers” 
were synthesized from their corresponding monomers according to a general procedure. 
Monomer (one from M3 - M7 and M9) was dissolved in 1 mL of mixed solvents (acetone/t-
butanol, 3:1 v/v) in a 7 mL vial equipped with a magnetic stirbar. N-methylmorpholine N-oxide 
(50% wt. in water) was added to the solution, followed by a catalytic amount of K2OsO4. Upon 
completion (monitored by TLC), the solvent was removed under reduced pressure, and the 
residue was re-dissolved in methanol. The solution was used in LC-MS analysis after further 
dilution in methanol. 
RUM2. The crude RUM1 residue was re-dissolved in 0.1M aqueous HCl. The 
deprotection was monitored by TLC. Upon completion, the solution was carefully neutralized 
with NaOH solution. The solution was used in LC-MS analysis after further dilution in methanol. 
 RUM6, RUM7 and RUM8. These 3 compounds were synthesized from their 
corresponding precursor RUMs according to a general procedure as shown below. The crude 
residue of RUM3, RUM4 or RUM5 was re-dissolved in 1 M aqueous NaOH. The deprotection 
was monitored by TLC (typically overnight). Upon completion, the solution was carefully 
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neutralized with aqueous HCl solution. The solution was used in LC-MS analysis after further 
dilution in methanol. 
 
3.7. Conclusion 
In summary, it has been demonstrated that the lipophilicity of polymeric ONPs prepared 
using a new ROMP-RCM strategy could be facilely tuned by using different monomers, which 
in turn significantly altered the corresponding ONP’s cell uptake profile. With an increase in 
repeating unit lipophilicity and a decrease of ONP size, the cell internalization rate of the 
corresponding ONP increased. In serum-containing biological environments, these ONPs did not 
irreversibly form the typical hard coronas and showed improved cell uptake efficiency as the 
particle lipophilicity increased, similar to the trend observed for many of the “naked” NPs. The 
use of different monomers and adjusting their feed ratios offers the possibility to control the 
ONP-cell interactions directly or in an “on-demand” manner. In addition, these findings further 
indicate that the ROMP-RCM strategy provides promising scaffolds for functional, tuneable, and 
biocompatible delivery vehicles. 
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CHAPTER 4 
DYE-CONTAINING ORGANIC NANOPARTICLES  
AS STABILIZED, FUNCTIONAL FLUOROPHORES 
 
Part of this chapter is adapted from the following publication: 
1. Yugang Bai, Hang Xing, Gretchen A. Vincil, Jennifer Lee, Essence J. Henderson, Yi Lu, N. 
Gabriel Lemcoff and Steven C. Zimmerman, Practical synthesis of water-soluble organic 
nanoparticles with a single reactive group and a functional carrier scaffold. Chem. Sci. 2014, 5, 
2862-2868. 
Collaboration and contribution statement: 
Syntheses of the dendron monomer, fluorescent monomers and polymerization were performed 
in collaboration with Ying Li and Gretchen A. Vincil. The cellular uptake, confocal microscopy 
and cytotoxicity study were performed in collaboration with Nan Zheng.  
 
4.1. Introduction 
A broad range of applications have been found for fluorophores in the field of bioimaging, 
particularly for probing biological processes at the molecular level.
1-5
 However, it is still not 
trivial to achieve aqueous solubility, brightness, photostability and biocompatibility 
simultaneously. Many efforts have been made to solve this problem from different perspectives 
through rational molecular design. For instance, polyglycerol dendrons (PGDs), which are of 
considerable interest because of their high biocompatibility, have been reported to solubilize 
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hydrophobic dyes and drugs to which they are covalently attached.
6-7
 The Haag group attached 
PDGs at the terminal positions of perylenediimide (PDI) and successfully suppressed its 
aggregation in aqueous solution.
8
 Concurrently, the Zimmerman group linked the PDGs at the 
bay positions of PDI so that the terminal positions were available for monovalent recognition 
unit to label living bacteria cell surfaces.
9
 A similar method was applied to a ring-fused 
borondipyrromethene (BODIPY) structure and striking photostability as well as non-blinking 
property for the dye-denron conjugate was observed.
10
 As an alternative to PGDs, hyperbranched 
polyglycrols (HPGs) have attracted increasing attention due to their one-pot large-scale 
polymerization and excellent bicompatibility.
11-15
 Improved photostability has also been 
observed when functionalized HPGs are covalently attached to dyes.
16
 Scientists have also been 
working on many other different strategies for solutions to photobleaching problems, for 
example, the addition of anti-fading agents,
17-18
 the development of new dyes derivatives or new 
fluorophore families with higher stability, and the introduction of quantum dots (QDs).
19
 For all 
of these methods, they all give improvements and disadvantages in different properties. 
Cytotoxicity,
20
 fluorescence quenching, difficulties for functionalization (for example, ligand-
exchange for QDs only),
21
 particularly long synthetic schemes that limit the scalability, were 
commonly found as potential problems. In addition, for few of the examples that have met all the 
criteria mentioned above, unique strategies were tailored for each specific dye. As a result, there 
is an increasing demand for a more facile but generalized approach. 
 In Chapter 2 and 3, a scalable synthetic strategy for ONPs by combining ROMP and 
intramolecular RCM crosslinking is described. Using this highly efficient polymerization 
technique, multiple functional groups, such as activated esters and fluorophores, can be 
incorporated onto polymer backbone and chain-ends. Furthermore, aqueous solubility can be 
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achieved via dihydroxylation (Scheme 4.1, R1 = acetonide). As a proof of concept, fluorescein-
conjugated ONPs were obtained and observed to have significantly increased photostability. In 
this preliminary study, some ONPs were observed to be visibly brighter than fluorescein at the 
same molar concentration because of multiple loading of fluorescein per ONP (Figure 4.1a).   
More importantly, the fluorophore’s performance over time was significantly improved, 
indicating the protective effect of the ONP scaffold (Figure 4.1, a and b). As an example, after 
several hours of UV irradiation on a fluorescent ONP solution (4 fluorophores per ONP), it could 
still show significant fluorescence, while free fluorescein was almost fully bleached. This ONP 
strategy holds promise in developing a generalized approach to solubilize and protect different 
dyes. In this chapter, continued research study on this direction will be described. 
 
 
Figure 4.1. Preliminary results showed improved fluorescent intensity and much improved 
photostability brought by the ONP-protected Fluorescein. The UV irradiation last for 24 h, and 
the fluorescence intensity of the sample was obtained on a fluorometer every 2 h. 
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4.2. Synthesis of dye monomers of different families 
In this collaboration with Ying Li, we seek to apply the strategy to 4,4-Difluoro-4-bora-
3a,4a-diaza-s-indacene (with the common name of borondipyrromethene, BODIPY), 
Coumarin343, PDI and rhodamine, in addition to fluorescein. These dyes were picked out 
according to their molecular structures and photoemission properties. Apart from the chemically 
 
 
Scheme 4.1. Synthetic illustration of the fluorescent ONPs (blue, pXG1-RD), and dendronized 
fluorescent ONPs (green, pXG3-R). R denotes RCM-mediated intramolecular crosslinking, and 
D denotes dihydroxylation. 
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stable PDI and previously reported acetylated fluorescein, other fluorophores used in this system 
were also designed to be compatible (Scheme 4.1). For BODIPY and coumarin343, all the 
alkenes are multi-substituted, significantly reducing their reactivity toward the alkene metathesis 
catalyst, e.g., in our case, the 1
st
 and 3
rd
 generation Grubbs Catalysts.
22
 For rhodamine and 
coumarin343, the amino groups are all alkylated to significantly reduce their nucleophilicity, 
preventing their coordination to the ruthenium catalyst.
23
 It was hoped that this molecular design 
would lead to compatibility with ROMP and RCM. In addition, these dyes have emission 
wavelengths ranging from 450 nm to 590 nm, covering most of the visible spectrum window and 
representing the most commonly used fluorophores in bioimaging studies. The required 
fluorescent monomers can be synthesized in a few steps in at least gram-scale if necessary, and 
the synthetic details are listed in the experimental section. Ying Li, Gretchen A. Vincil and I all 
contributed to the synthesis of monomers and polymers. 
 
4.3. Synthesis of the fluorescent ONPs: advantages and problems 
 Initially, we tried to apply the ONP strategy mentioned above directly to four other dyes: 
BODIPY, coumarin343, PDI and rhodamine. The synthetic scheme was outlined in Scheme 4.1 
(blue sphere). The monomer-to-initiator ratios (M/I ratios) were kept at M1:M2:Mdye:catalyst = 
25:50:2:1, and the synthetic procedure was identical to those described in the previous chapters. 
The fluorescein monomer was replaced by other dye monomers. As designed, all the dyes 
showed excellent compatibility with ROMP and RCM and could be fully incorporated onto the 
polymers. However, unfortunately, although ROMP and RCM were successful for all the dyes, 
BODIPY and coumarin moieties were observed to be unstable under Upjohn dihydroxylation 
condition, which is the mildest dihydroxylation condition.  Interestingly, in a control study using 
90 
 
the BODIPY and coumarin343 monomer directly under Upjohn dihydroxylation condition, 
oxidation or bleaching of the dyes was not observed. The study suggest that the dyes should be 
stable to the dihydroxylation condition as designed, yet the contamination of ruthenium 
compounds from the RCM step could potentially act as a co-catalyst and lead to oxidative 
bleaching of the dyes. This hypothesis is plausible considering the reported strong oxidation 
capabilities of ruthenium oxides as a co-catalyst in organic syntheisis.
24
 Attempts to reduce the 
ruthenium contamination using metal scavenger beads
9
 or DMSO treatment
25-26
 with previously 
reported protocols were conducted. Unfortunately, the metal scavenger tried, Smopex-105, was 
also found to lead to fluorescence quenching. DMSO treatment could significantly reduce the Ru 
contamination, yet the dihydroxylation results were not quite consistent. Because of partial 
oxidation, the molar absorptivity values of coumarin343 and BODIPY ONPs varied from batch 
to batch, and were significantly lower than expected in most cases. These observations suggested 
that the traditional ONP strategy be limited by oxidation-sensitive dyes. 
 Using free dyes (for water-soluble fluorophores) or PEG2k-dye conjugates (for water-
insoluble fluorophores) as comparison, the quantum yields of these fluorescent ONPs in pH 7.4 
phosphate buffer (0.1 M) were tested. After dihydroxylation, all the fluorescent ONPs were well 
soluble in water, but it must be emphasized that oxidative quenching was observed in the case of 
BODIPY and coumarin ONPs. The quantum yields of dyes and ONPs are summarized in Table 
4.1. These numbers confirmed the partial success of this strategy, as all the dyes, no matter 
whether they are aqueous soluble or not, could be transformed into water-soluble ONPs with 
corresponding fluorescence. However, the partial oxidation remained as a problem in the 
synthesis. Tedious purification before dihydroxylation must be performed, yet the outcomes of 
the dihydroxylation reactions were still not consistent. Even though, photobleaching studies were 
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conducted to see whether this ONP scaffold could protect the dyes against photobleaching as it 
did in the case of fluorescein ONP. With a home-made dark box equipped with 475 nm 
wavelength LED (15 V × 1 A), I was able to characterize all the ONPs’ photostability and 
compare the results with free dyes (or PEG2k-dye conjugates). The results were shown in Figure 
4.2. Clearly, with the exception of PDI-ONP, all other ONPs showed a higher photostability 
compared to the corresponding control compound (free dye or PEG2k-dye conjugate). For the 
case of PDI, since the control compound PEG2k-PDI has an extremely low quantum yield (< 
0.1%), it may not be fully appropriate to compare it with PDI-ONP, because such a low quantum 
yield suggests that the molecules’ chance to get into an activated energy state may be very low. 
In summary, the results indicate that a generalized strategy to synthesize stabilized, water-soluble, 
fluorescent ONPs from all 5 monomers is possible, if the problem of oxidative bleaching could  
 
Table 4.1. Excitation and emission wavelengths and the corresponding quantum yields for all 
fluorescent species studies in this chapter. 
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Figure 4.2. Photobleaching studies of dye-containing, non-dendronized ONPs. x-axis is UV 
irradiation time in hour, and y-axis is normalized fluorescence intensity of the ONPs. 
 
be solved in some way. This generalized strategy should also aim to keep the desirable features 
of the above-mentioned ONPs, such as water-solubility, biocompatibility, valence control, and 
photostability enhancement.  
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4.4. Fluorescent ONPs from polyglycerol dendron monomers 
 Although dihydroxylation was essential to grant water-solubility in the above strategy, it 
is definitely not the only approach. In the previous chapters, the property control of ONPs using 
different monomers has been demonstrated and described. Also, considering the abundance of 
hydrophilic hydroxyl groups on PDGs, compact molecular structure and their reliable 
scalability,
6
 we want the incorporation of such dendrons at ROMP step to be an alternative way 
to achieve aqueous solubility. Such PGD-ONPs prepared in this way can be 1) scaled up easily; 
2) sufficiently hydrophilic intrinsically; 3) still compact in hydrodynamic size; 4) compatible 
with many different fluorescent compounds by eliminating the dihydroxylation step. 
 
Scheme 4.2. Schematic illustration of the synthesis of the PGD monomer. The TBDPS-protected 
polyglycerol dendron was synthesized from TBDPS-protected allyl alcohol according to 
previously published procedures.
27
 The synthesis was performed by Ying Li. 
 
 The dendronized ONPs without dihydroxylation were prepared to demonstrate the 
concept with all five representative fluorophores described above. The synthetic process is 
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outlined in Scheme 4.1 (green sphere). In addition, some dihydroxylated PGD-ONPs (PXG3-RD) 
were also prepared as controls. Detailed synthetic procedure for the PGD monomer, 
polymerization conditions and work-up procedures can be found in the experimental section 
(Scheme 4.2). Despite the multiple synthetic steps, the overall yield of this PGD monomer was 
high, and the synthesis was readily scalable to ~10 grams. Considering the tiny amount of 
materials needed for common fluorescence studies, this is a very large scale. 
 
Figure 4.3. NMR spectra of the dendronized polymers. Top: allyl polymer before intramolecular 
crosslinking by RCM; Bottom: PGD-ONP after RCM. NMR spectra were taken by Ying Li. 
 
 Synthesis of the linear polymers and PGD-ONPs were performed using the same 
procedure as described in Chapter 3. The monomer to initiator ratio was M1:M2:Mdye:catalyst = 
25:50:2:1 (R1 = 3
rd
 generation dendron). Expected molecular weights and low polydispersity 
indices were obtained. The linear polymers were intramolecularly crosslinked to yield the ONPs, 
which were directly hydrolyzed using TFA/water without dihydroxylation. It is worth noting that 
the intramolecular crosslinking, although shown to be completed on NMR spectrum (Figure 
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Figure 4.4. (a) to (e): Photobleaching studies of dye-containing, dendronized ONPs; (f) 
photostability comparison between the dihydroxylated PGD-ONP (FG3-RD) and the non-
dihydroxylated PGD-ONP (FG3-R). 
 
4.3), gave much less “size-shrinking” during GPC analysis compared to traditional ONPs. It was 
assumed that it is because the PGD structure is already pretty dense. As designed, the PGD 
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monomers were hydrophilic enough to grant the ONPs water-solubility, and all the fluorophores 
were intact because of the elimination of the dihydroxylation step. Again, using free dyes (for 
water-soluble fluorophores) or PEG2k-fluorophore dyes (for water-insoluble fluorophores) for 
comparison, the quantum yields of these fluorescent PGD-ONPs were tested in pH 7.4 phosphate 
buffer (0.1 M). The quantum yields of dyes and ONPs are summarized in Table 4.1. These 
numbers were exciting, as the brightness of coumarin and BODIPY PGD-ONPs had been 
significantly increased compared to their corresponding non-dendronized ONPs. The results 
suggest that, these bulky PGD moieties not only provide water-solubility, but also hinder the 
potential aggregation of fluorophores because of their bulky size.  
 The photostability of the synthesized PGD-ONPs was also characterized, using the same 
procedures that were described earlier in this chapter. The results were summarized in Figure 4.4. 
As one can easily see in the figure, similar to traditional ONPs, these PGD-ONPs could also 
significantly improve the photostability of the wrapped fluorophores with the exception of PDI, 
which was similar to previous result. Dihydroxylation modifications were also attempted for PDI, 
rhodamine and fluorescein PGD-ONPs, because of their oxidation-resistant property. Results 
showed that these dihydroxylated PGD-ONPs had limited or no improvement on quantum yield 
or photostability (Table 4.1 and Figure 4.4), which further confirmed the feasibility of totally 
removing the dihydroxylation step with the introduction of PGD monomers. 
 All the fluorescent ONPs were also examined in cell uptake experiments. The cell uptake 
of the PGD-ONPs was visualized by confocal microscope, and the obtained images were shown 
in Figure 4.5. The study showed that the ONPs were able to enter the cell, showing their 
potential as imaging agents. Cytotoxicity studies were also conducted using all five dendronized 
fluorescent ONPs. Results were represented as percentage viability of control cells that did not  
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Figure 4.5. Cellular uptake study using all five fluorescent PGD-ONPs using HeLa cells. 
Hoechst 33258 dye was used to stain the nucleus region of the cells. The results clearly showed 
the ONPs’ capability of entering live cells. This study was performed by Nan Zheng. 
 
Figure 4.6. Cytotoxicity evaluation of PGD-ONPs by MTT assay using HeLa cells by Nan 
Zheng. All ONPs showed excellent biocompatibility even at highest concentration tested. 
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receive polymers treatment (Figure 4.6). Similar to other PGD-based soft materials, the 
dendronized PGD-ONPs showed little toxicity even at the highest concentration, confirming the 
excellent biocompatibility of these nanoparticles. 
 
4.5. The effect of incorporated trolox as anti-fading agents 
 Trolox is a vitamin E analog that acts as a triplet state quencher (TSQ) and is commonly 
used as anti-fading agent to improve fluorophores’ photostability and reduce blinking effect. 
Despite its usefulness in literatures, the application of Trolox in live cell imaging studies is 
limited because of its high dosage requirement, low water-solubility and cytotoxicity.
17
 As a 
possible solution, trolox has been conjugated covalently to fluorophores to introduce direct 
contact between the fluorophore and TSQ, which can result in a decrease in triplet-state 
occupancy and thus the rate of singlet-oxygen generation and photo-oxidation.
17
 This was an 
interesting finding, as it showed that such stabilization effect could be achieved by covalent 
linking of TSQ and fluorophores.  
 Considering the PGD’s capability of affording water-solubility and its compatibility with 
ROMP, the incorporation of trolox units into the water soluble dye-polymer scaffold may be 
advantageous in several aspects. First, trolox can be covalently linked with the fluorophores, 
possibly granting further photostability to the dyes. Second, both the dye and trolox can be made 
water-soluble. Lastly, due to the high biocompatibility of PGD, the cytotoxicity of trolox may be 
largely or fully eliminated. To validate this hypothesis, we synthesized a trolox monomer from 
commercially available 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and the lab-
made compound, N-(2-aminoethyl) cis-5-norbornene-exo-2,3-dicarboximide. The protocol of the 
synthesis is listed in the experimental section. 
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 Similar to the fluorescein monomer, the trolox monomer is inherently compatible with 
ROMP and RCM without additional phenol protection. This compatibility is because that 
unprotected phenol on the fluorescein monomer was known to lead to isomerization between 
acid and lactone form.
28
 The carboxylic acid form of the monomer is likely to cause 
incompatibility according to the literature.
29
 In addition, because of the elimination of possible 
isomerization and better organic solubility of fluorescein diacetate,
30
 its derivatives can be 
obtained in higher purity compared to free fluorescein derivatives. There may be unknown 
impurities in unprotected fluorescein monomer that affect the compatibility with ROMP catalysts, 
and the acetylation may also solve this problem. Also, it was noted before that the PGD-ONPs 
gave much less “size-shrinking” after intramolecular crosslinking according to GPC analysis, 
compared to traditional ONPs. This result suggests that the contribution of RCM to a more 
desirable particle diameter is limited in the case of PGD-ONPs. Thus, in addition to avoid the 
dihydroxylation step, it may be possible to skip the RCM step as well whereas the properties of 
dye-containing PGD-ONPs can be retained. 
 Using the same protocol, trolox-containing poly-PGDs were prepared using the same 
procedure as described in Chapter 3. The monomer to initiator ratio was Mdye:M2: 
Mtrolox:catalyst = 2:20:5:1 (R1 = 3
rd
 generation dendron, polymer was labelled as pFG3T-2-20-5 
accordingly). A control polymer that does not contain Mtrolox (FG3T-2-20-0) was also 
synthesized as a control. These PGD polymers were directly treated by TFA/water to afford 
water solubility without the RCM or dihydroxylation steps. Preliminary studies showed that with 
fluorescein as the fluorophore, the quantum yields for the trolox-containing polymer and the 
trolox-free polymer were quite close. Yet for more hydrophobic fluorophores like PDI, the 
trolox-containing polymers showed a much lower quantum yields compared to the corresponding 
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trolox-free polymer, possibly because of the hydrophobic trolox-induced dye aggregation, or the 
direct fluorescence quenching from the TSQ. However, for the fluorescein polymers, better 
photostability for trolox-containing polymer was observed, in the comparison with the control 
polymer (Figure 4.7). More experiments must be performed to validate this strategy. With the 
tuning of trolox loading and polymer molecular weight, a balance between brightness and 
photostability may be achieved. 
 
 
Figure 4.7. Photobleaching study of the trolox-containing, Fluorescein PGD polymer (FG3T-2-
20-5). A control polymer that does not contain trolox (FG3T-2-20-0) was used for comparison. 
 
4.6. Experimental section 
Instrumentation. The general instrument setup was described in Section 2.8. 
Materials. All reagents were purchased from Acros Organics, Fisher Scientific, AK 
Scientific, TCI America, or Sigma-Aldrich, and used without further purification unless 
otherwise noted. Dichloromethane (DCM), pyridine, THF, benzene, toluene, nitrobenzene, 
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DMSO and DMF were stored over activated 4Å molecular sieves. Other solvents were used as 
received. Triethylamine was dried over KOH pallets. Diisopropylethylamine was dried over 4Å 
molecular sieves. cis-5-Norbornene-exo-2,3-dicarboxylic anhydride
31
 and tris(allyloxymethyl)-
aminomethane (Triallyl-Tris)
32
 were synthesized according to procedures in literature. Pyridine-
modified Grubbs 2
nd
 Generation catalyst, which is usually referred as Grubbs 3
rd
 Generation 
catalyst for ROMP polymerization, was synthesized using a modified literature protocol
33
 from 
Grubbs 2
nd
 Generation catalyst and pyridine instead of bromopyridine. Coumarin343 methyl 
ester was synthesized according to a literature procedure.
34
 TBDPS-protected 3
rd
 generation 
polyglycerol dendron (TBDPSO-G3PGD-OH) was synthesized according to literature 
procedures.
27
 
Coumarin343 monomer. This monomer was synthesized by Ying Li. To a suspension of 
coumarin343 methyl ester (2 g, 6.7 mmol) in 30 mL of MeOH was added 10 mL of 4 M LiOH 
aqueous solution. The mixture was stirred at room temperature for 2 h and became a clear 
solution. The solution was acidified with 4 M HCl and extracted with DCM (50 mL) for 5 times. 
The combined organic layers were dried over Na2SO4 and concentrated under vacuum to afford 
580 mg of product as a brown solid. Yield: 30%. The crude product was used in the next step 
without further purification. 
1
H NMR is consistent with literature.
34
 
The synthesized Coumarin343-acid (200 mg, 0.70 mmol) and N-(3-aminopropyl) cis-5-
norbornene-exo-2,3-dicarboximide (synthesized from cis-5-norbornene-exo-2,3-dicarboxylic 
anhydride and 1,4-diaminobutane, 184 mg, 0.83 mmol) in 4 mL of DCM was added DMAP (40 
mg, 0.16 mmol) and EDC·HCl (400 mg, 2.1 mmol). The mixture was stirred overnight at room 
temperature, washed with saturated brine (4 mL), dried over Na2SO4 and concentrated under 
vacuum. The crude product was purified by gradient column chromatography (silica, 
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EtOAc/Hexanes, v/v 1:4 to 1:1) to give 315 mg of the product as a dark yellow solid. Yield: 92%. 
1
H NMR (500 MHz, CDCl3): δ 9.03 (br, 1H), 8.56 (s, 1H), 6.98 (s, 1H), 6.27 (s, 2H), 3.58 (m, 2 
H), 3.41 (m, 2H), 3.31 (m, 4H), 3.27 (s, 2H), 2.87 (m, 2H), 2.76 (m, 2H), 2.69 (s, 2H), 1.96 (br, 
4H), 1.87 (m, 2H), 1.51 (d, J = 10 Hz, 1H). 
BODIPY monomer. N-(2-chloroethyl) cis-5-norbornene-exo-2,3-dicarboximide (1.6 g, 
7.1 mmol), 4-hydroxybenzaldehyde (0.87 g, 7.1 mmol), K2CO3 (3.0 g, 21.7 mmol), dibenzo-18-
crown-6 (5 mg, catalytic), and tetrabutylammonium iodide (50 mg, catalytical) were mixed in 15 
mL of anhydrous DMF. The reaction was heated up to 130 
o
C and TLC was used to monitor the 
reaction. Upon total consumption of the dicarboximide, the mixture was cooled to room 
temperature, and partitioned between ethyl acetate (75 mL) and water (200 mL). The combined 
organic layers were collected, and washed by 1 M NaOH (75 mL), water (75 mL) and brine (50 
mL),  dried over Na2SO4. The solvent was evaporated and the residue was purified by column 
chromatography (silica, EtOAc/hexanes, 1:4 to 1:1) to give 0.6 g of the product, N-(2-(p-
fomylbenzoxy)ethyl) cis-5-norbornene-exo-2,3-dicarboximide, as a viscous brown oil. Yield: 
27%. Alternatively, this compound could also be afforded by reflexing cis-5-norbornene-exo-
2,3-dicarboximide (1.5 g, 9.2 mmol), p-(2-bromoethoxy)benzaldehyde (2.1 g, 9.2 mmol) and 
K2CO3 (3.0 g, 21.7 mmol) in 25 mL of ethanol for 15 h. Ethanol was removed by rotavap, and 
the residue was purified by column chromatography (silica, EtOAc/hexanes, 4:5) to give 2.1 g 
product as a yellow oil. Yield: 73%. 
1
H NMR (400 MHz; CDCl3): δ 9.85 (s, 1H), 7.80 (d, 2H), 
6.93 (d, 2H), 6.25 (s, 2H), 4.22 (t, 2H), 3.93 (t, 2H), 3.25 (s, 2H), 2.68 (s, 2H), 1.44 (d, 1H), 1.23 
(d, 1H). 
Synthesis of the BODIPY was analogous to a previously published protocol.
35-36
 Briefly, 
the synthesized N-(2-(p-fomylbenzoxy)ethyl) cis-5-norbornene-exo-2,3-dicarboximide (1.26 g, 
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4.0 mmol) was mixed with cryptopyrrole (1.0 g, 8.1 mmol) in 20 mL of DCM. A few drops of 
trifluoroacetic acid were added. The dark reaction mixture was stirred at room temperature until 
total disappearance of the aldehyde. Chloranil, (0.98 g, 4.0 mmol), DIPEA (3.62 g, 28 mmol, 5 
min after chloranil addition) and finally trifluoroborate etherate (6.24 g, 44 mmol, right after 
DIPEA addition) were successively added. The mixture was stirred at room temperature 
overnight. The filtrate was concentrated and the residue was purified by chromatography on 
silica (DCM/hexanes, 5:1). The obtained organge-red solid was then suspended in 25 mL of 1:1 
ether/hexanes mixture, sonicated, and filtered to give 1.4 g of the pure product as a reddish 
powder. Yield: 60%. 
1
H NMR (500 MHz; CDCl3): δ 7.15 (d, J = 8.6 Hz, 2H), 6.95 (d, J = 8.6 Hz, 
2H), 6.32 (t, J = 1.7 Hz, 2H), 4.22 (t, J = 5.8 Hz, 2H), 3.97 (t, J = 5.8 Hz, 2H), 3.32 (t, J = 1.5 Hz, 
2H), 2.75 (d, J = 1.0 Hz, 2H), 2.53 (s, 6H), 2.30 (q, J = 7.5 Hz, 4H), 1.48 (dt, J1 = 9.8 Hz, J2 = 
1.5 Hz, 1H), 1.34 (d, J = 9.8 Hz, 1H), 1.31 (s, 6H), 0.99 (t, J = 7.5 Hz, 6H). 
13
C NMR (500 MHz, 
CDCl3): 178.09, 158.60, 153.71, 140.11, 137.97, 132.81, 131.25, 129.65, 128.61, 115.15, 63.90, 
48.03, 45.48, 42.72, 37.85, 17.21, 14.78, 12.63, 11.96. 
11
B NMR (128 MHz, CDCl3): δ 0.85 (t, J 
= 33.4 Hz). 
19
F NMR (376 MHz, CDCl3): δ -146.3 (q, J = 33.5 Hz). 
Fluorescein monomer. This monomer’s synthesis is described in Chapter 3. 
PDI monomer. Tetrachloroperylene tetracarboxylic acid dianhydride (532  mg, 1.00 
mmol), N-(3-aminopropyl) cis-5-norbornene-exo-2,3-dicarboximide (231 mg, 1.05 mmol) and t-
butyl aminoacetate hydrochloride (176 mg, 1.05 mmol) were mixed in 15 mL of dry pyridine. 
The mixture was heated to 80 
o
C to generate a homogeneous solution, and was kept stirring for 
20 h. Solvent was removed under reduced pressure, and the residue was purified on column 
(silica, EtOAc/hexanes, 1:5 to 1:3) to give 210 mg of the PDI monomer as a bright orange 
powder. Yield: 25%. 
1
H NMR (500 MHz; CDCl3): δ 8.71 (s, 2H), 8.68 (s, 2H), 6.32 (t, J = 1.5 
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Hz, 2H), 4.89 (s, 2H), 4.25 (t, J = 7.4 Hz, 2H), 3.66 (t, J = 6.9 Hz, 2H), 3.32 (t, J = 1.9 Hz, 2H), 
2.74 (d, J = 1.0 Hz, 2H), 2.07 (tt, J1 = 7.4 Hz, J2 = 6.9 Hz, 2H), 1.59 (d, J1 = 9.4 Hz, 1H), 1.53 (s, 
9H), 1.34 (d, J = 9.4 Hz, 1H). 
13
C NMR (500 MHz, CDCl3): 178.3, 166.7, 162.4, 162.2, 138.1, 
135.7, 135.6, 133.5, 133.2, 131.6(9), 131.6(6), 129.1, 128.9, 123.7, 123.5, 123.3, 123.0, 83.0, 
48.1, 45.5, 43.1, 42.6, 38.8, 36.7, 28.3, 26.9. MALDI-TOF MS: Calculated for [M
+
] 845.1, 
obtained 846.1 [M+H
+
], 791.1 [M minus tert-butyl]. 
Rhodamine monomer. This monomer was synthesized by Gretchen A. Vincil. To a 
suspension of dimethylaminophenol (10.0 g, 73.0 mmol) and 1,2,4-benzenetricarboxy-anhydride 
(7.01 g, 36.5 mmol) in 500 mL of propionic acid was added p-toluenesulfonic acid (322 mg, 1.6 
mmol). The mixture was refluxed for 48 h. The solvent was removed via rotary evaporation and 
azeotroped with water. The crude product was purified by gradient column chromatography 
(silica, MeOH-DCM, v/v 1:4 to 3:2) to give 1.88 g of the product, 5(6)-
carboxytetramethylrhodamine, as a dark purple solid (5/6 isomer in an approx. 4:5 ratio). Yield: 
11.9%. 
1
H NMR (500 MHz; CD3OD): δ 8.79 (d, J = 1.5 Hz, 1H), 8.27 (d, J = 1.2 Hz, 1H), 8.25 
(d, J = 1.6 Hz, 1H), 8.17 (d, J = 8.2 Hz, 1H), 7.86 (d, J = 1.6 Hz, 1H), 7.38 (d, J = 7.9 Hz, 1H), 
7.25 (d, J = 9.5 Hz, 2H), 7.23 (d, J = 9.5 Hz, 2H), 7.032 (dd, J1 = 9.5 Hz, J2 = 1.0 Hz, 2H), 7.027 
(dd, J1 = 9.4 Hz, J2 = 0.8 Hz, 2H), 6.93 (d, J = 2.6 Hz, 2H), 6.92 (d, J = 2.6 Hz, 2H), 3.28 (s, 
12H). ESI (m/z): [M]
+
 calcd for 430.1; found 431.0 [M+H
+
].  
To a solution of 5(6)-carboxytetramethylrhodamine (578 mg, 1.38 mmol) and N-
hydroxysuccinimide (168 mg, 1.46 mmol, 1.05 eq) in 15 mL of dry DMF was added EDC·HCl 
(315 mg, 1.85 mmol, 1.3 eq). The mixture was allowed to stir at room temperature for 20 min. 
To the mixture was added N-(4-aminobutyl) cis-5-norbornene-exo-2,3-dicarboximide (350 mg, 
1.49 mmol, 1.08 eq) and the reaction was stirred overnight at room temperature. The DMF was 
105 
 
removed via rotary evaporation and the residue was dissolved in EtOAc (40 mL). The organic 
layer was washed with water (40 mL), 0.1 M HCl (40 mL), and brine (20 mL). The organic layer 
was dried over MgSO4 and concentrated down under reduced pressure. The crude product was 
purified via gradient column chromatography (silica, MeOH-DCM, v/v 1:9 to 1:3) to give 700 
mg of the 5(6)-rhodamine monomer as a dark purple solid. Yield: 79%. Note: isomers could be 
separated with careful chromatography. 5-Isomer: 
1
H NMR (500 MHz; CD3OD): δ 8.66 (d, J = 
1.5 Hz, 1H), 8.16 (dd, J1 = 7.9 Hz, J2 = 1.5 Hz, 1H), 7.45 (d, J = 7.9 Hz, 1H), 7.18 (d, J = 9.5 Hz, 
2H), 7.04 (dd, J1 = 9.5 Hz, J2 = 2.4 Hz, 2H), 6.96 (d, J = 2.4 Hz, 2H), 6.33 (t, J = 1.7 Hz, 2H), 
3.55 (m, 2H), 3.48 (m, 2H), 3.30 (s, 12H), 3.19 (t, J = 1.7 Hz, 2H), 2.73 (d, J = 1.1 Hz, 2H), 1.68 
(m, 4H), 1.50 (dt, J1 = 9.8 Hz, J2 = 1.4 Hz, 1H), 1.26 (d, J = 9.8 Hz, 1H). 6-Isomer: 
1
H NMR 
(500 MHz; CD3OD): δ 8.27 (d, J = 8.2 Hz, 1H), 8.12 (dd, J1 = 8.2 Hz, J2 = 1.8 Hz, 1H), 7.74 (d, 
J = 1.8 Hz, 1H), 7.20 (d, J = 9.5 Hz, 2H), 7.04 (dd, J1 = 9.5 Hz, J2 = 2.5 Hz, 2H), 6.96 (d, J = 2.5 
Hz, 2H), 6.30 (t, J = 1.7 Hz, 2H), 3.48 (m, 2H), 3.40 (m, 2H), 3.30 (s, 12H), 3.12 (t, J = 1.6 Hz, 
2H), 2.68 (d, J = 1.0 Hz, 2H), 1.60 (m, 4H), 1.42 (dt, J1 = 9.8 Hz, J2 = 1.4 Hz, 1H), 1.18 (d, J = 
9.8 Hz, 1H). 
13
C NMR was not attempted as the product was a mixture. MS ESI+ Calc’d: 646.28 
for lactone form [M
+
]. Found: 647.1 [M+H
+
]. 
Synthesis of the PGD monomer. This monomer was synthesized by Ying Li. To a 
solution of TBDPS-protected 3
rd
 generation polyglycerol dendron (TBDPSO-G3PGD-OH, 1.24 
g, 1.6 mmol) and 2,2’-dimethoxypropane (8 ml, 65 mmol) in 10 mL of DMF was added 4-
toluenesulfonic acid (1.04 g, 6.0 mmol). The mixture was stirred overnight at 60 
o
C. The reaction 
was quenched by adding TEA (0.5 ml, 3.6 mmol) and concentrated under vacuum. The mixture 
was re-dissolved in DCM and washed with water (50 mL) and brine (50 mL). The organic layer 
was dried over Na2SO4 and the solvent was removed under vacuum. The crude product was 
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purified by gradient column chromatography (silica, EtOAc/hexanes, v/v 1:4 to 1:1) to give 1.2 g 
of the ketal-protected product (TBDPSO-G3PGD-prot) as a brown oil. Yield: 82%. 
1
H NMR 
(500 MHz, CDCl3): δ 7.65 (br, 4H), 7.41 (br, 2H), 7.38 (br, 4H), 4.21 (br, 4H), 4.01 (br, 4H), 
3.75-3.40 (br, 28 H), 1.39 (m, 12H), 1.10 (m, 12H), 1.04 (s, 9H).  
To a solution of TBDPSO-G3PGD-prot (2 g, 2.1 mmol) in 15 mL of THF was added 
TBAF (1 M in THF, 4 mL, 4 mmol). The mixture was stirred at room temperature overnight and 
concentrated down under vacuum. The mixture was re-dissolved in DCM and washed with water 
and brine. The organic layer was dried over Na2SO4 and the solvent was removed under reduced 
pressure. The crude product was purified by gradient column chromatography (silica, 
EtOAc/hexanes, v/v 1:4 to 1:0) to give 1.3 g of the de-silylated compound (HO-G3PGD-prot) as 
a yellow oil. Yield: 87%. 
1
H NMR (500 MHz, CDCl3): δ 4.27 (br, 4H), 4.05 (br, 4H), 4.00 (m, 
2H), 3.72 (m, 4H), 3.63-3.48 (br, 20 H), 2.65 (br, 2H), 1.42 (br, 12H), 1.36 (br, 12H). ESI (m/z): 
[M]
+
 calcd for C33H60O15, 696.4; found, 697.6, [M+H]
+
. 
To a solution of HO-G3PGD-prot (1.31 g, 1.9 mmol) and 4-toluenesulfonic chloride 
(1.43 g, 7.5 mmol) in 10 mL of DCM was added TEA (3.2 mL, 23 mmol). The mixture was 
washed with saturated NH4Cl aqueous solution and brine. The organic layer was dried over 
Na2SO4 and the solvent was removed under reduced pressure. The crude product was purified by 
gradient column chromatography (silica, EtOAc/hexanes, v/v 1:4 to 2:1) to give 1.28 g of the 
tosylated dendron (TsO-G3PGD-prot) as a yellow oil. Yield: 80%. 
1
H NMR (500 MHz, CDCl3): 
δ 7.79 (d, J = 8.5 Hz, 2H), 7.35 (d, J = 8.5 Hz, 2H), 4.25 (m, 4H), 4.04 (m, 4H), 3.75-3.40 (br, 27 
H), 2.46 (s, 3H), 1.41 (br, 12H), 1.34 (br, 12H). ESI (m/z): [M]
+
 calcd for C40H66O17S, 850.4; 
found, 851.5, [M+H]
+
. 
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To a solution of TsO-G3PGD-prot (3.4 g, 4.0 mmol) in 10 mL of DMF was added 
sodium azide (4 g, 62 mmol). The mixture was heated overnight at 90 
o
C and concentrated under 
reduce pressure. The crude product was purified by gradient column chromatography (silica, 
EtOAc/hexanes, v/v 1:4 to 1:2) to give 2.8 g of the azido-dendron (N3-G3PGD-prot) as a light 
yellow oil. Yield: 97%. 
1
H NMR (500 MHz, CDCl3): δ 4.25 (br, 4H), 4.04 (m, 4H), 3.78-3.43 (br, 
25 H), 3.38 (br, 1H), 3.30 (br, 1H), 1.41 (br, 12H), 1.35 (br, 12H). ESI (m/z): [M]
+
 calcd for 
C33H59N3O14, 721.4; found, 744.3 [M+Na]
+
. 
To a solution of N3-G3PGD-prot (0.5 g, 0.69 mmol) in 10 mL of MeOH was bubbled 
through N2 for 30 min and added 10% palladium on carbon (30 mg, 0.028 mmol). The mixture 
was charged with H2 up to 200 psi and stirred overnight at room temperature. The reaction bomb 
was vented and the mixture was filtered with a celite plug. The filtration was concentrated down 
under vacuum to give 0.5 g of the reduced product (H2N-G3PGD-prot), which was used without 
further purification. Yield: > 95%. 
1
H NMR (500 MHz, CDCl3): δ 4.25 (br, 4H), 4.04 (m, 4H), 
3.78-3.38 (br, 25 H), 2.85 (br, 1H), 2.73 (br, 1H), 1.50 (br, 2H), 1.40 (br, 12H), 1.35 (br, 12H). 
ESI (m/z): [M]
+
 calcd for C33H61NO14, 695.4; found, 696.4, [M+H]
+
. 
To a solution of H2N-G3PGD-prot (696 mg, 1 mmol) and N-Glycine cis-5-norbornene-
endo-2,3-dicarboximide (230 mg, 1.04 mmol) in 10 mL of DCM was added DMAP (12 mg, 0.1 
mmol) and EDC (310 mg, 2 mmol). The mixture was stirred overnight at room temperature, 
diluted with additional DCM (20 mL), and washed with water (20 mL × 2) and brine (20 mL). 
The organic layer was separated and dried over Na2SO4. Solvent was removed under reduced 
pressure on a rotary evaporator. The crude product was purified by gradient column 
chromatography (silica, EtOAc/hexanes, v/v 1:4 to 2:1) to give 819 mg of the PGD monomer as 
an orange oil. Yield: 91%. 
1
H NMR (500 MHz, CDCl3): δ 6.29 (s, 2H), 4.24 (br, 4H), 4.13 (br, 
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2H), 4.04 (m, 4H), 3.78-3.42 (br, 28 H), 3.30 (s, 2H), 2.71 (s, 2H), 1.88 (d, J = 10 Hz, 1H), 1.51 
(d, J = 10 Hz, 1H), 1.41 (br, 12H), 1.35 (br, 12H). ESI (m/z): [M]
+
 calcd for C44H70N2O17, 898.5; 
found, 899.4, [M+H]
+
, 921.4,  [M+Na]
+
. 
Synthesis of the trolox monomer. 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic 
acid (1.25 g, 5.0 mmol) and N-(2-aminoethyl) cis-5-norbornene-exo-2,3-dicarboximide (1.03 g, 
5.0 mmol) was dissolved in 10 mL of anhydrous DMF. EDC·HCl (1.05 g, 5.5 mmol) and DMAP 
(10 mg, catalytical) was added. The reaction was stirred at room temperature overnight. The 
resulting solution was partitioned between ethyl acetate (75 mL) and water (200 mL). Organic 
layer was collected and washed by dilute hydrochloric acid (0.1 M, 50 mL), water (100 mL) and 
brine (100 mL), before it was dried over Na2SO4. Solvent was evaporated under reduced pressure, 
and the residue was purified by column chromatography (silica, EtOAc/hexanes, 1:1 to 2:1) to 
give 1.32 g of the product as a white solid. Yield: 60%. 
1
H NMR (400 MHz, CDCl3): δ 6.69 
(broad t, J = 5.0 Hz, 1H), 6.24 (t, J = 1.6 Hz, 2H), 4.26 (s, 1H), 3.59-3.65 (m, 2H), 3.50-3.59 (m, 
1H), 3.27-3.35 (m, 1H), 3.18 (d, J = 1.2 Hz, 1H), 3.14 (d, J = 1.2 Hz, 1H), 2.54-2.63 (m, 2H+1H), 
2.43-2.53 (m, 1H), 2.25-2.33 (m, 1H), 2.19 (s, 3H), 2.16 (s, 3H), 2.06 (s, 3H), 1.74-1.84 (m, 1H), 
1.43 (s, 3H), 1.40 (dt, J1 = 9.9 Hz, J2 = 1.4 Hz, 1H), 1.09 (d, J = 9.9 Hz). 
Polymerization. Polymerization was effected analogous to the procedures described in 
Chapter 3 of Part 1. 
Cellular uptake study of the PGD-ONPs. This study was performed by Nan Zheng. 
HeLa cells cultured on coverslips in 6-well plate were incubated with polymers in DMEM (2 mL) 
at a concentration of 15 μg polymer per well for 4 h. The ONP-treated cells were washed three 
times with PBS, fixed with 4% paraformaldehyde solution, and stained with Hoechst 33258 dye 
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(2 μg/mL). The stained cell was visualized by confocal laser scanning microscopy on different 
wavelength channels (CLSM, LSM700, Zeiss, Germany). 
Cytotoxicity study of the PGD-ONPs. This study was performed by Nan Zheng. HeLa 
cells were seeded on 96-well plates at 1×10
4
 cells/well and cultured in serum-containing media 
for 24 h. The medium was replaced with fresh DMEM containing serum (100 μL/well), into 
which polymers were added at the final concentrations of 100, 50, 20, and 10 μg/mL, 
respectively. The cells were incubated at 37 °C for 4 h, and the medium was changed to fresh 
serum-containing DMEM. The cells were further cultured for 24 h and their viability was 
assessed by the MTT assay. Results were represented as percentage viability of control cells that 
did not receive polymers treatment. 
 
4.7. Conclusion 
 In conclusion, together with my collaborators, we devised a new strategy to protect 
organic dyes by wrapping them in intramolecularly crosslinked polymers. The unstable dyes 
such as fluorescein showed much greater stability against UV irradiation after polymeric 
wrapping, indicating that the crosslinked polymer had a strong protective effect. With the 
incorporation of PGD monomers, a more generalized strategy could be acquired because of the 
elimination of dihydroxylation step. Such general strategy was applied on fluorophores from 
different families, including fluorescein, coumarin, BODIPY, PDI and rhodamine. The dye 
loading of the particles could be facilely adjusted, with the possibility of achieving high loading 
numbers per particle. The particles could be tuned to be monovalent, divalent or polyvalent to 
meet different requirements. The study on real application of such ONPs in imaging and tracking 
fields could be possible in the future. 
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CHAPTER 5 
ONP-DNA CONJUGATES AS USEFUL HYBRID BIOMATERIALS 
 
Collaboration and contribution statement: 
The TEM characterization was performed in collaboration with Hang Xing. The flow cytometry 
study was performed in collaboration with Hang Xing and Peiwen Wu. The titration and 
adenosine sensor studies were performed in collaboration with Hang Xing and Jing Tao.  
 
5.1. Introduction 
Nanotechnology has offered many opportunities to synthesize ultra-small functional 
materials, which can be used as imaging agents, targeting moieties and delivery carriers.
1-9
 
Conjugation and hybridization of functional, nano-sized “modular parts” become more necessary 
for further development in these applications, as they enable the preparation of more complicated 
materials in a facile way.
10-12
 Along with the advantages of nanomaterial “parts”, the 
functionalization of functional DNAs (fDNAs) as recognizing and targeting molecules onto these 
nanomaterials has been reported to be highly selective and efficient in cellular analysis, imaging 
and targeted delivery.
13-19 The development of fDNA-nanomaterial conjugates for diagnostic and 
therapeutic applications has been rapid in the past decade. Researchers have identified a wide 
range of fDNA with high binding affinity to different targets, including multiple protein families 
of clinical interest including kinases, growth factors, and cell-surface receptors (Table 5.1).
20-23
 
One DNA aptamer-based drug has already been approved by the US Food and Drug 
Administration (FDA), and several others are currently under clinical evaluation.
24
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Table 5.1. A selection of DNA aptamers that are known to target proteins of therapeutic 
interests.
25
 
Aptamer Protein Target Target Function Cell Lines 
AX102 
Platelet-derived growth 
factor B (PDGF-B) 
Related to mesangial cell 
proliferation and matrix 
accumulation 
SKOV3ip1, 
KAT-4, 3T3 
TD05 
Immunoglobulin heavy 
mu chain (IGHM) 
Related to Burkitt’s lymphoma 
development 
Ramos 
AS1411 Nucleolin Cell proliferation 
MCF-7, MDA-
MB-231, 4T1 
Sgc8c 
Protein tyrosine kinase 7 
(PTK7) 
Transmembrane receptor, colon 
carcinoma kinase-4 
CCRF-CEM 
GBI-10 Tenascin-C 
Involved in embryogenesis and 
oncogenesis pathways 
U251 
 
The previous chapters have described a new strategy for the preparation of water-soluble, 
readily functionalized, and biocompatible ONP scaffolds.
26
 Various chemical strategies can be 
used to control the properties of the ONPs as shown in Chapter 3 and 4, yet a combination with 
fDNA technologies is still attractive because of the simple chemistry, commercially available 
fDNA library, and the various functions that fDNAs can offer. In this chapter, a general strategy 
to prepare ONP-DNA conjugates is described, and some application examples will be given to 
show the usefulness of this chemistry. 
 
5.2. Valence control, orthogonal conjugation and the usefulness of block copolymers 
 A special advantage of this ONP-DNA conjugate is the possibility to facilely control the 
valence of the resulting ONP, thus the number of DNA per ONP is easily tuned. The ROMP 
process in the ONP synthesis allows three valence control modes. From a ROMP-RCM process 
using M1, M2, M3 and azido-CTA (Scheme 5.1 and Figure 5.1), the resulting ONP can be 1) 
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monovalent, 2) divalent, or 3) multivalent with precise control over the average number of 
reactive groups per particle. Monovalent and divalent ONPs can be easily synthesized from the 
intramolecular crosslinking of the corresponding linear polymers, and the syntheses of such 
monotelechelic and bis-telechelic linear polymers are well established.
27-30
 Many literature 
examples have shown that monovalent linear polymers can be synthesized by end-capping of the 
active chain-end of the polymer using chain-transfer agents (CTAs).
26, 28-30
 Similarly, divalent 
linear polymers can be synthesized by using an in situ generated functionalized initiator, 
followed by end-capping using a CTA.
28
 For multivalent ONPs, the simplest strategies are to 
introduce the functionalities by using functionalized monomers or through post-functionalization. 
The three pathways for valence control are summarized in Scheme 5.1. 
 To maximize the conjugation efficiency between the two macromolecules, ONP and 
DNA, copper-free click chemistry using azide and azadibenzocyclooctyne (ADIBO) was 
utilized.
31
 In short, the ONPs were pre-loaded with azido groups by using an azido-CTA. 
Functional DNAs were purchased from commercial resources, with a protected thiol group on 
the 3’-end. The thiol group was released by reduction using tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP·HCl), and was then reacted with ADIBO-maleimide to give an ADIBO-
functionalized DNA. The DNA was coupled with the azido-ONP at 37 
o
C to give the desired 
conjugate (Scheme 5.2). ONP or DNA can be used in excess (based on the reaction) in order to 
improve the conjugation yield. 
Another procedure to improve the reactivity of ONPs is to adopt a block copolymer 
strategy. Because the ONPs are synthesized from a random intramolecular crosslinking process, 
the terminal azido groups have a chance to be deeply buried inside the particle, making them 
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Scheme 5.1. Illustration of ONP functionalization. NHBoc-CTA is shown as an example here to 
grant mono- or dual-functionalized, aqueous soluble ONPs, and the Sharpless 
aminohydroxylation is shown as a post-functionalization strategy to grant multi-valence. 
Functional groups other than amine can be easily incorporated by using different CTAs, and 
functional monomers can also be used to generate multiple functional moieties for the final 
ONPs. 
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Figure 5.1. Monomers and chain-transfer agent used in the ONP synthesis. 
 
 
 
Scheme 5.2. Illustration of ADIBO functionalization of thiol-DNA, and the copper-free click 
chemistry between ONP and DNA. 
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Scheme 5.3. “Tailed” monofunctional ONPs obtained from diblock polymers. Similarly, di-
functional ONPs can be prepared from triblock linear polymers. 
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inaccessible for conjugation to the DNA, leading to low yields. To solve this potential problem, 
spacer blocks can be added between the terminal azido group(s) and the crosslink-able backbone. 
The spacer blocks do not contain any allyl groups, rendering them totally irrelevant to the 
crosslinking process. Once the polymer is crosslinked, this spacer block will become an 
uncrosslinked tail, and have a better chance to remain outside of the resulting particle, granting a 
higher chance for the azido groups to react with ADIBO-DNAs (Scheme 5.3). Divalent ONP 
could be synthesized using a similar strategy, in which a bis-telechelic triblock copolymer was 
effected from a pre-functionalized Grubbs 3
rd
 catalyst and end-capped by excess of CTAs. 
 
5.3. Synthesis, purification and characterization ONP-DNA conjugates 
 The polymerization, allylation, crosslinking, dihydroxylation and deprotection steps 
during the preparation of the monovalent and divalent ONPs could be conducted using the 
general procedures described in Chapter 3. The protocol for multivalent polymer preparation 
differed slightly. Briefly, the poly(activated ester) was functionalized with 6-azidohexyl-1-amine 
first. The average amount of azido functional groups per polymer chain was be controlled by 
tuning the equivalence of the added 6-azidohexyl-1-amine. The polymer was then allylated, 
crosslinked and dihydroxylated using the general procedure described in Chapter 3. The TEM 
images of three different sized ONPs can be found in Figure 5.2. 
To provide evidences for ratiometric conjugation of the DNA on the ONPs, multiple 
experiments were performed to validate the ONP-DNA ratio, the covalent connection, and the 
functionality of DNA. Alexa594-containing DNA (A594-M18T20b-SH, with a sequence of 5’-
Alexa594-/TTG CTG AGT ATA ATT GTT TTT TTT TTT TTT TTT TTT TT/-SH-3’) were used 
for conjugation in these studies. First, elution curves of ONP-DNA conjugate and a simple 
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Figure 5.2. Different sized ONPs under bright field TEM. This study was performed by Hang 
Xing with the help of Li Huey Tan.  
 
mixture of ONP and DNA were compared (Figure 5.3). Under the same eluting condition, 
fluorescein-loaded ONP in the mixture had a shorter elution time, giving a peak in the green 
fluorescence channel but no peak in the red fluorescence channel. The M18T20b DNA had a 
longer elution time, giving a peak only in the red fluorescence channel but not the green channel. 
In contrast, the ONP-DNA conjugate only showed a single peak in both green and red channel, 
confirming that the ONP and DNA were bonded. 
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Figure 5.3. Elution curves of the mixture of DNA and ONP, and the DNA-ONP conjugate. FL: 
fluorescence at 522 nm from fluorescein on ONPs. Alexa: fluorescence at 617 nm from Alexa594 
on DNA strands. Fluorescence intensities were normalized. 
 
 A co-localization experiment was also conducted to confirm the connection between 
ONP and DNA. Using a fluorescence microscope, the DNA-ONP conjugate was observed to 
emit at two fluorescence wavelengths corresponding to Alexa594 on DNA and fluorescein in 
ONP, respectively. The fluorescence images of DNA (red channel) and ONP (green channel) 
overlapped well with each other, confirming the successful functionalization of DNA to ONP 
(Figure 5.4). 
The titration experiment also served as good evidences that the ONP-DNA conjugates 
had a pre-defined valence number and the DNAs were functional after being conjugated to ONPs. 
Briefly, a monovalent azido-ONP was reacted with Alexa594-M18T20b-ADIBO and purified as 
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Figure 5.4. Colocalization study of DNA-ONP conjugate using fluorescence microscopy. (a) 
Cy3 channel image of DNA-ONP conjugate, showing the fluorescence emission of Alexa 
Fluor® 594 dye on DNA strands. (b) FITC channel image of DNA-ONP conjugate, showing the 
fluorescence emission of fluorescein in ONPs. This study was performed by Hang Xing. 
 
above to give a conjugate that contains two fluorescent dyes. Free ONP that was used in the 
conjugate synthesis was dissolved in 1× PBS to give stock solutions of multiple known 
concentrations. The concentration was based on the MALLS detected absolute molecular weight 
of the parent linear polymer. By using a fluorospectrometer, a calibration curve of the ONP 
could be generated, and the concentration of the ONP-DNA conjugate could be then measured, 
assuming that the DNA attachment only has a minimal effect on the fluorescence intensity of the 
ONP. For the titration study, a complimentary quencher M18a-BHQ2 (5’-/AAC AAT TAT ACT 
CAG CAA/-BHQ2-3’) of known concentration was gradually added to the ONP-DNA solution, 
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Figure 5.5. Titration curves of (a) ONPSmall-mono-DNA, (b) ONPMedium-mono-DNA and (c) 
ONPLarge-mono-DNA. The results indicate that the ONPs were mono-DNA-functionalized. The 
study of ONPMedium-mono-DNA, e.g. Curve (b), was performed by Jing Tao. 
 
annealed at 70 
o
C for 5 min and cooled to room temperature, to hybridize with Alexa594-
M18T20b. The hybridization brought the BHQ2 moieties in close proximity to the Alexa dye, 
quenching the fluorescence. The amount of quenching was recorded and plotted against the 
molar ratio of [Quencher DNA]/[ONP-DNA conjugate]. The slope-changing point of the curve 
would indicate the ratio of Alexa594-M18T20b to ONP. The titration curves for three different 
sized ONP-DNA conjugates are shown in Figure 5.5, and the results clearly showed the 1:1 ratio 
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of DNA/ONP. The titration experiments of divalent and multivalent ONP-DNA conjugates are 
currently underway. 
 
5.4. ONP-DNA conjugate as a ratiometric adenosine sensor 
As demonstrated in Section 5.3, DNA-ONP conjugate features a monovalent DNA 
modification. To further demonstrate the DNA functionality and the broad application potential 
of the DNA-ONP system, the use of monovalent DNA-functionalized ONP as a ratiometric 
sensor for adenosine detection is described in this section. The design of the DNA-ONP 
adenosine ratiometric sensor is illustrated in Figure 5.6. The working mechanism for the sensor 
is that the ONP with carboxyfluorescein modification (496 nm excitation / 522 nm emission) 
serves as the internal standard, whereas a reported DNA-based adenosine sensor
32-33
 consisting 
of an aptamer strand (5’-/ACT CAT CTG TGA AGA GAA CCT GGG GGA GTA TTG CGG 
AGG AAG GT/-3’), a fluorescence reporter strand (5’-Alexa594-/ TCA CAG ATG AGT AAA 
AAA AAA A/-SH-3’), and the quencher strand (5’-/CCC AGG TTC TCT/-BHQ2-3’) was 
conjugated to the azide tail of the ONP using the ADIBO-N3 click reaction and hybridization. To 
prepare the ratiometric probe, ONP was first modified with the thiolated-Alexa594 fluorescence 
reporter strand. The DNA-ONP probe was purified by removal of unreacted ONP using DEAE 
ion exchange column followed by removal of free DNA strands using Amicon-30K and further 
concentrated to 200 nM. Finally, the DNA-ONP conjugate was annealed with excess amounts of 
the aptamer strand.  
 To study the DNA functionalization of ONP as well as to confirm the formation of 
adenosine sensor, a quenching strand with BHQ2 on the 3′-end was introduced to hybridize with 
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Figure 5.6. Mechanism of the DNA-ONP adenosine sensor. Similar to the reported DNA 
sensor,
32
 in the absence of adenosine the aptamer hybridizes both with ONP-DNA conjugate and 
the quencher DNA, bringing the Alexa594 and BHQ2 quencher in close proximity, leading to 
fluorescence quenching. The addition of adenosine disrupts the hybridization and turn on the 
fluorescence by removing BHQ2.  Fluorescence of ONPs were not affected by the quencher and 
served as internal standard. The sequence that binds adenosine is underlined in blue.  
 
the adenosine aptamers on ONPs. The performance of the ONP-DNA ratiometric probe was first 
evaluated in 20 mM HEPES buffer (200 mM NaCl, and pH 7.4). As shown in Figure 5.7, the 
fluorescence peak centered 520 nm on the left was assigned to the emission of the fluorescent 
ONP internal standard, whereas the peak centered at 617 nm was from the emission of the 
Alexa594. Because BHQ2 is an efficient quencher for Alexa594, by increasing the concentration of 
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the BHQ2 quencher from 0 nM to 521 nM in the ONP-DNA solution, the fluorescence intensity 
of Alexa594 decreased, whereas the fluorescence spectrum of the ONP remained almost 
unchanged after adding the BHQ2 quencher strand. This confirmed the minimal interference of 
the ONP internal standard and the adenosine sensor strand, validating the design of the 
ratiometric sensor. The normalized fluorescence ratio of emission at 620 nm (Alexa594) and the 
emission at 520 nm (ONP internal standard) was plotted against the concentration of DNA 
quencher strand. The fluorescence ratio decreased with the concentration increase of BHQ2 
strand, reaching a plateau after 200 nM, which was consistent with the concentration of DNA-
ONP in the system. This finding further confirms the 1:1 ratio between ONP and DNA (Figure 
5.8a).  
 
 
Figure 5.7. The observed fluorescence quenching upon addition of the quencher DNA. ONP 
fluorescence was not affected by the quencher and was able to serve as an internal standard. This 
quenching study was conducted by Jing Tao. 
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Figure 5.8. (a) The decrease of fluoerescence of Alexa594 upon quencher DNA addition; (b) the 
increase of Alexa594 fluorescence upon Adenosine addition. The quenching and detection studies 
were conducted by Jing Tao. 
 
To study the ratiometric adenosine detection using DNA-ONP probe, the fluorescence 
spectra measurement were performed before and after the addition of adenosine with 
variousconcentrations ranging from 167 µM to 5 mM. ONP-DNA and DNA strands were 
annealed in a 70 
o
C water bath for 20 min, followed by adding adenosine to further react for 30 
min before the measurement. As shown in Figure 5.8b, higher concentrations of adenosine 
resulted in increased fluorescence emission of the Alexa594 fluorophore, because adenosine 
molecules disrupted the 3-strand complex and removes BHQ2 from the proximity of Alexa dye. 
In contrast, the fluorescence emission of ONP at 520 nm kept constant, which suggested the 
success of this turn-on ratiometric design. To quantify the adenosine-dependent response, the 
normalized fluorescence ratio of DNA and ONP was used to plot against the adenosine 
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concentration to give the response curve (Figure 5.8b). The fluorescence ratio increased at low 
concentration of adenosine from 0 to 2 mM, and gradually reached a plateau around 3 mM at a 
normalized fluorescent ratio of ~ 0.4. The results clearly showed that the DNA modification of 
ONP was fully functional and followed the stoichiometric requirement as we designed. The 
DNA-ONP probe we developed responses to adenosine ratiometrically without the need of an 
external fluorescence standard, indicating the potential of DNA-ONP as a quantitative sensing 
platform for future biomedical applications. 
 
5.5. Valence effect on the targeting efficiency of ONP-aptamer conjugates 
 The controllable number of DNA strands per particle offers a simple platform to 
investigate the effect of individual DNA strand on cell uptake behavior of the NP to which it is 
attached. For example, aptamers of specific sequences can be used as targeting moieties for 
selective NP cellular uptake, yet the efficacy of each single aptamer on the NP is unknown. In 
this sub-project, six different ONP-aptamer conjugates were synthesized and used to evaluate the 
targeting efficiency of the aptamers. 
 Two different aptamer strands were used in this study. The AS1411 Aptamer
34-35
 with a 
sequence of 5’-/GGT GGT GGT GGT TGT GGT GGT GGT GGT TTT TTT TTT TT/-3’ was 
reported to be effective in helping NPs get into specific cells, and an aptamer with a random 
sequence of 5’-/GTA TAC CAT TCT CAT TAT ATC TCC AAT TTT TTT TTT TT/-3’ was 
used as a control. Each aptamer was conjugated to monovalent azido-ONPs, divalent azido-
ONPs and multivalent azido-ONPs using the same synthetic and purification procedures 
described in Section 5.3 and experimental section. These conjugates (1.5 µM) were incubated 
with MBA-MD-231 cells for 2 h, then the cells were analyzed by flow cytometry to evaluate the 
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uptake efficiency. The results can be found in Figure 5.9, which was quite evident. For ONPs 
with only one or two targeting aptamers conjugated, only a slight uptake improvement was 
observed compared to the control study, with di-aptamer ONP showing slightly better 
improvement on uptake profile than mono-aptamer ONP. However, multiple aptamers on the 
same particle afforded significant improvement in uptake efficacy. The study was a good support 
for two hypotheses: 1) the number of aptamers on the ONP (e.g., the valence of ONP) is 
important for targeted NP cell uptake; 2) an individual aptamer strand might provide only very 
limited targeting efficiency, and effective usage of such aptamers requires many such targeting 
moieties to be attached on each NP. In addition, this study served as another evidence for the 
successful valence control of the ONP-DNA conjugate. 
 
 
Figure 5.9. The effect of covalently-bonded targeting aptamers on ONP cellular uptake. The 
aptamers showed a cumulative targeting efficiency. The flow cytometry study was performed by 
Peiwen Wu. 
 
 
132 
 
5.6. Experimental section 
Instrumentation. The general instrument setup was described in Section 2.8. 
Materials. All reagents were purchased from Acros Organics, Fisher Scientific, AK 
Scientific, TCI America, or Sigma-Aldrich, and used without further purification unless 
otherwise noted. Dichloromethane (DCM), pyridine, THF, benzene, toluene, nitrobenzene, 
DMSO and DMF were stored over activated 4Å molecular sieves. For synthesis performed in the 
Argon-filled glovebox, all the solvents were taken from a MBraun solvent purification system. 
Water was purified by a Milli-Q water purification system. Other solvents were used as received. 
Triethylamine (TEA) and diisopropylethylamine (DIPEA) was dried over KOH pallets. 
Diisopropylethylamine was dried over 4Å molecular sieves. Preparation of monomers, CTA and 
catalyst has been described in Chapter 3. 6-azidohexylamine was synthesized according to a 
literature procedure.
36
 Functional DNAs are purchased from Integrated DNA Technologies. 
ADIBO-maleimide was purchased from Alfa Aesar.  
 Synthesis of monovalent, mid-size ONP for DNA conjugation. In a 20 mL vial was 
charged with the activated ester monomer M1 (31.8 mg, 45 eq), acetonide monomer M2 (55.5 
mg, 90 eq) and carboxyfluorescein diacetate monomer M3 (4.5 mg, 3 eq).  4 mL of dry DCM 
was added and the mixture formed a homogeneous solution. Pyridine-modified 2
nd
 generation 
Grubbs catalyst (0.025 M in DCM, 88.9 µL, 1 eq) was added with vigorous stirring, and the 
green solution gradually turned yellow during 8 min of fast stirring. M2 (6.2 mg, 10 eq) was 
added to construct the second block (spacer block), and the stirring was continued for another 2 
min. Azido-CTA (0.125 M, 88.9 µL, 5 eq) was added, and the mixture was stirred for 3 h to 
allow complete chain-end functionalization. Butyl vinyl ether (1 mL) was added to quench the 
catalyst. Solvent was removed under reduced pressure. The solid residue was re-dissolved in 
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DCM (1.5 mL) and precipitated in ether (12 mL) in a 15 mL polypropylene centrifuge tube. The 
mixture was sonicated, centrifuged, and the supernatant was discarded. The solid was further 
triturated, sonicated, and centrifuged in ether (12 mL) for another 2 times. The solid was 
thoroughly dried under reduced pressure to give the product polymer as an off-white solid. Yield: 
78 mg. 
Synthesis of the parent linear polymer of monovalent, small-size ONP for DNA 
conjugation. In a 20 mL vial was charged with the activated ester monomer M1 (31.8 mg, 15 
eq), acetonide monomer M2 (55.5 mg, 30 eq) and carboxyfluorescein diacetate monomer M3 
(13.5 mg, 3 eq).  4 mL of dry DCM was added and the mixture formed a homogeneous solution. 
Pyridine-modified 2
nd
 generation Grubbs catalyst (0.025 M in DCM, 267 µL, 1 eq) was added 
with vigorous stirring, and the green solution gradually turned yellow during 5 min of fast 
stirring. M2 (9.3 mg, 5 eq) was added to construct the second block (spacer block), and the 
stirring was continued for another 1 min. Azido-CTA (0.125 M, 267 µL, 5 eq) was added, and 
the mixture was stirred for 3 h to allow complete chain-end functionalization. Butyl vinyl ether 
(1 mL) was added to quench the catalyst. Solvent was removed under reduced pressure. The 
solid residue was re-dissolved in DCM (1.5 mL) and precipitated in ether (12 mL) in a 15 mL 
polypropylene centrifuge tube. The mixture was sonicated, centrifuged, and the supernatant was 
discarded. The solid was further triturated, sonicated, and centrifuged in ether (12 mL) for 
another 2 times. The solid was thoroughly dried under reduced pressure to give an off-white 
solid. Yield: 71 mg. 
Synthesis of the parent linear polymer of monovalent, large-size ONP for DNA 
conjugation. In a 20 mL vial was charged with the activated ester monomer M1 (31.8 mg, 90 
eq), acetonide monomer M2 (55.5 mg, 180 eq) and carboxyfluorescein diacetate monomer M3 
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(2.3 mg, 3 eq).  4 mL of dry DCM was added and the mixture formed a homogeneous solution. 
Pyridine-modified 2
nd
 generation Grubbs catalyst (0.025 M in DCM, 44.5 µL, 1 eq.) was added 
with vigorous stirring, and the green solution gradually turned yellow during 12 min of fast 
stirring. M2 (6.2 mg, 20 eq.) was added to construct the second block (spacer block), and the 
stirring was continued for another 3 min. Azido-CTA (0.125 M, 44.5 µL, 5 eq.) was added, and 
the mixture was stirred for 3 h to allow complete chain-end functionalization. Butyl vinyl ether 
(1 mL) was added to quench the catalyst. Solvent was removed under reduced pressure. The 
solid residue was re-dissolved in DCM (1.5 mL) and precipitated in ether (12 mL) in a 15 mL 
polypropylene centrifuge tube. The mixture was sonicated, centrifuged, and the supernatant was 
discarded. The solid was further triturated, sonicated, and centrifuged in ether for another 2 times. 
The solid was thoroughly dried under reduced pressure to give an off-white solid. Yield: 83 mg. 
Synthesis of the parent linear polymer of divalent, mid-size ONP for DNA 
conjugation. In a glove box under argon atmosphere, a 20 mL vial was charged with Pyridine-
modified 2
nd
 generation Grubbs catalyst (0.025 M in DCM, 88.9 µL, 1 eq), Azido-CTA (0.125 M 
in DCM, 53.3 µL, 3 eq) and 2 mL of DCM. The mixture was slowly stirred for 30 min, during 
which time the color of the solution turned brown from green. M2 (6.2 mg, 10 eq) in 0.5 mL of 
DCM was added and the reaction was stirred for 30 sec to form the first block. A solution of M1 
(31.8 mg, 45 eq), M2 (55.5 mg, 90 eq) and M3 (4.5 mg, 3 eq) in 2 mL of DCM was quickly 
added with vigorous stiring. The reaction was stirred for 4 min, and another portion of M2 (6.2 
mg, 10 eq) in 0.5 mL of DCM was added. The solution was stirred for another 1 min and Azido-
CTA solution (0.125 M in DCM, 53.3 µL, 3 eq) was added. The vial was moved out of the glove 
box, stirred for 3 h at room temperature, and quenched with 1 mL of butyl vinyl ether. Solvent 
was removed under reduced pressure. The solid residue was re-dissolved in DCM (1.5 mL) and 
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precipitated in ether (12 mL) in a 15 mL polypropylene centrifuge tube. The mixture was 
sonicated, centrifuged, and the supernatant was discarded. The solid was further triturated, 
sonicated, and centrifuged in ether for another 2 times. The solid was thoroughly dried under 
reduced pressure to give an off-white solid. Yield: 75 mg. Note: reaction time control for each 
block is very important for this synthesis, because of the reactivity of extra CTA species towards 
the polymer propagation sites.
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The allylation, crosslinking, dihydroxylation and deprotection of all monovalent and 
divalent linear polymers can be performed using the general procedures described in Chapter 3. 
Synthesis of the parent linear polymer multivalent (10), mid-size ONP for DNA 
conjugation. In a 20 mL vial was charged with the activated ester monomer M1 (31.8 mg, 60 
eq), acetonide monomer M2 (41.6 mg, 90 eq) and carboxyfluorescein diacetate monomer M3 
(3.4 mg, 3 eq).  4 mL of dry DCM was added and the mixture formed a homogeneous solution. 
Pyridine-modified 2
nd
 generation Grubbs catalyst (0.025 M in DCM, 66.7 µL, 1 eq) was added 
with vigorous stirring, and the green solution gradually turned yellow during 7 min of stirring. 
Butyl vinyl ether (1 mL) was added to quench the catalyst for 10 min, and solvent was removed 
under reduced pressure. The solid residue was re-dissolved in DCM (1.5 mL) and precipitated in 
ether (12 mL) in a 15 mL polypropylene centrifuge tube. The mixture was sonicated, centrifuged, 
and the supernatant was discarded. The solid was further triturated, sonicated, and centrifuged in 
ether for another 2 times. The solid was dried under reduced pressure to give the product 
polymer as an off-white solid. Yield: 70 mg. 
The product polymer from the above procedure (70 mg) was dissolved in 4 mL of DCM 
in a 20 mL vial. 6-azidohexylamine (2.0 mg, 10 eq of polymer), nitrobenzene (50 µL) and butyl 
vinyl ether (50 µL) was added. The vial was capped and sealed by parafilm, and was heated to 
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40 
o
C for 6 h with stirring. Triallyl-Tris (100 µL, > 5 eq of NHS ester, > 250 eq of the polymer) 
was then added to the reaction mixture, and the vial was capped/sealed again and stirred at 40 
o
C 
overnight. Most of the solvent was removed under reduced pressure, and the viscous residue was 
re-dissolved in DCM (1.5 mL) and precipitated in a 2:1 (v/v) mixture of cold ether-hexanes (-15 
o
C) in a 15 mL polypropylene centrifuge tube. The mixture was sonicated, centrifuged, and the 
supernatant was discarded. The solid was further triturated, sonicated, and centrifuged in ether 
for another 2 times. The solid was dried under reduced pressure to give the allylated polymer as 
an off-white solid. Yield: 58 mg. 
The crosslinking, dihydroxylation and deprotection of the above multivalent linear 
polymer can be performed using the general procedures described in Chapter 3. 
ADIBO functionalization of DNAs. All the DNAs used for conjugation have a protected 
thiol group on their 3’-end (e.g., a structure of 5’-DNA-3’-S-S-CH2CH2CH2OH). To 
functionalize the DNA, the thiol group must be firstly deprotected using TCEP·HCl. Briefly, the 
DNA (1 mM, 5 µL, 5 nmol) was dissolved in 100 µL of acetate buffer (10 mM, pH = 5.2) in a 1 
mL plastic tube. TCEP·HCl (freshly prepared solution, 100 mM, 10 µL, 1 µmol) was added. The 
reaction tube was incubated at room temperature for 2 h. The solution was loaded on a 0.5 mL 
Amicon tube (3 kDa MWCO), centrifuged for 10 min (13300 RPM), and the filtrate at the 
bottom was discarded. The concentrated DNA solution was further washed by pure water (0.4 
mL) for 4 times to fully remove excess TCEP, leaving the pure DNA with activated thiol group 
on the filtering unit. 
The thiol-DNA (5 nmol) was diluted to 100 µL with 10 mM phosphate buffer (pH = 7.4) 
in a 2 mL plastic centrifuge tube. ADIBO-maleimide (10 mM in dioxane, 20 µL, 200 nmol) was 
added. This homogeneous solution mixed thorough using a vertex and was incubated at room 
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temperature overnight. The solution was diluted to 0.8 mL with water. DCM (0.5 mL) was added, 
and the tube was sealed and vigorously vortexed. The tube was centrifuged (10000 RPM) for 1 
min, and the lower layer (DCM) was removed using an autopipette. This extraction procedure 
was repeated 3 more times, and the aqueous solution was bubbled with N2 to remove residual 
DCM. Finally, the solution was loaded on a 0.5 mL Amicon tube (3 kDa MWCO) and washed 
by water for 5 times to give the pure DNA-ADIBO. MALDI test should show a peak with a 
+337 Da shift compared to the original DNA-S-S-CH2CH2CH2OH. 
Conjugation of azido-ONP and DNA-ADIBO. Azido-ONP and DNA-ADIBO were 
mixed in 100 µL of pH 7.4 phosphate buffer (10 mM) in a 1 mL plastic tube. The ratio of ONP 
and DNA were varied based on the number of valences on the ONP. For monovalent ONP, 
ONP/DNA = 10:1 to ensure complete reaction of DNA, which was the more expensive reagent. 
For divalent ONP, ONP/DNA = 1/2.5 to 1/3. For multivalent ONP, ONP/DNA = 1/N, N is the 
number of valences of the multivalent ONP. The tube was incubated at 37 
o
C for 5 d. The 
resulting solution was loaded on a column packed with DEAE Sepharose CL-6B gel (GE 
Healthcare, column was 10 cm long with 1 cm diameter). The mixture was first eluted with an 
acidic buffer (20 mM citrate buffer, 300 mM NaCl, pH = 3) until all the unreacted ONP was 
removed (monitored by fluorescence). The mixture was then eluted with 2 M NaCl and the 
product band (containing ONP-DNA and unreacted DNA) was collected (monitored by 
fluorescence or DNA’s UV-vis absorption). The collected fractions were combined and loaded 
on a 0.5 mL Amicon tube (30 kDa MWCO, pre-treated, see notes), centrifuged (10000 RPM, 10 
min) to remove the unreacted DNA. The filtrate was discarded and water (0.4 mL) was added to 
the Amicon tube again, centrifuged, to wash away the DNA. The washing was repeated for 
totally 5 times. The pure ONP-DNA conjugate is then collected from the filtering unit.  
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Note: a major yield loss of this reaction happened at the Amicon washing step, as the ONP tend 
to be absorbed and fixed on the Amicon membrane via non-specific binding. To alleviate this 
problem, before using the Amicon filter unit, it was submerged in bovine serum albumin (BSA) 
solution (6 mg/mL) for 1.5 h. The filtering unit full of BSA solution was then taken on a 
centrifuge (13300 RPM, 10 min), and washed thoroughly with water. In this way, some BSA 
proteins will be fixed on the filter membrane and reduce the chance of an ONP-DNA conjugate 
getting fixed. The method was shown to be effective without causing BSA contamination. 
 
5.7. Conclusion 
 In conclusion, a bottom-up strategy to synthesize ONP-DNA conjugates with controlled 
valence was designed and realized. The synthesized material was well characterized by column 
chromatography, fluorescence microscopy and fluorescence titrations, and was confirmed to be a 
covalently linked ONP-DNA conjugate with pre-defined loading ratio (valence). Two possible 
application of this new material was highlighted in this section, indicating the potential of DNA-
ONP as an excellent platform for future biological research and applications. 
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PART 2 
POLYMERIC (CUG)n BINDING LIGANDS WITH CELL-PENETRATING 
CAPABILITY AS POTENTIAL THERAPEUTIC AGENT FOR 
MYOTONIC DYSTROPHY TYPE I TREATMENT  
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CHAPTER 6 
INTRODUCTION 
 
Part of this chapter is adapted from the following publication: 
1. Hua Lu, Yugang Bai, Jing Wang, Nathan P. Gabrielson, Fei Wang, Yao Lin, and Jianjun 
Cheng, Ring-opening polymerization of γ-(4-vinylbenzyl)-L-glutamate N-Carboxyanhydride for 
the synthesis of functional polypeptides. Macromolecules 2011, 44, 6237–6240. 
 
6.1. Ring-opening polymerization of amino acid N-carboxyanhydrides 
Synthetic polypeptides are a class of biopolymers that have shown significant potential in 
various biological and biomedical applications, such as drug/gene delivery and tissue 
engineering.
1-4
 Because of their similarities to naturally-occurred polypeptides and proteins, such 
materials can be stable at ambient conditions but enzymatically degradable. Synthetic 
polypeptides can reach high molecular weights (MWs) in large scale by adopting ring-opening 
polymerization (ROP) of α-amino acid N-carboxyanhydrides (NCAs), and living polymerization 
techniques for NCA-ROPs are readily available.
5-11
 Theoretically, all 20 natural amino acids can 
be used for the preparation of NCAs, which can be subsequently used for the synthesis of 
polypeptides bearing protein-like side chains,
12-15
 as well as complicated copolymers with 
different monomers.
16-18
 However, because of the difficulties in synthesizing, purifying and 
handling most of such NCAs,
19
 as well as the insolubility of a large number of the resulting 
polypeptides,
20-21
 only a limited number of NCAs have been used extensively for the synthesis of 
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polypeptides. These NCAs are with moieties for post-functionalization, such as alkyne,
22
 
protected amine, halide
23
 and allyl groups,
24
 and are usually crystalline, which facilitates 
purification. They are typically synthesized from natural amino acids with reactive side-chains, 
such as glutamic acid, aspartic acid and lysine. Because of the high chemical stability of amide 
bonds on the polypeptide backbone, polymers from the ROP of these monomers can endure 
many harsh functionalization and deprotection conditions, such as strong acid, ozonolysis and 
radical addition,
24
 in post-functionalization stages. The combination of a rich monomer library 
and abundant functionalization pathways can result in well-defined materials with pre-designed 
complicated structures. 
 
6.2. Ligand development for myotonic dystrophy type I treatment 
Myotonic dystrophy type I (DM1) is a genetic disease that affects on average 1 in 8,000 
people worldwide.
25
 Like most diseases that result from genetic disorders, DM1 is currently 
incurable. Significant efforts have been directed toward understanding the cause and mechanism 
of DM1, yet many details about this disease are still unknown. Nevertheless, in 1992, it was 
discovered that DM1 is caused by the trinucleotide CTG expansion located in the 3’-untranslated 
region of the dystrophia myotonica protein kinase (DMPK) gene.
26-27
 This expansion normally 
has a length of < 37, yet much longer expansion up to 2,000 or higher are found in those with the 
disease, and patients with longer abnormal expansions typically suffer from more severe 
symptoms.
27
 A generally accepted mechanism for the disease is a toxic RNA gain-of-function 
model for the non-coding RNA transcripts of the CTG expansion (Figure 6.1). The resulting 
abnormal RNA sequences, r(CUG)n, can bind to and sequester an alternative splicing protein 
named muscleblind-like 1 (MBNL1).
28
 These MBNL1-RNA complexes were observed as  
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Figure 6.1. Proposed mechanism for DM1 treatment using (CUG)n RNA as a drug target, based 
on the hypothetic toxic RNA gain-of-function model. The structure and proposed binding mode 
of the acridine-malemine ligand was also illustrated. 
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nuclear foci in the DM1 cell models. As a consequence, the loss of function of MBNL1 proteins 
leads to mis-regulated gene splicing, with more than 100 pre-mRNAs affected. The combined 
splicing errors result in the symptoms of the DM1 diseases, such as myotonia, muscle weakness, 
atrophy, cataracts, and cardiac defects. 
Considering the proposed mechanism, the toxic RNAs can be the most natural and 
obvious targets for potential treatment (Figure 6.1). Our group reported a rationally designed 
small molecule ligand that recognizes the U-U mismatches in (CUG)n repeats in 2009 (Figure 
6.1 and 6.2).
29
 This small molecule has excellent selectivity, and can disrupt the MBNL1-RNA 
complex in molecular binding studies. However, this compound is very poorly soluble in water, 
and showed no efficacy in in vitro studies because of their inability to enter the cells. Later 
improvements of this compound, including the introduction of an oligoethyleneimine tail
30
 and 
dimerization,
31
 led to water solubility, better Ki and good performance in DM1 model cells. 
Following a similar recognition unit design, our group reported another rationally designed small 
molecule groove binder that has inherent water solubility, low toxicity, cell and nucleus 
permeability in 2014 (Figure 6.2).
32
 Suppression of (CUG)n RNA-induced toxicity in a DM1 
Drosophila model was also observed after treatment with this ligand. 
Many other compounds with in vitro or in vivo efficacy have been reported, such as 
pentamidine,
33
 neomycin B, and oligopeptides of specific sequences
34
 (Figure 6.1). The Disney 
group reported peptoid-based oligomeric ligands for inhibiting MBNL1-RNA interactions, by 
taking advantage of the repetitive nature of the toxic RNA and the multidentate binding between 
RNA and the oligomeric binder.
35-36
 This result is explicitly important, as it confirms the 
possibility to generate a large, stronger RNA binder by combining multiple small ligands. The 
small molecule binders we developed in the lab already have excellent performance.  
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Figure 6.2. A selection of known compounds that bind toxic (CUG)n repeats. Names from left to 
right: melamine-acridine ligand, melamine-bisamidinium ligand, pentamidine, neomycin B, D-
hexapeptide developed by Artero and coworkers, and Disney’s oligopeptoid. The studies on 
these compounds confirmed that inhibition by small molecular (CUG)n binders is a viable 
approach for the treatment of DM1 in cell and/or animal models. 
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Taking this fact into account, it is intriguing to see whether a polymeric approach based 
on these ligands can further improve their performance. In this chapter, several polymeric 
ligands that have been synthesized and tested in molecular and cellular studies will be described 
in detail. The polypeptide-based polymeric ligand was shown to be very effective in relieving the 
symptoms on myotonic dystrophy type I model cells. 
 
6.3. Terms and abbreviations 
NCA: N-carboxyanhydride. This family of compounds all bear unstable oxazolidine-2,5-dione 
structure and can be polymerized by nucleophiles. NCAs can be synthesized from naturally-
occurred α-amino acids and phosgene. 
MBNL1: Muscleblind-like 1 protein. Some external IDs of MBNL1 are listed as following: 
OMIM: 606516; MGI: 1928482; HomoloGene: 23186; ChEMBL: 1293317. 
DMPK: Dystrophia myotonica protein kinase (DMPK), also known as Myotonin-protein kinase 
(MT-PK) or myotonic dystrophy protein kinase (MDPK), is an enzyme that in humans is 
encoded by the DMPK gene. Some external IDs of DMPK are listed as following: OMIM: 
605377; MGI: 94906; HomoloGene: 3247; IUPHAR: 1505; ChEMBL: 5320.  
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CHAPTER 7 
POLYPEPTIDE-BASED SYSTEM  
WITH ACRIDINE-MELAMINE LIGANDS 
 
Collaboration and contribution statement: 
Syntheses of NCAs and click-able polypeptides were performed in collaboration with Ziyuan 
Song. The molecular inhibition study was performed in collaboration with Iti Kapoor and Juyeon 
Lee. Foci dispersion, splicing reversal and the RNA level reduction study were performed in 
collaboration with Lien T. Nguyen. The cellular uptake study was performed in collaboration 
with Nan Zheng.  
 
7.1. Introduction 
 Extensive efforts in the development of toxic r(CUG)n binding ligands for a potential 
DM1 treatment have yielded many molecules with good or excellent selectivity and binding 
affinity (see Chapter 1). However, despite the low micromolar or even nanomolar Ki’s of these 
RNA binders, these ligands typically can show only partial rescue of gene mis-splicing in the 
DM1 model cells at 10 to 100 µM concentrations.
1-5
 The reason for such partial rescue is 
unknown, but it could hypothetically be any one – or any combination – of the following 
problems: (1) insufficient RNA binding capacity; (2) insufficient cell and nucleus permeability; 
(3) partial or total loss of binding affinity due to aggregation, unspecific binding or any other 
unknown reasons inside the cytoplasm or nucleus; and (4) limited ligand dosage and continuous 
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production of the toxic RNA in the cells. To find a solution for these possible problems, the 
development of new ligands or improvements on current ligands must be completed. 
A polymeric approach may be able to counter all the potential problems listed above. 
First, multiple ligands conjugated on the polymer give a multivalence advantage.
2
 This 
advantage means that the polymeric conjugate may potentially bind much more tightly with the 
r(CUG)n repeat than the molecular ligand alone by utilizing the multidentate effect, countering 
the above-mentioned problem (1). Second, polymers have been used as drug and gene delivery 
vehicles for decades.
6-10
 The delivery of the DM1 ligand requires a polymer that can transport the 
ligands into the cell and/or nucleus, necessitating a membrane-penetration capability. In this case, 
the polymer has to play a role similar to its role in a polymeric gene delivery system where it 
moves its cargo into the cell to allow for interaction with DNAs. Utilizing such a polymer as a 
ligand transporter may counter the above problem (2). Third, synthetic cell-penetrating peptides 
(CPPs) can adopt a charged helical structure under physiological conditions.
11-12
 By loading the 
ligands on the side-chains of a CPP, one can expose the ligands on the exterior of the helical rod 
for binding, whereas the charged nature of the polymers can prevent the aggregation of the 
ligands and polymers. This may solve problem (3). Finally, RNAzyme mimics can be introduced 
on the polymer, potentially providing a continuous regulation on the toxic RNA level through a 
“bind-and-degrade” approach, which is potentially a solution for problem (4). 
With a consideration of the above hypotheses, a cell-penetrating polymeric vehicle that is 
available for functionalization should be adopted in this polymeric DM1 ligand approach. Many 
membrane-penetration polymers have been reported, and among them the guanidium-rich 
polypeptide system reported by the Cheng group fits in this scenario the best.
12
 These polymers 
can be synthesized from facile and controllable living polymerizations and allow multiple easy 
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post-functionalization pathways. As a result, the DM1 ligands can be conjugated onto the 
polymer with ease by using a functionalized ligand and a correspondingly functionalized NCA 
monomer. In addition, guanidium-rich materials are reported to catalyze the degradation of 
RNAs,
13-14
 which adds a huge bonus to choosing this polypeptide system. 
 
7.2. Synthesis of the polypeptides with acridine-melamine ligands 
Preparation of the polymer started with the monomer synthesis from scratch. Briefly, the 
functionalized amino acids, γ-(3-Chloropropyl)-L-glutamate, γ-(3-Chloropropyl)-D-glutamate 
and γ-(3-Chloropropyl)-DL-glutamate, were synthesized by acid-catalyzed esterification of 3-
chloro-1-propanol and the corresponding glutamic acid (L- or D-isomer).
15-16
 The L-, D- and DL-
NCAs were synthesized from the reaction of the parent amino acid and phosgene in THF, and 
were purified by recrystallization in THF/hexanes. Polymerization of the NCAs was performed 
by following a literature procedure using hexamethyldisilazane (HMDS) as the initiator
17
 to give 
poly[γ-(3-chloropropyl)-L-glutamate] (PCPLG), poly[γ-(3-chloropropyl)-D-glutamate] (PCPDG), 
and poly[γ-(3-chloropropyl)-DL-glutamate] (PCPDLG). The degree of polymerization (DP) of 
the polypeptide was controlled with monomer-to-initiator feed ratio (Figure 7.1), and the 
stereochemistry of amino acid residues on polypeptides (L-, D-, or DL-) was controlled by using 
different NCA monomers. NaN3 was then used to convert all the –Cl groups on the side chains to 
azido groups, generating poly[γ-(3-azidopropyl)-L-glutamate] (PAPLG), poly[γ-(3-azidopropyl)-
D-glutamate] (PAPDG), and poly[γ-(3-azidopropyl)-DL-glutamate] (PAPDLG), respectively. 
This azide-rich polypeptides will serve as the parent polymers for the conjugation of N-
propargylguanidine, alkyne-functionalized acridine-melamine ligand and RNAzyme-mimicking 
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Figure 7.1. GPC curve overlay of the parent polymers, poly[γ-(3-chloropropyl)-L-glutamate] 
(PCPLG), of different molecular weights. Polydispersity indices were below 1.10 for all three 
polymers. 
 
 
Figure 7.2. HPLC elution curve of the alkyne-bearing DM1 ligand (C-18 reverse-phase column, 
Eluent A: CH3CN with 0.1 % TFA, Eluent B: H2O, A/B = 20/80 to 80/20). 
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pentapeptide.
18
 A schematic illustration for the synthesis of the alkyne-bearing ligand and 
polymers is given in Scheme 7.1 and Scheme 7.2. 
 
 
Scheme 7.1. Synthetic route of the alkyne-bearing, r(CUG)n binding ligand. 
 
7.3. Helicity and cellular uptake of the polymer by confocal microscope 
 Helicity of the ligand-polypeptide conjugates is one of the key design features of this 
project because it is essential to 1) grant the conjugates cell membrane permeability and 2) keep 
all of the ligand on the exterior of the helical rod where it is available for binding. To validate 
that the ligand-loaded polypeptide can still adopt a helical structure, circular dichroism (CD) 
studies were conducted to measure the helicity of the synthesized macromolecules. The 
polypeptide samples were prepared at a concentration of 0.4 mg/mL in aqueous solutions at pH =  
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Scheme 7.2. Synthesis of the ligand-polypeptide conjugates. 
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7. The solution was then placed in a quartz cell with a path length of 0.10 cm. The mean residue 
molar ellipticity of each polypeptide was calculated on the basis of the measured apparent 
ellipticity by following the literature-reported formula: ellipticity ([θ] in deg·cm2·dmol-1) = 
(millidegrees × mean residue weight)/(path length in millimeters × concentration of polypeptide 
in mg·mL
-1
). For helical α-polypeptides, CD will show a double minimum at 208 and 222 nm on 
the spectrum, which is characteristic and used to estimate the percent of helical substructures 
present for the measured peptides. In this way, the helicity % of a given α-polypeptide in water 
can be calculated as:
19-20
 
𝐻𝑒𝑙𝑖𝑐𝑖𝑡𝑦 % =
−[θ]222 + 3000
39000
× 100% 
where [θ]222 is the molar ellipticity of the polypeptide at 222 nm wavelength, in the unit of 
deg·cm
2
·dmol
-1
.  
 The CD spectra of PLG50-1/5, PDG50-1/5 and PDLG50-1/5 are shown in Figure 7.3. A 
characteristic double minimum of PLG50-1/5 was observed at 208 and 222 nm, indicating the 
ligand-loaded polypeptide adopt a helical structure. The helicity % was estimated using the 
equation above to be approximately 50%. For PDG50-1/5, the complete opposite helicity was 
observed due to the opposite chirality of the monomer used. A double maximum at 208 and 222 
nm was observed on the CD spectrum of PDG50-1/5, which was almost the exact mirror image of 
the spectrum of PLG50-1/5. In contrast, the random D-/L-copolymer, PDLG50-1/5, showed a flat 
curve near the baseline, indicating that the polymer adopted a random-coil form in water.  
Confocal microscope images were taken for all of the polymer samples as qualitative 
proofs of the ligand-bearing polymers’ cell permeability. The results for PLG50-1/5, PDG50-1/5, 
gave and PDLG50-1/5 (see Section 7.7) are shown in Figure 7.4. Clearly, the D- and L- polymers 
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Figure 7.3. CD spectra of PLG50-1/5, PDG50-1/5 and PDLG50-1/5. The L- and D-polymers 
showed characteristic double minimum for helical polypeptides at 208 and 222 nm. On the 
contrary, the DL-polymers did not show any helicity. The CD study was performed by Ziyuan 
Song. 
 
showed considerably better cellular uptake because of the cell penetration capability granted by 
the helical structure, whereas the random-coiled DL-polymer showed little uptake by the HeLa 
cells. The helical polypeptides could be found both in cytoplasm and the nucleus regions. These 
results also re-emphasized the importance of desirable vectors for these ligands, as the ligands 
must be transported into the cells to find their targets. 
 
7.4. Molecular binding study of the polymers: Kd, Ki and IC50. 
 To study the efficacy of the conjugates in releasing MBNL1 protein through binding to 
the toxic RNA, the MBNL1 protein was first expressed according to previously reported 
literature,
3
 using BL21-CodonPlus(DE3)-RP competent cells (Stratagene). The molecular weight 
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Figure 7.4. Cellular uptake studies of PLG50-1/5, PDG50-1/5, PDLG50-1/5 and PLG50-1/5-2P by 
confocal microscopy performed by Nan Zheng. Hoechst dye was used to stain the DNA, and the 
acridine moieties on the polypeptide had inherent green fluorescence, indicating the location of 
the polymer-ligand conjugates. In these studies, helical polypeptides showed much better cell 
uptake compared to their non-helical counterpart, the DL-polymers.  
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of the protein was confirmed by MALDI mass spectrometry and the concentration was 
determined by Bradford assay. Electrophoretic mobility shift assay (EMSA) was first tried for 
the binding capacity determination; however it was not possible to generate any number because 
the highly charged polypeptides did not move on the gel (performed by Juyeon Lee). Therefore, 
a fluorescence anisotropy titration technique was used to study the capability of such polymeric 
ligands in disrupting the MBNL1-r(CUG)n complex.
21
 By plotting fluorescence anisotropy 
against concentration of the polymeric ligand added into the RNA-MBNL1 complex solution, 
IC50 and Ki values were measured. The measured Ki values were in the low nanomolar range. In 
the preliminary studies, PLG50-1/2 gave the best Ki value due to its highest ligand loading. 
 
Table 7.1. Preliminary results on the measurement of Ki and IC50 of selected polymers. 
 
PLG50-1/10 PLG50-1/5 PLG50-1/2 
IC50 93.0 nM 47.7 nM 29.7 nM 
Ki 4.8 nM 3.1 nM 1.5 nM 
 
 
7.5. Foci dispersion study of the polymers 
 A characteristic phenomenon of DM1 cells is the formation of nuclear foci, which results 
from the aggregation of r(CUG)n and MBNL1 proteins. The ribonuclear foci can be easily 
visualized by confocal microscope technique using genetically modified DM1 model cells with a 
protocol analogous to previously reported procedures.
21
 As a representative example, PLG50-1/5 
was used in the initial study while a polymer without any ligands, PLG30-0/1, was used as a 
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control. The results were shown in Figure 7.5. The red fluorescence clearly indicated the 
formation of nuclear foci in the nucleus of DM1 model cells. After the treatment by 500 nM 
PLG50-1/5 for 2 days, confocal microscope study showed obvious dispersion of the foci, giving 
red color across the whole cell. Meanwhile, dramatic decrease in the total amount of foci in the 
 
 
Figure 7.5. Reduction of nuclear foci in the DM1 model cells was observed by treating the cells 
with 500 nM polymeric ligand (PLG50-1/5). Control polymer (without ligand conjugated) 
showed no efficacy. This study was performed by Lien T. Nguyen. 
 
treated cells was observed at the same time. Treatment by the control polymer (PLG30-0/1) did 
not produce apparent change of the foci in the model cells. These results confirmed the 
bioactivity of the ligand-polymer conjugates in the DM1 model cells. Also, it is worth noting that 
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the polymer concentration used (500 nM) in this experiment was 2 orders of magnitude lower 
than the concentration used in the study of the monomeric ligand (50 – 100 µM),3, 5 showing a 
significant efficacy improvement of this rationally designed polymeric ligand system. Even with 
a consideration of the fact that one polymer contains several ligand moieties, the total 
concentration of ligand moieties in this study was still much lower than the concentration used 
for the corresponding monomeric ligand. 
  
7.6. IR splicing reversal study of the polymers 
After the polymers were confirmed to bind to the toxic RNA and release free MBNL1 
protein, further research was focused on the study of alternative splicing as a downstream 
measure of recovered MBNL1 regulatory activity with the help of my collaborator Lien Nguyen. 
Based on the hypothetical mechanism, MBNL1 is considered to be a key regulatory protein in 
alternative splicing. Many pre-mRNAs are included in this vital process, with the insulin 
receptor (IR) being one of them. The mis-splicing leads to abnormal isoform ratios of the 
affected genes. As a solution for reverting these abnormal ratios, a bioactive ligand is designed to 
free the MBNL1 proteins and correct the errors in splicing. 
To study whether the ligand-polymer conjugate can correct the mis-splicing by releasing 
free MBNL1, HeLa cells were co-transfected with an IR mini-gene to study the regulation of 
splicing of IR by measuring the relative amounts of its two isoforms. The splicing of IR mRNA 
in normal HeLa cells leads to two isoforms, with approximately 47 % of isoform A (with exon 
11 exclusion) and 53 % of isoform B (with exon 11 inclusion) (Figure 7.6a). As a negative 
control, truncated DMPK gene containing (CUG)960 repeats were expressed in HeLa cells to 
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Figure 7.6. (a) Cartoon illustration of the splicing pattern of IR mRNA. (b) and (c) Complete 
reversal of IR mRNA mis-splicing in DM1 model cells by treatment of 1 µM polymer PLG50-
1/10. Numbers below the gel images are the results from a single experiment, and the column 
figure shows the average of three independent experiments. This study was performed by Lien T. 
Nguyen. 
 
produce the DM1 model cell, and such cells showed obvious mis-splicing of IR mRNAs, with 
72 % of isoform A and 28 % of isoform B, respectively. Following this study, the DM1 model 
cells were treated with PLG50-1/10 at 1 μM for 72 h. After the treatment, the model cell showed 
exactly the same isoform ratio as the normal cell (47 % isoform A and 53 % isoform B), which 
means that a rescue of 100% for the IR splicing defect was observed at such a low concentration 
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(Figure 7.6b and 7.6c). PLG50-1/2 and PLG50-1/5 are stronger binders compared to PLG50-1/10 
because of the higher ligand loading, and showed excellent splicing reversal efficacy at this 
concentration similarly. 
 
7.7. RNA level regulation mediated by the guanidine-rich polymers 
 The acridine-melamine ligand used in this study is a RNA-binder that inhibits the 
formation of (CUG)n-MBNL1 complexes, which in turn suppresses the symptoms of DM1. 
However, using RNA as drug targets has an inherent problem: The dosage of RNA-binding 
ligand is always limited, whereas the production of toxic r(CUG)n never stops. Once the RNA-
binders are saturated by the toxic RNA, newly generated r(CUG)n will continue to bind to 
MBNL1 and cause DM1 symptoms. Repetitive treatment by the ligand can possibly solve the 
saturation problem for at least a certain period of time; however, the accumulation of ligand and 
ligand-RNA complex may lead to additional problems. Therefore, a long-term regulation over 
(CUG)n level in the cells may be necessary for such RNA-targeting strategy to have clinical 
applications. 
 Possible solutions for RNA level regulation can be either 1) the selective degradation of 
toxic RNA molecules, or 2) the inhibition of toxic RNA biosynthesis. Considering the fact that 
an RNA-binder acts by selectively targeting and binding RNA, it may be possible to introduce 
certain functionalities so that the bound RNAs can be selectively degraded by the RNA-binder 
due to their close proximity. It has been reported that guanidium moieties may catalyze the 
degradation of RNAs.
13-14
 By having multiple guanidium functional groups at the exterior of the 
polymeric helical rod, we hope that the ligand-polypeptide conjugates can help degrade the RNA 
that binds to the polymer, decreasing the toxic RNA level in the model cells.  
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 In addition, my collaborator Lien Nguyen synthesized a pentapeptide that mimics the key 
structures of a RNAzyme, RNase A (Figure 7.7).
22
 This alkyne-bearing pentapeptide with a 
sequence of 2-propargylglycine-His-Gly-His-Lys was synthesized from solid-phase peptide 
synthesis (SPPS). The pentapeptide was then clicked onto the azido-polypeptide together with N-
propargylguanidine and the ligand, in an attempt to further decrease the (CUG)n level in the cells. 
This synthesis gave a new polymer, PLG50-1/5-2P, on which the ligand to guanidine ratio was 
1:5, and averagely 2 pentapeptides were conjugated on each polypeptide chain. The yielded 
polymer was first analyzed by CD, which confirmed that the attached pentapeptides do not 
disrupt the helical structure (Figure 7.8a). This result is important because the helicity of the 
polypeptide is essential for the cell penetration capability. Cell uptake study using confocal 
microscope also showed similar uptake profile for PLG50-1/5-2P, compared to PLG50-1/5 (Figure 
7.4). With helicity and cell uptake confirmed, both PLG50-1/5 and PLG50-1/5-2P were examined 
using the same strategy. 
 
 
Figure 7.7. Design and structure illustration of the RNA-cleaving oligopeptides. This 
pentapeptide was designed and synthesized by Lien T. Nguyen. 
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Figure 7.8. (a) Circular dichroism spectrum of the oligopeptide-bearing polypeptide-ligand 
conjugate (PLG50-1/5-2P) taken by Ziyuan Song. The spectrum clearly indicates alpha helical 
structure of the polypeptide is not distrupted by the attached oligopeptides. (b) Cellular uptake 
studies of PLG50-1/5-2P by confocal microscopy (taken from Figure 7.4). 
 
The DM1 model cells were treated with 500 nM of both polymers and the results clearly 
indicated that the level of the toxic mRNA was dramatically decreased in both cases after a 3-day 
treatment (Figure 2.9). In the case of PLG50-1/5, the RNA level was brought down by 
approximately 75 %, showing a significant efficacy of this polymer-ligand conjugate. The 
polypeptide bearing RNAzyme mimicking moieties, PLG50-1/5-2P, appreciably outperformed 
PLG50-1/5 by lowering the (CUG)n-RNA level by more than 80 % compared to the untreated 
model cells. However, despite the drastic decrease of toxic RNA level in the cell after the 
treatment, this study could not serve as an absolute proof of RNA degradation. For example, the 
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inhibition of (CUG)n-RNA biosynthesis by the polymers could also lead to similar results. 
Nonetheless, the polymers successfully decreased the toxic mRNA level in addition to the 
disassembly of (CUG)n-MBNL1 complex, which could be an important step toward the 
development of applicable DM1 drugs. 
 
 
Figure 7.9. The change of (CUG)n mRNA levels in DM1 model cells after a 3-day treatment of 
polymer-ligand conjugates. Significant decrease of the mRNA level was observed for both 
polymers, PLG50-1/5 and PLG50-1/5-2P. This study was performed by Lien T. Nguyen. 
 
7.8. Experimental section 
Instrumentation. The general instrument setup was described in Section 2.8. 
Materials. All reagents were purchased from Acros Organics, Fisher Scientific, AK 
Scientific, TCI America, or Sigma-Aldrich, and used without further purification unless 
otherwise noted. Amino acids used for NCA synthesis were purchased from Chem-Impex 
International Inc. (Wood Dale, IL, USA). For bench synthesis, dichloromethane (DCM), 
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pyridine, THF, toluene, DMSO and DMF were stored over activated 4 Å molecular sieves. For 
synthesis performed in the Argon-filled glovebox, all the solvents were taken from a MBraun 
solvent purification system. 9-Oxo-9,10-dihydroacridine-4-carboxylic acid
3-4
 and N
2
-(4-
aminobutyl)-1,3,5-triazine-2,4,6-triamine
23
 were synthesized according to procedures in 
literature.  
Synthesis of N-propargylguanidine. This synthesis was performed by Ziyuan Song. 
Propargylamine (0.36 g, 6 mmol), 1H-pyrazole-1-carboxamindine hydrochloride (0.87 g, 6 
mmol) and triethylamine (0.78 g, 6 mmol) were dissolved in DMF (3 mL), and the mixture was 
stirred at room temperature for 16 h. The solution was then added into 40 mL of diethyl ether 
and the supernatant containing DMF and other impurities was discarded. The oily product was 
thoroughly dried under high-vac to give 0.70 g of the pure product as a viscous oil. Yield: 88 %). 
Characterization results of the compound were identical to these previously reported.
12
 
Synthesis of the alkyne-functionalized DM1 ligand. 9-oxo-9,10-dihydroacridine-4-
carboxylic acid (1.20 g, 5 mmol) was dried under vacuum in a round-bottom flask. The acid was 
suspended in 10 mL of thionyl chloride and 1 drop of DMF was added. The mixture was heated 
up to reflux for 2 h to give a homogeneous solution. The solution was concentrated to dryness on 
a rotary evaporator, and additional dry chloroform (20 mL × 2) was added to the flask and 
evaporated to help remove the residual SOCl2. The resulting yellow solid was dried under high-
vac for 1 h. The solid was dissolved in DCM (20 mL), cooled in an ice bath, and added DIPEA 
(1.29 g, 10 mmol) and pent-4-yn-1-ol (0.46 g, 5.5 mmol). The mixture was stirred, warmed to 
room temperature naturally and allowed to react overnight at room temperature. Evaporation of 
the volatiles afforded the crude product. NMR showed > 99% yield of the product with the 
contamination of DIPEA hydrochloride. Due to the sensitivity of this compound toward 
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hydrolysis, the crude product was directly used in the next step without further purification, 
assuming a 100 % yield in equivalence calculation. 
Crude product from the previous step (assuming 100% yield, 5 mmol) was dissolved in 
20 mL of dry DMF. N
2
-(4-aminobutyl)-1,3,5-triazine-2,4,6-triamine (1.08 g, 5.5 mmol) and 
DIPEA (1.29 g , 10 mmol) were added, and the solution was heated to 85 
o
C for 5 h. The 
solution was cooled down to room temperature and poured into 150 mL of ether. The precipitates 
were collected by vacuum filtration, and were further purified by preparative HPLC (C-18 
reverse-phase column, Eluent A: CH3CN with 0.1 % TFA, Eluent B: H2O, A/B = 20/80 to 80/20). 
The compound could also be purified by normal-phase column chromatography (basic alumina, 
DCM/MeOH, 20:1 to 10:1). Repeating the column purification once was needed to achieve 
desirable purity. Product from alumina column purification contained approximately 10 % 
methyl ester as the impurity (by LC-MS analysis). The methyl ester was from methanolysis 
catalyzed by basic alumina. Possibly due to the alkyne-containing hydrophobic tail, this 
compound is prone to self-assembly into more complicated structures with itself or DIPEA/TEA, 
giving broad peaks on NMR using DMSO-d6 as a solvent. This problem could be solved by 
conducting the NMR characterization in TFA-d, which is very effective in disrupting hydrogen 
bonding. Yield: 45 % to 65 %, depending on the purification method. 
1
H NMR (500 MHz, TFA-d): 8.95 (d, J = 7.5 Hz, 1H), 8.71 (d, J = 8.5 Hz, 1H), 8.43 (d, J 
= 8.5 Hz, 1H), 8.12 (m, 1H), 8.01 (d, J = 8.5 Hz, 1H), 7.72 (m, 2H), 4.77 (t, J = 6.2 Hz, 2H), 
4.33 (t, J = 7.1 Hz, 2H), 3.78 (t, J = 7.2 Hz, 2H), 2.53 (dt, J1 = 2.6 Hz, J2 = 6.8 Hz, 2H), 2.16-
2.25 (m, 4H), 2.07 (t, J = 2.6 Hz, 1H), 1.99 (m, 2H). 
13
C NMR (500 MHz, TFA-d): Melamine 
moiety: 168.5, 168.4, 168.4; carbonyl: overlapped with TFA peak (between 161-163); acridine: 
159.1, 155.2, 153.4, 152.3, 139.7, 136.9, 125.6, 123.0, 119.6, 119.5, with 3 peaks overlapping 
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with TFA peaks (1 between 161-163 and 2 between 111-118); aliphatic: 82.5, 68.9, 66.0, 49.6, 
41.7, 26.8, 26.6, 25.2, 14.4. High-resolution ESI-MS: calculated for C26H29N8O2
+
 ([M+H
+
]): 
485.2413, Obtained 485.2411. HPLC elution curve of the compound is shown in Figure 7.2. 
Conjugation of ligands and N-propargylguanidine with the polypeptide using Click 
Chemistry. This series of syntheses were performed and optimized with together with Ziyuan 
Song. In an Ar-filled glovebox, PAPLG50 (16 mg, 0.075 mmol of azido groups), PMDETA (79 
μL, 0.38 mmol), N-propargylguanidine (63 wt.% in DMF, 14.6 mg, 0.095 mmol), and the 
alkyne-bering ligand (9.2 mg, 0.019 mmol) were dissolved in DMF (1 mL). The ratio of alkyne 
compounds (ligand and propargylguanidine combined)/azide was set to 1.5:1, and the ratio of 
guanidine and ligand was set to 5:1. The resulting solution was transferred into a small vial 
charged with CuBr (22 mg, 0.15 mmol) and a magnetic stir bar. The mixture was stirred at room 
temperature for 36 h, and was quenched by transferring the vial out of the glove box and 
exposing it to the air. The product was added to a dialysis bag (MWCO = 1 kDa) containing 5 
mL of 0.1 M HCl, and purified through dialysis against DI water for 2 d (DI water changed every 
8 h). For larger scale synthesis, 0.1 M HCl could be added to the dialysis bag to facilitate this 
dissolution-dialysis process, and the dialysis should be kept running until the mixture in the bag 
turned almost fully clear. The obtained greenish-yellow solution was filtered through a Millex 
pre-filter, and lyophilized to give the final polymer PLG50-1/5 (1/5 donates the average ratio of 
ligand and guanidine on the polymer) as a yellow fluffy solid (25-30 mg).  
Other ligand-bearing polymers were synthesized and named similarly, namely PLG50-1/2, 
PLG50-1/10, PLG75-1/5, PLG25-1/5, PDG50-1/5 and PDLG50-1/5, from their corresponding parent 
polymers PAPLG50, PAPLG75, PAPLG25, PAPDG50 and PAPDLG50, respectively. For all the 
synthesis, the ratio of alkyne (ligand and propargylguanidine combined) to azide was set to 1.5:1, 
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same as the above protocol, yet the ratio of guanidine and ligand was varied according to the 
desired loading. 
Cellular uptake study by confocal microscopy. For these studies, HeLa cells cultured 
on coverslips in 6-well plate were incubated for 4 h with polymers in DMEM (2 mL) at a 
concentration of 15 μg polymer/well. The cells were washed three times with 1× PBS, fixed with 
4 % paraformaldehyde, and stained with Hoechst 33258 (2 μg/mL). The stained cells were 
visualized by confocal laser scanning microscopy (CLSM, LSM700, Zeiss, Germany). 
Synthesis and purification of MBNL1 protein. MBNL1 protein was first expressed 
according to previously reported literature,
3
 using BL21-CodonPlus(DE3)-RP competent cells 
(Stratagene), induced with 1 mM IPTG at OD600 0.6 in LB media with ampicillin for 2 h at 37 °C. 
Bacterial cells were collected by centrifugation. The cells were re-suspended in a lysis buffer 
(0.5 M NaCl, 25 mM Tris hydrochloride (pH = 8), 10 mM imidazole, 5 % glycerol, 2 mM BME, 
0.1% Triton X-100, 2 mg/mL lysozyme, 0.1 mM PMSF, 1 μM pepstatin, and 1 μM leupeptin) 
and sonicated six times for 15 sec each. The cell pellet was centrifuged, and the supernatant was 
collected and filtered through a 0.45 μm Millex filter to give the crude protein. To purify 
MBNL1, Ni-NTA agarose was incubated with the lysate for 1 h at 4 °C and washed with a 
washing buffer  (0.5 M NaCl, 25 mM Tris hydrochloride (pH = 8), 20 mM imidazole, and 0.1 % 
Triton X-100). Elution of the protein was performed with the elution buffer (0.5 M NaCl, 25 mM 
Tris-Cl (pH = 8), 250 mM imidazole, and 0.1 % Triton X-100). The desired fractions containing 
GST-MBNL1 were collected, combined and dialyzed against 1× PBS buffer. The molecular 
weight of the protein was confirmed by MALDI mass spectrometry, and the concentration was 
determined by Bradford assay. 
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 Molecular binding study by fluorescence anisotropy titration technique. This study 
was performed together with Iti Kapoor. r(CUG)16 was incubated with GST-MBNL1 (GST = 
Glutathione S-transferase) of varied concentrations for 15 min, and the complex were measured 
by an Analyst HT instrument for its fluorescence anisotropy. A dissociation constant (Kd) for 
r(CUG)16-MBNL1 was obtained by curve-fitting (anisotropy against the concentration of GST-
MBNL1). The inhibitory constant of the polymeric ligands (Ki) was measured by incubating the 
polymer of different concentrations (serially diluted) with MBNL1–r(CUG)16 complex. The 
fluorescence anisotropy of the complex solutions was measured by an Analyst HT instrument. 
By plotting normalized fluorescence anisotropy against concentration of the polymeric ligand, 
IC50 and Ki values were measured.  
Protocol for nuclear foci dispersion study. Approximately 50,000 HeLa cells were 
plated in a 12-well plate in DMEM media supplemented with high glucose, L-glutamine, and no 
antibiotics a day before transfection. HeLa cells were transfected with 1 mg GFP-DT0 or GFP-
DT960 plasmids using Lipofectamine (Life Technologies) following the recommended protocol. 
After 4 h, the transfection cocktail was replaced with the growing media and cells were treated 
with 1 µg Dox. Polymeric ligands or control polymer were added to the media at the same time 
at desired concentrations for 2 d. Cell were stained following a previously reported protocol.
21
 
Briefly, CUG repeats were stained with Cy3-(CAG)10, MBNL proteins were probed with mouse 
anti-MBNL (EMD Millipore) and stained with  goat anti-mouse secondary antibody Alexa 647 
(Thermo Scientific Pierce). Nuclei were stained with Hoechst. Cell images were taken using a 
LSM700 confocal microscope (Zeiss). 
Splicing reversal study. Approximately 120,000 HeLa cells were seeded in each well of 
a 6-well plate in complete growth media the day before transfection. For the test of IR pre-
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mRNA, cells were transfected the following day at 70–80% confluence with 500 ng each of IR 
and DT960 or DT0 minigenes with Lipofectamine 2000 (Invitrogen, Life Technologies) 
according to the manufacturer’s protocol. After 4 h, the transfection media was removed and the 
polypeptide (1 µM) was added to the complete growth media. Cells were harvested after 72 h. 
To harvest the cells, cells were washed once with 1× PBS and detached using trypsin with EDTA 
solution (0.05 %, Fisher Mediatech). RNA was immediately isolated using Total RNA kit I 
(Omega Bio-Tek) from the harvested cells. 1 µg of isolated RNA was reverse transcribed with an 
iScript cDNA synthesis kit (Bio-Rad) according the manufacturer’s protocol. The synthesized 
cDNA (50 ng) was subjected to PCR amplification for 30 – 35 cycles using gene specific primers. 
The forward primer was 5’-GTA CCA GCT TGA ATG CTG CTC CT, and the reverse primer 
was 5’-CTC GAG CGT GGG CAC GCT. The PCR products were ran on an 8 % polyacrylamide 
gel with 1× TBE (National Diagnostics) at 180 V for 40 min. The gel was post-stained with 
ethidium bromide and subsequently imaged using a Gel Doc XR+ system (Bio-Rad). The bands 
were quantified using ImageJ software (NIH). 
Cellular mRNA level study with Dox treatment. Approximately 50,000 HeLa cells 
were plated in a 12-well plate in DMEM media supplemented with high glucose, L-glutamine 
and no antibiotics a day before transfection. HeLa cells were transfected with 1 mg GFP-DT0 or 
GFP-DT960 plasmids using Lipofectamine (Life Technologies) following the recommended 
protocol. After 4 h, the transfection cocktail was replaced with the growing media and cells were 
treated with 1 µg Dox. Ligand-polymer conjugate was also added at the same time at desired 
concentrations, and the cells were incubated for 3 d. Cells were checked under fluorescence 
microscopy using a GFP signal as a marker of successful transfection and then harvested. Total 
mRNA was isolated using E.Z.N.A.® total RNA kit I (Omega). Approximately 1.5 mg of total 
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mRNA was subjected to DNase treatment to remove all DNA contaminants. cDNA synthesized 
using Iscript cDNA synthesis kit (Bio-Rad) was used as template in real time PCR using 
SYBR® master mix (Applied Biosystem). The results from real time PCR experiments were 
analyzed using the DDCt method.
24
 The CUG mRNA levels in treated samples were compared 
with the mRNA level in untreated samples, which was normalized to 100 %. 
 
7.9. Conclusion 
 In conclusion, a strategy has been developed to allow the combination of a small 
molecule r(CUG)n binder and a guanidium-rich helical polypeptide previously used for gene 
delivery. The strategy can lead to polymeric ligands that are candidates for further development 
in DM1 treatment. The positive results obtained by using the polymeric ligands, including low Ki 
and IC50, full IR splicing reversal, and successful regulation over r(CUG)n level in the cell, well 
support the rationally designed mechanism of action. The structure and composition of these 
polymers may be further optimized to give better results, and the regulation over toxic RNA 
levels may be a new goal to pursue in DM1 ligand development due to the success of this project. 
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